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“You can know the name of that bird in all the languages of the world, but when 
you’re finished, you’ll know absolutely nothing whatever about the bird. You’ll 
only know about humans in different places, and what they call the bird. So let’s 
look at the bird and see what it’s doing—that’s what counts.” 
 
Richard P. Feynman 
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Abstract 
Enzyme immobilisation is the conversion of a soluble enzyme molecule into a solid 
particle form. This allows the recovery of the enzyme catalyst for its re-use and 
avoids protein contamination of the product streams. A better understanding of 
immobilised enzymes is necessary for their rational development. A more rational 
design can help enormously in the applicability of these systems in different areas, 
from biosensors to chemical industry. Immobilised enzymes are challenging systems 
to study and very little information is given by conventional biochemical analysis 
such as catalytic activity and amount of protein. Here, solid-state NMR has been 
applied as the main technique to study these systems and evaluate them more 
precisely. Various approaches are presented for a better understanding of 
immobilised enzymes, which is the aim of this thesis. Firstly, the requirements of a 
model system of study will be discussed. The selected systems will be 
comprehensibly characterised by a variety of techniques but mainly by solid-state 
NMR. The chosen system will essentially be the enzyme α-chymotrypsin covalently 
immobilised on two functionalised inorganic supports – epoxide silica and epoxide 
alumina – and an organic support – Eupergit®. The study of interactions of 
immobilised enzymes with other species is vital for understanding the 
macromolecular function and for predicting and engineering protein behaviour. The 
study of water, ions and inhibitors interacting with various immobilised enzyme 
systems is covered here. The interactions of water and sodium ions were studied by 
17O and 23Na multiple-quantum techniques, respectively. Various pore sizes of the 
supports were studied for the immobilised enzyme in the presence of labelled water 
and sodium cations. Finally, interactions between two fluorinated inhibitors and the 
active site of the enzyme will be explored using 19F NMR, offering a unique approach 
to evaluate catalytic behaviour. These interactions will be explored by solution-state 
NMR firstly, then by solid-state NMR. NMR has the potential to give information 
about the state of the protein in the solid support, but the precise molecular 
interpretation is a difficult task. 
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Colour code for chemical structures1  
Hydrogen  
Boron  
Carbon  
Nitrogen  
Oxygen  
Fluorine  
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1 The colour convention used in this thesis is CPK, named after the CPK molecular models designed 
by chemists Robert Corey and Linus Pauling [2], and improved by Walter Koltun [3]. 
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CHAPTER 1 
 
Introduction 
Enzymes, as catalysts, possess the astonishing characteristic of allowing product 
formation in mild and environmentally friendly conditions with a high specificity. 
Because of their excellent functional properties (activity, selectivity and specificity) 
enzymes are capable of catalysing most chemical reactions promptly and in mild 
conditions [4].  
Enzymes have been modified during evolution to optimise their behaviour in living 
cells. Clearly, the enzymes have not been optimised through evolution to be used as 
catalysts in industry, therefore many of their properties are not best suited for this 
purpose. They are soluble, unstable at conditions which differ from physiological 
ones, are frequently inhibited by substrates and products, and have narrowed 
substrate specificity. 
In most cases it is possible to improve their properties for use as industrial 
biocatalysts through the engineering of enzymes involving different techniques such 
as the screening of new enzymes, molecular biology, immobilisation and 
post-immobilisation, and improvement via reaction and reactor engineering. 
For technical and economic reasons, many chemical processes catalysed by enzymes 
require continuous use or reuse of biocatalysts for a very long time [5-7]. In this 
context, the immobilisation of enzymes proves to be a strong technique to promote 
the reuse or continuous use in industrial biocatalysis and therefore improves 
cost-effectiveness, as well as providing a powerful approach to stabilisation [8].  
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Since the advent of immobilisation of single enzymes in the 1940s, innumerable 
methods have been developed. Despite extensive study on different systems there is 
no clear approach for a given process and enzyme. One reason for this is that little is 
known about the state of protein molecules in the preparation except, of course, what 
is deduced from its catalytic activity.  
Enzymes, being proteins, possess an inherent flexibility in different environmental 
conditions. The structure and flexibility of enzymes affects their functionality due to 
proteins not occupying one structure, rather they are more accurately described by 
an equilibrating set of time-dependent structures [8]. 
Figure 1.1 shows a general scheme highlighting the complexity of an immobilised 
enzyme system. However, much of the detail of the state of the enzyme molecules is 
speculative, though the use of high resolution techniques should help confirm the 
detail in the future. 
With the purpose of evaluating the dynamic aspects of the protein, structural biology 
has become a powerful tool for visualising biological processes in space and time at 
atomic resolution. This tool gathers a group of techniques including X-ray 
crystallography, electron microscopy and solution-state nuclear magnetic resonance 
(NMR). Recently, other techniques have been incorporated, all seeking to investigate 
biological material in its non-crystalline native state, such as small-angle X-ray 
scattering, electron tomography, femtosecond X-ray and solid-state magic angle 
spinning nuclear magnetic resonance (solid-state MAS NMR) [9].  
The great utility of NMR lies in its unique selectivity where different sites are clearly 
identified by distinct chemical shifts. Also it is an excellent source of information 
describing connectivity between different nuclei via scalar and dipolar coupling. 
NMR is nowadays an established tool in the field of structural biology, and provides 
insight into molecular interactions and macromolecular structure that is barely 
attainable by other techniques such as crystallography. The application of NMR to 
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materials in solid form developed at a slower rate than its counterpart for the 
solution state.  This situation arises principally because of an overload of information 
from dipolar and quadrupolar interactions that generally are negligible in solution 
state but can diminish the resolution of distinct sites in the solid state. On the other 
hand, these interactions contain valuable structural and dynamic information. The 
nature of the sample and the multiple anisotropic NMR interactions are some of the 
reasons that solid-state NMR is a relatively challenging technique to master. One of 
the crucial steps in the use of this technique is finding the right approach to refine the 
information content [10]. However, the work of several research groups in the field 
of solid-state NMR over the last 15 years has clearly proved its capabilities in the 
study of biological systems not accessible by either X-ray crystallography or 
solution-state NMR – for example, insoluble heterogeneous biological systems such 
as membrane proteins [11]. 
As mentioned previously, little is known about the protein state in the preparation, 
and owing to this lack of knowledge it is not possible to achieve the immobilisation 
of enzymes in a more rational way. Consequently the study of heterogeneous 
 
Figure 1.1. Diagram of immobilised enzyme on a porous support. (a) Single particle of 
porous support, (b) magnified interior slice of porous support particle and (c) magnified 
pore region. The diagram shows a support particle of 15 µ m of diameter (Figure 1.1a) and 
a pore size of 20 nm (Figure 1.1b). The diameter of the enzyme molecule in Figure 1.1c is 
around 5 nm. 
15 μm 500 nm
Enzyme
20 nm
(a) (b) (c)
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enzyme systems via solid-state MAS NMR becomes an appropriate approach and an 
entirely novel one with the aim of studying the protein state. 
This thesis has the general objective to achieve a better understanding of the 
behaviour of immobilised enzymes by solid-state MAS NMR. Our general aim is to 
establish if solid-state NMR can help to characterise these systems. A particular focus 
is to see if it is at all possible to use NMR techniques (both solid-state and 
solution-state methods adapted to hybrid solid-liquid samples) to obtain information 
about the interaction of the protein molecules with ions, water molecules and 
inhibitors.  
Although widely used in both solution- and solid-state NMR studies of protein 
structure, the use of isotopically-labelled enzymes (e.g., with enrichment of 13C or 
15N) is not envisaged in this work, though such enrichment would make acquisition 
of the NMR data easier. Potentially, the methods proposed here can be applied 
diagnostically to immobilised enzymes developed by others, both in industry and 
academia. These will of course not be isotopically labelled and these potential users 
will have little interest in our methods if they first have to manufacture labelled 
proteins, then repeat the immobilisation. In many industrial cases our methods 
might be considered for application to immobilised derivatives made on a large scale 
(even tons), where a repeat with labelled material would be inconceivable.  
Because of the multidisciplinary nature of this thesis some background topics have 
not been covered in detail. It is assumed that the reader is familiar with some basic 
NMR knowledge that can be found in Reference [12]. 
Chapter 2 introduces the NMR phenomenon and the theoretical framework upon 
which the experiments described in the later chapters are based. Solution- and 
solid-state NMR concepts, applied in this thesis, are treated separately in this 
chapter. A separate section of this chapter is dedicated to introduce the 
immobilisation of enzymes, describing the elements involved in the process. 
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In Chapter 3, the systems of study are introduced, discussed and defined. The 
supports and enzyme are reviewed. A detailed consideration of the enzyme selected 
for the present study – α-chymoptrypsin – is included here. This is followed by a 
review of some interesting interactions between this enzyme and ligands.  
Chapter 4 introduces the experimental protocols for the evaluation of the systems of 
study. Biochemical protocols for the quantification of functional groups involved in 
the immobilisation, immobilised protein and enzymatic activity are described. The 
procedure of immobilisation on different supports is included here. Finally, a section 
describing the experimental NMR details is presented. 
Chapter 5 presents the characterisation of the covalent immobilisation of 
α-chymotrypsin on functionalised silica and alumina particles 
(glycidoxypropyltrimethoxysilane, GOPS, grafted onto the surface) and Eupergit® 
(rigid methacrylic cross-linked polymer bearing pendant epoxide groups) by 1H, 13C 
and 29Si magic angle spinning (MAS) NMR. Also relevant results from analytical 
techniques unrelated with NMR are included in this chapter.  
In Chapter 6, multiple-quantum 23Na ( I = 3/2 ) and 17O ( I = 5/2 ) MAS NMR 
experiments are used to measure transverse relaxation for quadrupolar nuclei in 
immobilised enzymes systems. A brief description of the theoretical and 
experimental principles behind multiple-quantum experiments with the purpose of 
measuring relaxation is introduced. These studies focus in examining the behaviour 
of sodium ions (23Na) and isotopically enriched water (H217O) associated with 
immobilised enzymes. 
Chapter 7 presents an experimental 1H and 19F NMR investigation of two fluorinated 
inhibitors interacting with α-chymotrypsin. These two inhibitors are potassium 
4-fluorophenyl trifluoroborate (PFPTB) and 
(R)-1-acetamido-2-(4-fluorophenyl)ethane-1-boronic acid (AFEB). Both 
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enzyme-inhibitor complexes were firstly analysed by solution-state NMR (using free 
enzyme) and then by solid-state NMR for the immobilised enzyme. 
Finally, although Chapter 5 to Chapter 7 each has a Discussion and Conclusions 
Section where the limitations of the approaches used and future work are identified, 
Chapter 8 summarises and discusses the most important findings in the thesis and 
makes recommendations for future research directions.  
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CHAPTER 2 
 
Theoretical background 
2.1 Methods in structural biology for proteins 
Crystallisation of biological macromolecules and their subsequent structure 
determination by X-ray scattering techniques remain the foundation for much of 
structural biology. This is reflected in the Protein Data Bank, wich holds over 100000 
structures of proteins, nucleic acids and their complexes, with around 90% of these 
having been obtained by X-ray crystallography and the rest by NMR spectroscopy. 
Very few structures have been obtained by other methods, such as electron 
microscopy. 
However, there are limitations to using X-ray crystallography. These include 
difficulties in protein crystallisation owing to limited solubility and unresolved 
protein dynamics [13]. Solubility is a key bottleneck in macromolecular X-ray 
crystallography because many systems are anchored to the cell membrane or/and 
insoluble.  
Recent advancements in cryo-electron microscopy (cryo-EM), which allow structure 
determination with near-atomic resolution (higher than 3.5 Å) [14], provide an 
alternative approach for determining macromolecular structure without 
crystallisation and, although still requiring sample homogeneity, are less dependent 
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on issues of solubility [15]. Solid-state NMR methods for biological macromolecules 
provide another approach for determination of insoluble protein structures [16]. 
As the majority of X-ray crystal structures of proteins are modelled as single 
conformation in crystalline environments, the dynamical information is limited. 
Dynamics are often indirectly addressed by X-ray crystallography by theoretical 
estimates of uncertainty in atomic positions using B-factors that measure primarily 
molecular disorder in the crystal in addition to thermal motion [17, 18]. NMR is able 
to provide detailed information about the dynamics of the molecules studied. The 
use of NMR data for evaluating conformational dynamics, especially around 
substrate binding sites, is of particular interest for examining protein interactions 
[19].  
Over the last few years, the application of solid-state NMR to heterogeneous protein 
systems has made tremendous progress, showing the capability of the method for 
determining structures and studying ligand binding and insoluble protein dynamics 
over a variety of time scales at atomic resolution [16]. Electron paramagnetic 
resonance (EPR) also provides additional information about different conformation 
states on insoluble protein systems [20]. 
Immobilised enzymes are composite materials, with a biological and an inorganic (or 
organic polymer) component. They are inherently non-crystalline and so lack 
long-range order. Hence they cannot be very usefully studied by diffraction based 
methods. Solid-state NMR can be applied to these systems as the method does not 
require long-range order in the sample. However, the intention of this thesis is not 
trying to determine the three-dimesional structure of the protein immobilised. 
Protein structure determination is a long-term aim of the project.  
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2.2 Nuclear magnetic resonance (NMR) 
Matter is made of atoms. Atoms are made up of electrons and nuclei. Some 
important physical properties of the atomic nucleus are mass, electric charge, 
magnetism and spin. Nuclear magnetism and nuclear spin have almost no effect on 
the normal chemical and physical behaviour of substances. Nevertheless, these two 
properties provide scientists with a wonderful tool for “spying on” the microscopic 
and internal structures of objects without disturbing them [21].   
In a general sense nuclear magnetic resonance exploits the magnetic interaction of 
atomic nuclei nuclei with an external magnetic field. This phenomenon was first 
reported in 1946 [22, 23]. 
2.2.1 Fundamentals 
Any nucleus that has a magnetic moment can interact with a magnetic field therefore 
can be studied by NMR. Nuclei with spin angular momentum quantum number  
 I ≥ 0 can be found in  2I +1  spin states and possess a nuclear magnetic dipole 
moment, of magnitude 
  2.1 
where  is the gyromagnetic ratio of the nucleus,  is the Planck constant and  I  is 
the spin quantum number. The spin quantum number  I  of a nucleus may have one 
of following values: 
  2.2 
The degeneracy of the spin states may be lifted through the Zeeman interaction with 
an external magnetic field. The energy of a state is then given by 
  2.3 
µ ! µ = γ [I(I +1)]1/2
γ  
!
 
I = 0, 12 ,1,
3
2 ,2,...,
! EmI = −γ mIB0
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where  is the magnetic field and  is the spin orientation quantum number and 
has  2I + 1 values in integral steps between  +I and  −I : 
  2.4 
The spin magnetisation may exist in two types of states depending on the value of 
 ΔmI , which is known as the coherence order and denoted by the symbol  p . States 
with  p = 0  are populations of energy levels, while coherent superpositions between 
the energy levels, termed coherences, are characterised by  p > 0 . Depending on the 
number of energy levels between which the state of coherence occurs, coherences are 
known as single-quantum coherences ( p = ±1 ), double quantum coherences ( p = ±2 ) 
and so on. 
Observable transitions between spin states are given by the selection rule , 
resulting in resonance frequencies and energies of 
  
2.5 
where  is called the Larmor frequency (written here in units of rad s–1) and  ΔE  the 
energy gap. 
A selection of some nuclides is given in Table 2.1, where  ν0 , defined as the frequency 
of the nucleus in Hz, 
  2.6 
has been calculated for a 9.4 T field using Equation 2.5.  
When  is applied, various populations of magnetic nuclei are found in the  
states according to the Boltzmann distribution, 
 B0  mI
! mI = I ,I −1,I − 2,...,−I +1,−I
 ΔmI = ±1
!
 
ω0 =
ΔE

= −γ B0 ,
 ω0
 ν0 =ω0 /2π
 B0  2I +1
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Nupper
Nlower
= e
− ΔE
kT   2.7 
where  N  represents the population of either of two non-degenerate levels (upper 
and lower states),  k  is the Boltzmann constant and  T  is temperature. 
The fundamental principle governing the NMR technique centres on the induction of 
transitions between different energy states or Zeeman levels of a particular nucleus. 
In NMR spectroscopy, an electromagnetic field excites nuclei from a lower energy 
level to upper energy level (and vice versa). To cause these transitions, a variable 
radiofrequency field (RF), referred to as , acts perpendicular to the applied 
magnetic field ( ). When the frequency of the applied RF is close to the precessional 
 B1
 B0
Table 2.1. Properties of some important nuclides at 9.395 T. 
Nuclides  γ  / 107 T−1 s−1 ν0 / MHz Natural abundance (%) 
1H 1/2 26.75 400 99.985 
2H 1 4.11 61.4 0.015 
10B 3 2.87 42.9 19.9 
11B 3/2 8.58 12.8 80.1 
12C 0 - - 98.9 
13C 1/2 
1 
6.73 100.6 1.108 
14N 1.93 28.9 99.63 
15N 1/2 −2.71 40.5 0.37 
16O 0 - - 99.762 
17O 5/2 −3.63 54.3 0.037 
19F 1/2 25.18 376.5 100 
23Na 3/2 7.08 105.84 100 
29Si 1/2 −5.32 79.6 4.7 
31P 1/2 10.84 162.1 100 
 
	I
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frequency ( ) of the nuclei observed, transitions between nuclear spin states occurs. 
Upward and downward transitions occur with the same probability and so the net 
signal strenght is proportional to the population difference between the two levels 
involved. This means that the NMR technique generally only detects one nucleus in 
every 104-106. The use of strong magnetic fields helps to increase signal strength by 
increasing the energy gap ( ΔE ) and thus increasing the population difference 
between states at equilibrium. Similarly, nuclei with large γ and a high abudance in 
nature will yield greater signals (see Table 2.1) [12]. 
2.2.2 Internal interactions 
The Zeeman effect (see Section 2.2.1), responsible for lifting the degeneracy of the 
energy levels of the nucleus, is usually by far the largest contribution to the energy 
terms arising from the interaction of the spins in the magnetic field.  Also, as 
discussed above, the fluctuating magnetic fields arising from RF radiation give rise to 
small perturbations in the energy and so cause transitions. The remaining 
interactions, which are all intrinsic to the sample and are orientation dependent, 
contribute with important chemical information about the system. In this section, 
four of these interactions will be briefly discussed. 
2.2.2.1 Chemical shift interaction 
When a molecule is placed in a magnetic field, the nuclei are magnetically shielded 
by the presence of electrons, resulting in a shielding field. The circulation of electrons 
in their atomic or molecular orbits produces an induced magnetic field  Bin  that may 
either augment or oppose the external field. The effective field  B  at the nucleus is 
then 
  B = B0 −Bin = B0(1−σ )   2.8 
 ω0
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where σ  is the shielding constant, modifying the Larmor frequency defined in 
Equation 2.5 to 
  ω = γ B0 (1−σ )   2.9 
Shielding leads to the well known phenomenon of chemical shift. The shielding 
constant, σ , is an inconvenient measure of the chemical shift. Therefore, it is a 
common practice to define the chemical shift in terms of the difference in resonance 
frequencies between the nucleus of interest ν  and a reference nucleus  ν ref  to give 
 
 
δ = 106 (ν −ν ref )
ν ref
 2.10 
where δ  is a dimensionless parameter that represents the chemical shift. 
The chemical shift has been one of the most important sources of information in 
NMR, allowing chemical structures to be determined.  
The fact that the electrons are not spherically distributed around the nucleus gives to 
the shielding field an anisotropic character. The observed chemical shift in an NMR 
spectrum, δ , is the sum of the isotropic and anisotropic components: 
 
 
δ = δ iso +
1
2 ΔCS(3cos
2ϑ −1+ηCS sin2ϑ cos2φ)  2.11 
where  δ iso   is the isotropic chemical shift,  ΔCS  the chemical shift anisotropy,  ηCS  is the 
chemical shift asymmetry, and ϑ  and φ  are angles that define the orientation of the 
 B0  field with respect to the main principal axis of the chemical shielding tensor 
(further details about the shielding tensor can be found in reference [10]).  
The rapid tumbling motion of molecules in the solution state is responsible for 
averaging out the anisotropic contribution of the chemical shift to zero. In solids, the 
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anisotropic chemical shift often plays a large part in determining the characteristic 
width and shape of the NMR spectrum.  
2.2.2.2 The dipolar interaction 
Since each nuclear spin is magnetic, it generates a magnetic field, looping around in 
the surrounding space. A second nuclear spin can interact with this magnetic field, 
while the first nuclear spin also experiences the field generated by the second nuclear 
spin. This interaction is called direct dipole-dipole coupling. Dipolar coupling is a 
through-space interaction that provides an important route to understanding 
correlations between spins. This interaction may be either intramolecular or 
intermolecular. 
In solids the dipolar interaction is a significant broadening mechanism. A pair of 
dipolar-coupled spins will yield a distinctive “Pake doublet” lineshape. As the 
interaction is anisotropic, the splitting between lines will vary according to crystallite 
orientation. A typical powder sample will contain many randomly-orientated 
crystallites: each of these will give rise to a different splitting and the overall 
spectrum will consist of all these contributions. For this reason, coupled with the fact 
that usually more than two spins will be coupled to each other, the solid-state 
spectrum will have a broad lineshape. 
Unlike the chemical shift interaction, the dipolar coupling interaction is  averaged to 
zero by rapid tumbling of molecules in solution. However, it contributes to 
relaxation processes (see Section 2.2.3) and is important in experiments involving the 
nuclear Overhauser effect (NOE) (see Section 2.2.6.3). 
2.2.2.3 J-coupling 
J-coupling, also known as scalar coupling, is a through-bond interaction between two 
nuclei. Electrons perturbing the nuclear spins mediate this interaction. The effect of 
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this perturbation is observed in NMR spectra as splitting patterns (e.g., if two 
non-equivalent spins  I = 1/2  are scalar coupled, the spectrum of each will present a 
doublet and the separation between the two components will represent the 
characteristic coupling constant). These patterns can assist in determining molecular 
structure in solution state. In solids, the J-coupling is usually much smaller than 
other interactions; consequently resolved J-coupled multiplets are not a common 
feature of spectra. 
2.2.2.4 The quadrupolar interaction 
Nuclei with  I ≥ 1  have an electric quadrupole moment,  eQ , that interacts strongly 
with the electric field gradient (EFG) generated by the surrounding electron density. 
This effect arises from the non-spherical distribution of the charge in the nucleus, 
where this distribution can be described as a series of multipoles. In contrast, a spin 
 I = 1/2  nucleus only has electric monopole and magnetic dipole components and 
thus would not have any orientation dependence in the same field gradient.  
The magnitude of the interaction between the nuclear quadrupole moment and the 
EFG is expressed as  CQ   
 
 
CQ =
e2qQ
!
 2.12 
where  q , the magnitude of the EFG is given by 
 
 
q = VZZe  2.13 
where  VZZ  is the strongest principal component of the EFG and  e  is the electric 
charge. 
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Quadrupolar coupling produces splittings in NMR spectra of single crystals and 
gives rise to broad lines for powders and disordered solids. This anisotropic 
interaction also causes spin relaxation when modulated by molecular tumbling.  
2.2.3 Relaxation 
According to Bloch, a macroscopic sample containing many identical-non-interacting 
spins can be considered classically in terms of a bulk magnetisation vector in three 
dimensional space, providing a simple geometrical insight into the NMR experiment. 
In an esemble of spin  I = 1/2  nuclei at thermal equilibrium in a magnetic field, there 
is a population difference between the spin states according to the Boltzmann 
distribution given by Equation 2.7. This gives rise to a stationary net magnetisation 
where the vector aligns with the magnetic field  B0  along the z axis, with no xy 
component at equilibrium. 
During the NMR experiment the bulk magnetisation will experience a tendency to 
revert to its equilibrium situation. The process of regaining equilibrium over a period 
of time is known relaxation. In NMR there are three important modes of relaxation:  
a) Spin-lattice relaxation (or longitudinal relaxation) causes the component of the 
bulk magnetisation along z-axis to return to its equilibrium. For homogeneous 
solid samples, this process is generally exponential with a relaxation time 
constant T1. 
b) Spin-spin relaxation (or transverse relaxation) causes the decay of the 
magnetisation in the x-y plane. In general, for solids, transverse relaxation is 
unlikely to be single exponential with a relaxation time constant T2. 
c) Spin-lattice relaxation in the rotating frame describes the return to equilibrium 
of transverse magnetisation in the presence of spin-locking from an RF 
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magnetic field, where values of relaxation time constant T1ρ in 
cross-polarisation experiments. 
For quadrupolar nuclei (I > 1/2), the rates of longitudinal and transverse relaxation 
are, commonly, not single exponential functions. 
The dominant cause of relaxation is the fluctuation in the local field at the excited 
nucleus. Molecular motion generally causes this fluctuation and can be characterised 
by a time correlation function 
  G(t) ∝ e
−t
τ c   2.14 
where  τ c  is the correlation time and is the time constant that characterises the motion 
in question. 
The Fourier transform of the correlation function (Equation 2.15) is called the spectral 
density 
 
 
2.15 
where  is frequency. Spectral density can be written in terms of correlation time 
dependence as 
 
 
J(ν) = 2τ c1+ (2πντ c)2
 2.16 
The expression above allows two motional regimes to be identified. The first one is 
the extreme narrowing condition where  2πντ c ≪1  then  J(ν ) ! 2τ c  and the relaxation rates 
are proportional to  τ c . This regime applies for fast molecular motion. The second is 
the rigid lattice limit where  2πντ c ≫ 1  so that  J(ν )  becomes proportional to  τ c
−1 (and 
so do the relaxation rates) and applies to slow motions. The latter regime is of 
!
 
J(ν ) ∝ G(t)e− i2πνt
−∞
∞
∫ dt
ν
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interest for quadrupolar nuclei because it is here that multi-exponential relaxation is 
observed  (Chapter 6). 
2.2.4 Fourier Transform NMR 
For many years the main technique for recording NMR spectra was continuous wave 
(CW) NMR [23]. This technique involves sweeping the applied magnetic field, , or 
frequency, , and observing each transition as it comes into resonance. The main 
disadvantage of CW NMR is the long time required to record a single spectrum. This 
method has been superseded by Fourier transform NMR [24] in which pulses are 
used to induce a precessing magnetisation. The resulting precession of bulk 
magnetisation induces a voltage in the receiver coil. This current is the time-domain 
NMR signal, known as the free induction decay (FID), which arises as the result of 
the superposition of many oscillating waves of differing frequencies, amplitudes, 
phases and decay constants.  
The time-domain signal of a single frequency Ω  can be written, 
  s(t) = Cexp(iΩt)exp(−t/T2 )exp(iφ)   2.17 
where  C  is an overall scaling factor,  exp(−t/T2 )  accounts for the relaxation and 
 exp(iφ)  is an arbitrary phase factor dependent on instrumental influences. 
The free induction decay is converted into a spectrum in the normal frequency 
domain by calculation of its Fourier transform. This transformation is given by [24]  
 
 
S(ω ) = s(t)
0
∞
∫ exp(−iωt)dt   2.18 
The time-domain signal  s(t)  is converted to a the frequency-domain spectrum  S(ω ) . 
 B0
 ω rf
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In practice, the FID decays to zero from relaxation processes ( T2 ≠ ∞ ) and the 
resulting spectrum comprises a real and an imaginary component assuming  φ = 0 , 
  2.19 
where 
 
 
2.20 
 
 
2.21 
represent absorptive and dispersive Lorentzian functions. Here,  is the decay 
rate constant in rad s−1 for transverse relaxation. The frequency offset   is 
measured with respect to the centre of the resonance, Ω.  The real part, A(Δω), of the 
spectrum contains absorptive Lorentzian lineshapes centred on frequency Ω with a 
full-width at half-height equal to  2/T2  (measured in rad s
–1) while the imaginary 
part, D(Δω), is the corresponding dispersive Lorentzian (see Figure 2.1). In practice 
these lineshapes are not purely absorptive or dispersive if  φ ≠ 0 , and so a “phase 
correction” is applied by taking linear combinations of the two lineshapes.  
2.2.5 Instrumentation 
A simple NMR experiment consists of a sequence of four events: initialisation, 
excitation, detection and finally processing and display. In the first event, before the 
experiment starts, the computer sends instructions to the pulse generator and to the 
RF (radiofrequency) generator, setting up the reference frequency, the sampling 
frequency and the number of sampled points, etc. (see Figure 2.2). Secondly, sample 
excitation occurs, where the pulse generator executes a timed sequence of 
! S(ω ) = A(Δω )− iD(Δω )
!
 
A(Δω ) =
1
T2
1
T2
⎛
⎝⎜
⎞
⎠⎟
2
+ (Δω )2
!
 
D(ω ) = Δω
1
T2
⎛
⎝⎜
⎞
⎠⎟
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+ (Δω )2
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instructions to set the phase of the RF generator and open the switch. An RF pulse 
travels into the probe from RF amplifier. 
Following this, the pulse is switched off and detection starts. The precession of the 
nuclear spin magnetisation sets up oscillations in the tuned circuit, which gives rise 
to a radiofrequency NMR signal  (the free induction decay, FID). The free induction 
decay (FID) is the observable time-domain NMR signal generated by 
non-equilibrium nuclear spin magnetisation precessing about the magnetic field.  
This signal is amplified by a RF amplifier, and converted down in frequency by the 
quadrature receiver (detector), and then the pulse generator issues an instruction to 
the ADC (analogue to digital converter), which proceeds to digitise receiver outputs.  
Finally, the digitised time-domain signal stored in the computer memory is subjected 
to various mathematical operations or processing such as Fourier transform. Fourier 
transform (FT) turns a time-domain signal, the FID, into a frequency-domain signal 
 
Figure 2.1. A complex Fourier transform (FT) performed on the real and imaginary 
components of an exponentially decaying FID results in absorptive and dispersive 
Lorentzian lineshape, repectively. 
!
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(see Section 2.2.4). Subsequently the NMR spectrum may be displayed on the 
computer screen to be processed by a user [21].  
2.2.6 Solution-state NMR 
The purpose of this section is to give an introductory insight into some important 
concepts used in solution-state NMR that are applied principally in Chapter 7. 
2.2.6.1 The spin echo 
An NMR signal will decay after an excitation pulse owing to effects that cause 
different spins in a sample to precess at different frequencies. Two factors are 
responsible: spin-spin relaxation induced by intra- or intermolecular magnetic fields 
and the spatial inhomogeneity of the static  B0  field. In solution-state NMR, this 
dephasing can result principally from the latter reason; an inhomogeneous  B0  field, 
where different volumes of the sample will have different precession frequencies 
according to the field they experience. It is a very common practice in NMR 
experiments to insert a pulse sequence into periods of free precession to refocus the 
 
Figure 2.2. Main components of an NMR spectrometer 
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precession arising from  B0  inhomogeneity. Usually this is done by the use of a 
spin-echo pulse sequence. The most popular sequence is the Hahn or Carr-Purcell 
echo, 90° – τ  – 180°, where a 90° pulse is used to excite single-quantum coherence. A 
180° pulse is applied after duration τ . After a further period of free precession of 
duration τ  a spin echo is formed. 
2.2.6.2 Water suppression 
The presence of high concentration of solvent (molar range) compared to low 
concentration of solutes in NMR samples (millimolar to micromolar range) is a 
common problem in 1H experiments. This situation leads to a variety of problems 
such as overlapping resonances of interest by the intense solvent signal and 
saturation of the NMR receiver causing poor quality spectra. When desirable, the use 
of deuterated solvents instead of protonated ones is a simple solution to reduce 
solvent resonances. However, this method is not generally applicable for protein 
samples, in which protonated solvent (e.g., water) is required for the observation of 
exchangeable protons (e.g., amide protons). The last four decades has seen a 
progressive technique development to undertake solvent suppression to meet 
demanding requirements. Of all the pulse sequence suppression methods, the 
frequency differentiation-based methods are the most versatile [25]. Frequency 
differentiation methods are based on selective excitation and/or inversion 
with/without the application of pulsed magnetic gradients. The most prevalent 
frequency differentiation methods are: 
a) Pre-saturation. Pre-saturation related suppression methods are based on the 
selective saturation of the solvent resonances by a low-power selective RF 
pulse on the solvent resonances. One of the main drawbacks of pre-saturation 
related methods is when signals that resonate very close to the solvent signal 
may be partially saturated by the RF field applied [25]. 
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b) WATERGATE and excitation sculpting. The WATERGATE (WATER 
suppression by Gradient-Tailored Excitation) technique [26] relies on a 
selective spin-echo pulse (which inverts all the resonances except the solvent 
resonances) flanked by two symmetrical pulsed field gradients (PFGs). This 
method evolved from the realisation that echo techniques provided superior 
phase properties compared with conventional selective phase properties [27]. 
However, one of the difficulties with a gradient echo is spectral phase 
distortion because the phase of the magnetisation is affected by the phase 
properties of the spin-echo pulse. This difficulty is overcome by applying a 
Double Pulsed Field Gradient Spin Echo (DPFGSE) first proposed by Hwang 
and Shaka [28] under the name Excitation Sculpting. It turns out that the phase 
of the magnetisation excited by this sequence is independent of the phase 
properties of the spin-echo’s pulses [29].  
2.2.6.3 Nuclear Overhauser Effect 
All substances possess a variety of internal spin interactions: chemical shift terms 
(one-spin), quadrupolar couplings, J-couplings (two-spin), spin-rotation interactions 
(one-spin) and dipole-dipole couplings (two-spin). The study of the through-space 
dipole-dipole couplings of spin pairs in a molecule can tie down the molecular 
structure and conformation unambiguously where these couplings may be either 
intramolecular or intermolecular [21]. Dipolar couplings do not usually produce 
observable splittings in solution NMR spectra because they are averaged to zero by 
rapid tumbling of a molecule.  
A remarkable phenomenon known as the nuclear Overhauser effect (NOE) [30] can 
provide us with information about these dipole-dipole interactions. This effect may 
be defined as the change in intensity of one resonance when the spin transitions of 
another are perturbed from their equilibrium populations, usually by saturation or 
by population inversion.  
 
 
Theoretical background 
 
24 
The most simple system to understand the origin of the NOE is a two homonuclear 
spin  I = 1/2  system. Consider that both nuclei do not possess scalar coupling but are 
sufficiently close in space to share a dipolar coupling.  Six possible spin-lattice 
relaxation pathways can be identified for a two-spin system (Figure 2.3). Four of 
these correspond to the single-quantum transitions involving the flip of a single spin. 
The transitions probabilities are represented by the label W where the subscript 
corresponds to the  ΔmI  for the transition and the superscript the spin (I or S). The 
other two transitions (W0 and W2) involve the simultaneous flipping of both I and S 
spins. Although these transitions do occur, they cannot be directly observed by an 
NMR experiment, unlike single-spin flips, because the overall change in magnetic 
quantum number does not equal one [31]. If the single-quantum transitions for spin S 
are saturated by a continuous RF field W0 and W2 are able to act as relaxation 
pathways. This phenomenon is the origin of the NOE.  
The W2 process will remove spins from the ββ  state and transfer them to the αα  state 
in an attempt to recover the population differences across the S transitions. This 
process results in a net increase in I-spin resonance intensities in the spectrum 
(positive NOE). Similarly, the W0 process will transfer spins from the βα  to the 
αβ  state to regain the spin population differences across the S transitions. In this 
situation  there will be a decrease in population across I transitions therefore there 
will be a net reduction in the I spin resonance intensities in the spectrum (negative 
NOE). The NOE enhancement factor definition ( εNOE ) is given by 
 
 
εNOE = 1+
γ I
γ S
W2 − W1
W0 + 2W1S + W2
⎡
⎣
⎢
⎤
⎦
⎥ =
γ I
γ S
σ IS
ρIS
  2.22 
where  and  are the gyromagnetic ratios of the two spins,  represents the 
cross-relaxation rate constant for two spins and  is the total dipolar longitudinal 
relaxation constant of spin I. 
 γ I  γ S  σ IS
 ρIS
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Rapid molecular tumbling, corresponding to a short correlation time  τ c  favours the 
higher energy W2 process in the extreme narrowing condition. Contrary, slow 
molecular tumbling (long correlation time) favours the lower energy W0 process in 
the rigid lattice limit. 
The principal techniques that exploit the NOE are [31]: 
a) Nuclear Overhauser Effect (NOE) Difference. This technique establishes NOEs 
and hence spatial proximity between protons. It is suitable for small 
molecules, for which NOEs are positive. It is possible to detect steady-state or 
equilibrium NOEs generated from saturation of a target. 
b) Nuclear Overhauser Effect Spectroscopy (NOESY). One- or two-dimensional 
technique that establishes NOEs and hence spatial proximity between protons. 
It is suitable for small and large molecules for which NOEs are positive and 
negative, respectively, but may fail for mid-sized molecules (zero NOE). The 
method detects transient NOEs generated from the interversion of a target. 
The pulse sequence for this experiment consists of three 90° pulses (Figure 
 
Figure 2.3. Transitions in a two-spin system where αα , αβ , βα  and ββ  are spin states 
and the double-arrows represent the transitions between states. 
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2.4), the second and the third separated by a fixed delay  τm  during which z 
magnetisation is transferred between neighbouring spins via the NOE.  
c) ROtating-framE nuclear Overhauser Effect Spectroscopy (ROESY). One- or 
two-dimensional technique that establishes NOEs and hence spatial proximity 
between protons. Suitable for any molecule but often essential for mid-sized 
molecules. NOEs are positive for all molecules sizes. The methods is used to 
observe transient NOEs in the rotating frame. 
d) Heteronuclear nuclear Overhauser Effect Spectroscopy (HOESY). Two-
dimensional technique that establishes NOEs and consequently spatial 
proximity between different nuclides (e.g., {1H, 13C}). 
2.2.7 Solid-state NMR 
2.2.7.1 Magic-Angle Spinning 
When a conglomerate of nuclei in a solid sample is placed into a magnetic field, no 
nucleus resonates at precisely the same frequency as another, and hence the 
frequency range of resonances will be quite broad. This broad frequency range is due 
to orientation dependence within the chemical shift anisotropy, dipolar couplings 
and quadrupolar effects.  
 
Figure 2.4. NOESY experiment. 
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A complementary technique called magic angle spinning (MAS) [32] is the single 
most used technique in solid-state NMR. The technique relies on the rapid rotation of 
the solid sample around an axis which subtends the magic angle of 54.74° (Figure 
2.5) to the applied magnetic field. This technique allows the elimination of 
anisotropic interactions (chemical shift anisotropies and direct dipole-dipole 
couplings) resulting in high-resolution NMR signals.  
The molecular orientation dependence of nuclear spin interaction is proportional to 
the form  (3cos2ϑ −1)  (see Equation 2.11) where ϑ  is the angle which describes the 
orientation of the spin interaction tensor (Figure 2.5) relative to the applied magnetic 
field  B0 . If the sample is spun about an axis inclined at an angle  ϑR  to the applied 
field,  B0 , then ϑ  varies with time as the molecule rotates with the sample. The 
average of the orientation dependence of nuclear spin interaction can be shown to be 
 
 
2.23 
where the angles β   and  ϑR   are defined in Figure 2.5. If  ϑR  is set to 54.74, then  
 (3cos
2ϑR − 1) = 0 and the effects of anisotropies vanish since  
3cos2ϑ − 1  is zero also.  
2.2.7.2 Cross-Polarisation 
In 1962, the cross-polarisation phenomenon was first observed by Hartmann and 
Hahn [33], and later in 1972 the technique was adapted by Pines, Gibby and Waugh 
[34], to improve the sensitivity of nuclei with a low gyromagnetic ratio or low natural 
abundance. 
A cross-polarisation pulse sequence consists of the application of a simple 90° pulse 
to the abundant spin (nucleus I, generally 1H), aligning the magnetisation of the 
nuclei along the rotating-frame y-axis. Next, both nuclei (I and S) are continuously 
and simultaneously irradiated with a “spin lock” pulse along the y-axis. During this 
!
 
3cos2ϑ −1 = 12 (3cos
2ϑR −1)(3cos2 β)
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period, due to the dipolar interactions between the two spins, the magnetisation of 
the nucleus I is transferred to the nucleus S. This time period, during which 
cross-polarisation takes place, is known as the contact time. Subsequently, the FID is 
recorded (Figure 2.6a). 
Cross-polarisation is often used in conjunction with MAS (CPMAS), a combination 
that was first demonstrated by Schaefer and Stejskal [35]. However, despite the use 
of MAS, the observation of some nuclei, such as 13C with a natural abundance of 
1.1% (Table 2.1), is complicated owing to the strong heteronuclear dipolar coupling 
to protons, resulting in a broad spectrum. The effects of these couplings can be easily 
removed by RF irradiation of the protons, called decoupling. The method consists of 
applying continuous irradiation of very high power at the frequency of the proton 
resonance during the FID acquisition [12]. 
For a static sample, it can be shown that the transfer of magnetisation between the 
two set of spins will take place during the period of simultaneous spin-locking when 
a unique “Hartmann-Hahn” matching condition is satisfied  
 
Figure 2.5. This diagram shows the angles ϑ ,  ϑR  and β , relevant to the magic-angle 
spinning experiment. The rotor – represented by a cylinder – is inclined at  ϑR ≈ 54.74
!  
relative to  B0 . The elipisoid in the middle of the rotor represents the principal axis system 
(PAS). The dashed line represents the axis of rotation of the sample.  
!
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  γ
IB1I = γ SB1S  2.24 
where  γ
I  and  γ
S  are the gyromagnetic ratios of the I and S spins, and  B1
I  and  B1
S  are 
the strengths of the radiofrequency fields applied to the I and S spins, respectively. 
The application of MAS during cross-polarisation is desirable for the acquisition of 
high-resolution spectra, but sample rotation will introduce a time dependence into 
the dipolar interaction that mediates the polarisation transfer. As a consequence, 
optimum polarisation is not obtained at the conventional Hartmann-Hahn condition 
given in Equation 2.24. The new match condition under magic-angle spinning 
becomes (see Equation 2.5) [36]  
  2.25 
where  ω1I  and  ω1S  are the inherent nutation rates, is the spinning frequency, and n 
is an integer, usually 1 or 2. The matching condition is no longer at the centerband, n 
= 0 (Equation 2.14), but shifted to sidebands either side of the normal condition. 
Consequently, it is necessary to optimise the cross-polarisation conditions at the 
target spin rate. At high spin rates the matching conditions become narrower and 
more delicate than at slow rates [10]. 
! ω1I −ω1S = ±nωR
 ωR
 
Figure 2.6. Representation of (a) the conventional cross-polarisation pulse sequence and 
(b) cross-polarisation ramped pulse sequence. 
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The simplest solution to the problems related with the sensitive nature of the 
matching condition is to use ramped cross-polarisation (Figure 2.6b). Ramped 
cross-polarisation varies the RF nutation rate on one of the channels, sweeping the 
RF amplitude through the matching condition [10]. 
Heteronuclear correlation (HETCOR) 
Two-dimensional NMR experiments find such wide utility in chemical research 
because they map out interactions within or between molecules of interest. The 
interactions that can be observed by two-dimensional techniques are through-bond 
coupling, through-space coupling and chemical exchange. 
The name HETCOR (from HETeronuclear CORrelation) is given to the two 
dimensional experiment which aims to correlate the resonances of a pair of 
heteronuclei within a sample through a coupling interaction, i.e., correlating 13C with 
1H via a J coupling. Heteronuclear correlation via the dipolar interaction is 
particularly straightforward in solids since the necessary magnetisation transfer can 
generally be achieved using cross-polarisation [10]. 
The HETCOR experiment starts with the preparation period, a simple 90° pulse 
applied to the I spin, which creates transverse magnetisation that evolves for the 
evolution period, t1, before cross-polarisation starts in a mixing time, followed by 
detection of the S-spin FID (with or without decoupling) (Figure 2.7).  
2.3 Dynamic processes in proteins 
Protein dynamics play a crucial role in many important biological processes, such as 
ligand binding, allosteric regulation, protein folding, signaling and enzymatic 
catalysis [37]. A wide range of motions in terms of both time and distance scales are 
spanned by these processes. Many spectroscopic and computational techniques have 
been developed to monitor various aspects of protein dynamics.  
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2.3.1 NMR approaches 
As mentioned earlier in Section 2.1, NMR is capable of providing information about 
molecular dynamics. The clear advantage of NMR methods is that they can deliver 
timescales, together with atomic resolution, in contrast with other high-resolution 
methodologies such as X-ray crystallography or electron microscopy. 
Biological functions span a range of timescales depending on the underlying 
conformational changes of cellular proteins. These changes can be studied using an 
array of NMR experiments that are like windows into the dynamic landscape of a 
protein [38]. NMR dynamics measurements can correlate changes in enthalpy and 
entropy of a protein to its function. Figure 2.8 shows how NMR can probe dynamics 
on timescales similar to processes involved in each function. Dynamic NMR can be 
organised into slow, intermediate and fast exchanges, compared to a time commonly 
referred to as the NMR timescale. The commonly used NMR timescale is that of direct 
peaks observation. In the case of a two-site exchange, if the exchange is slow, the 
separate sites are observable. In intermediate exchange the lines are significantly 
broadened and may even have started to coalesce. In the fast exchange limit the 
 
Figure 2.7. Two-dimensional HETCOR experiment with  I-spin decoupling. 
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signals have coalesced and only a single sharp line is observed at the average 
chemical shift.  
The motional correlation time  τ c  (see Section 2.2.3) can be obtained by different 
NMR approaches depending on the timescale (see Figure 2.8). One of the simplest 
NMR approaches for the measurement of slow motion dynamics is real-time (RT) 
NMR. Dynamic processes on the second timescale are directly detected by 
quantifying the time-dependence of NMR signal intensities [39]. Physical processes 
on this timescale include protein folding and solvent hydrogen-exchange. 
EXchange SpectroscopY (EXSY) can quantify dynamic processes in the 10-5000 ms 
time window [42]. Physical processes in this time window include conformational 
changes such as domain movement and ligand binding. 
 
Figure 2.8. Timescale of dynamic processes in proteins (bottom) and the NMR approaches 
to probe them (top) from references [37, 40, 41]. 
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Intermediate motion dynamics events between the microsecond to millisecond time 
window, can be probed by lineshape analysis. This approach derives from 
well-defined theoretical work by McConell [43]. Typically, a series of spectra are 
acquired along a titration coordinate such as ligand concentration, temperature or 
pH to observe their incremental effect upon the three NMR observables (chemical 
shift, intensity and linewidth). 
Another NMR approach for measurements of intermediate motions dynamics is 
Carr-Purcell-Meiboom-Gill (CPMG) relaxation dispersion NMR spectroscopy. This 
experiment is a particularly a powerful tool to obtain high-resolution structural 
information about protein folding events on the millisecond timescale [44].  
Fast motions can only be deduced from NMR relaxation measurements. NMR 
relaxation times depend on the fluctuations of the nuclear interactions (such as 
nuclear dipoles, chemical shift anisotropies or quadrupolar interactions) with respect 
to the static magnetic field due to the overall rotational diffusion of the protein as 
well as local fast motions in the protein [45]. The precise range of applicability for 
relaxation is different in solution and solid state. In solution, relaxation methods 
report on motions from picoseconds to the correlation time of the overall rotational 
diffusion (correlation time increases with the size of protein but generally falls within 
the picosecond-nanosecond range). In the solid state where overall tumbling is 
absent, the relaxation may be used to characterise amplitudes and time scales of 
motions from picoseconds to milliseconds. Furthermore, the absence of overall 
tumbling in the solid state removes the intrinsic limitation on the size of proteins that 
can be studied by NMR [41].  
The longitudinal relaxation rate constant ( R1 = 1/T1 ), transverse relaxation rate 
constant ( R2 = 1/T2 ), and the nuclear Overhauser effect are generally measured to 
evaluate different relaxation processes in proteins (e.g., backbone NH group 
dynamics). All of these parameters are typically measured using two-dimensional 
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(HSQC type) experiments in which the intensities of the peaks are modulated as a 
function of a time delay placed at a point in the sequence when the relevant 
relaxation process is active [46]. These experiments normally require incorporation of 
specific isotopic labels. 
The use of computational tools such as molecular dynamics to correlate NMR 
relaxation measurements is becoming increasingly useful for a better interpretation 
of the experimental data [47, 48]. 
Currently, the solid-state relaxation methodology toolbox is still not as rich its 
solution-state equivalent. One of the main reasons behind this problem is that 
relaxation rates measured in solid state are generally affected not only by processes 
such as random thermal fluctuations (which is the case in solution) but also processes 
originating from the incomplete averaging of strongly coupled networks of 
anisotropic interactions in solid proteins. One approach to remove such anisotropic 
broadening involves mechanical rotation of the samples around the so-called magic 
angle (see Section 2.2.7.1). A complementary approach to reduce the effect that the 
multiple couplings to proton have is to chemically remove protons and replacing 
them with deuterons (i.e., perdeuteration) [41]. 
The majority of traditional NMR methodologies to measure fast motions in protein 
are applied to spin  I = 1/2  nuclei. A significant number of biologically relevant 
elements in protein dynamics (e.g., allosteric modulation) have nuclides that possess 
spin quantum numbers greater than  1/2  (e.g., 
23Na, 35Cl and 43Ca) and thereby 
possess nuclear quadrupole moments. The quadrupolar interaction is usually much 
stronger than other interactions causing relaxation. This means that the quadrupolar 
mechanism normally dominates the relaxation and not other interactions. Relaxation 
of quadrupolar nuclei has been studied in solution using multiple-quantum filtered 
NMR methods [49, 50] and in Chapter 6 we attempt to apply these methods under 
 
 
Theoretical background 
 
35 
MAS to hybrid liquid-solid samples with the aim of investigating ion- and 
water-binding to immobilised enzymes. 
2.3.2 Other approaches 
Other atomic resolution methods such as X-ray and neutron diffraction also report 
on dynamics. X-ray diffraction generally reports on global changes in protein size 
and shape in a time-resolved manner and neutron diffraction on amplitudes and 
time scales for hydrogen atomic positions in proteins. X-ray crystallography itself 
yields some dynamic information. This information is extracted from temperature 
factors (B factors) [51]. 
Lower resolution techniques such as Mössbauer [52], Raman [53] and 
two-dimensional infrared [54] spectroscopy also provide new insights into protein 
dynamics. Fluorescence is an important tool to understanding protein dynamics both 
in the ensemble and in single molecules [55]. 
Computer simulations such as molecular dynamics, serve as a theoretical basis for 
predicting protein motion, analysing inputs from the wide variety of experimental 
techniques such as NMR, and probing dynamic information beyond what can be 
assessed experimentally [37].  
2.4 Analysis of protein-ligand interactions  
Protein-ligand interactions are fundamental to almost all processes occurring in 
living organisms. Enzyme catalysis involves diverse protein-ligand interaction, 
including substrate and cofactor binding to the enzyme. There are many techniques 
to characterise protein binding and new methods emerge every few years. In a 
general sense characterisation methods can be divided into two main categories: 
biophysical and computational. Here a general description of the most important 
techniques is given. Section 2.5.3 explores in more detail the different tools for 
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analysis of protein interactions (i.e., enzyme-surface and enzyme-ligand interactions) 
for immobilised enzyme systems. 
2.4.1 Biophysical methods 
To detect experimentally the formation of a complex between a ligand and a target 
protein, a measurable response, or signal, and an appropriate detection technology 
are required. Signals can arise from an intrinsic interaction from the ligand, the 
target, ligand-target complex or a combination of them all. In the absence of intrinsic 
interactions, one approach to studying these interactions is the attachment of a label 
(probe) to one of the species involved. Labelling can be advantageous in giving more 
sensitivity and specificity to the experiments [56]. 
Several biophysical experimental techniques have been used with the purpose of 
studying protein-ligand interactions. There are direct techniques to detect binding 
such as nuclear magnetic resonance (NMR), surface plasmon resonance (SPR), mass 
spectroscopy and X-ray crystallography or indirect methods such as thermal shift or 
isothermal titration calorimetry.  
2.4.1.1 NMR approaches 
Several NMR techniques have been developed to detect binding. NMR is typically 
used in two distinct configurations with the purpose of studying protein interactions: 
monitoring the ligand or the protein. The immediately visible NMR evidence that the 
binding has occurred is likely to be either a change in the resonance frequency of a 
nucleus in the ligand or the protein, or a change in a linewidth. Chemical shift 
changes result from a change in the environment of the reporter nucleus. They can be 
obvious and readily observable. A change in linewidth (or more directly the 
relaxation rate constant  1/T1  or  1/T2 ) may result from a change in the motional 
characteristic of the reporter nucleus.  
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Protein-Detected NMR Techniques 
Monitoring the protein brings much more information as the structural and 
dynamics implications of binding can be evaluated [57].  
Two-dimensional NOE experiments to evaluate backbone chains (e.g., {1H-15N} 
HSQC) and SAR (structure-activity relationship) experiments to detect changes in the 
chemical shifts have been used in the past for monitoring the protein after a ligand 
event [58]. These methodologies require 15N and/or 13C labelling. 
Ligand-Detected NMR Techniques 
When the ligand is monitored, any modification of its spectrum in the presence of 
protein implies an interaction. This approach can be quite fast and sensitive but not 
very informative in terms of the interaction geometry. Ligand examination has the 
technical advantage of not requiring labelled protein. The size of the protein does not 
limit this technique, and in many examples, larger proteins provide better sensitivity 
because binding of a large protein causes a more distinguishable change to the 
observable signals [59]. Ligand-based methods are attractive because they are 
broadly applicable, impose few constraints on the composition of the target protein 
and do not require isotopic labelling of the protein or ligands. Such experiments 
include relaxation experiments, diffusion experiments (DOSY) and methods 
involving magnetisation transfer (STD-NMR, NOE pumping, waterLOGSY, 
SALMON, transferred-NOE and INPHARMA) [60].  
2.4.1.2 Other approaches 
Surface plasmon resonance (SPR) involves immobilising the protein on a sensor 
surface before a ligand is flowed over the surface. Binding events are measured by 
monitoring change in resonance angle (angle of minimum reflectivity) for the 
immobilised component. Observed binding levels and binding rates can be 
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interpreted in different ways to provide information on the specificity, kinetics and 
affinity of the interaction, thermodynamics or on the concentration of a molecule. 
Mass spectroscopy (MS) is another technique to study protein-ligand complexes. The 
strengths of MS are supreme sensitivity as well as accuracy of molecular weight 
determination. In all MS techniques, the sample is vaporised, ionised, and 
accelerated through an electric field. The trajectory that molecules fly on depends on 
their molecular weight and their charge. The most obvious method to study protein 
complexes using MS is determine the molecular mass of these complexes, and hence 
the stoichiometry of a complex. In addition to molecular mass determinations, MS 
also offers other methods to study protein interactions. For example, an interesting 
application of MS is in study of kinetics of protein complex formation and 
dissociation, or subunit exchange, where the appearance of new molecular mass 
species can be monitored after mixing [61].  
As was mentioned earlier in Section 2.1, protein structures are typically determined 
using X-ray crystallography. A key step in the study of protein-ligand interaction 
using X-ray crystallography is obtaining co-crystals structures of protein-complexes. 
Soaking and co-crystallisation are the two most widely used approaches to obtain 
them. These methodologies require the ligand to bind to the protein either before or 
after crystallisation. In soaking, the ligand is incubated with preformed crystals of 
either the ligand-free protein or cocrystals of a previously bound ligand that can be 
displaced with a new one. In the cocrystallisation method, the protein is incubated 
with excess ligand to form a complex prior to setting up the crystallisation 
experiments [56]. 
The thermal shift (TS) technique measures the change in thermal unfolding 
temperature of the protein caused by ligand binding (via a fluorescent dye that 
preferentially binds to the unfolded state). As the temperature of the sample is 
increased and the protein unfolds, the dye binds to the more exposed hydrophobic 
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regions of the protein and an increase in fluorescence signal is detected. The stability 
(Tm) of the protein can be measured from the midpoint of this thermal unfolding 
curve.  Ligand binding to native protein results in an increase in stability and a 
measurable increase in Tm [56]. 
When a protein interacts with a ligand, usually, heat is either released or absorbed. 
The determination of this heat gives necessary insight into the nature of an 
interaction. Isothermal titration calorimetry (ITC) is the only technique that measures 
this heat change and therefore gives detailed thermodynamic information about the 
binding process. The energy released or absorbed is measured when a ligand is 
titrated into a cell where the protein is located. The heat change is proportional to the 
amount of ligand bound and the binding enthalpy [56].  
2.5 Immobilisation of enzymes 
As noted above enzymes, as catalysts, possess the astonishing quality of leading to 
product formation at mild and environmentally friendly conditions with a high 
specificity. A core technology is the immobilisation of enzymes – the conversion of 
the soluble protein molecules into a solid particle form that can be easily separated 
from the reaction mixture. This allows the expensive enzyme catalyst to be recovered 
and re-used and avoids protein contamination of the product streams.  
In 1972, Wingard [62] defined immobilisation as the process where the enzyme is 
confined or located in a defined region of space, to yield to insoluble forms which 
retain their catalytic activity and can be reused repeatedly. Later this definition was 
extended to be that process which restricts, in whole or in part, the degrees of 
freedom of movement of enzymes, organelles, cells, etc. by binding to a support or 
other means [63]. 
The main advantages of immobilisation are derivative reusability (thus reducing the 
costs of the process) and obtaining a product uncontaminated by the catalyst. 
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At a molecular level there are some disadvantages to using this process. Some of 
these drawbacks stem from the alteration of the native conformation of the enzyme 
and the heterogeneity of the enzyme–support system where different protein 
fractions can be immobilised with a number of bonds to the support. Also, from a 
performance point of view, it is common to observe loss of activity of the enzyme 
during the immobilisation and the biocatalyst produced is more expensive than the 
free enzyme.  
The success of an immobilisation procedure is based on the ability of the support to 
bind the enzyme and efficiently express the activity: however there is no ideal 
support universal for all enzymes [64].  
Since the advent of immobilisation of single enzymes in the 1940s, innumerable 
methods have been developed. 
2.5.1 Methods of immobilisation 
There are a large number of methods of immobilisation that can be broadly divided 
into those that involve the interaction of the enzyme with a matrix (usually through a 
chemical bond) and those in which the enzyme is contained within a restricted space 
[65]. 
Among the most popular immobilisation methods (Figure 2.9), there are two that 
involve the interaction with a matrix or carrier: covalent and non-covalent 
immobilisation. The latter case is more commonly known as adsorption. Other 
methods involve the use of the enzyme without a carrier, such as cross-linked 
enzyme aggregate (CLEA) and cross-linked enzyme crystal (CLEC). Also there are 
methods that involve the confinement of the enzyme, involving entrapment inside a 
gel and retention by a membrane. 
 
 
Theoretical background 
 
41 
2.5.1.1 Covalent enzyme immobilisation 
Covalent immobilisation was the second method of immobilisation developed after 
adsorption. The immobilisation methods through covalent bonding usually provide 
the strongest support–enzyme linkages, compared with other types of 
immobilisation such as adsorption [66]. Therefore, through covalent immobilisation 
methods, it is possible to minimise losses of enzyme from the matrix. 
In general, covalent binding of an enzyme to a carrier is based on chemical reaction 
between the reactive amino acid residues (RARs) located on the enzyme surface and 
active functionalities also known as carrier bound groups (CAGs) (Figure 2.10) that 
are attached to the carrier surface. To achieve efficient linkage, the functionality of 
carrier and/or the enzyme must be activated before immobilisation. Often, carriers 
are activated before their use for binding enzymes [66]. 
Factors affecting covalently immobilised enzyme performance 
Covalent binding is considered to be a radical method of immobilisation. This is 
because of the irreversible nature of the binding, fixing the enzyme conformation and 
 
Figure 2.9. Methods of enzyme immobilisation. The enzyme is labelled in colour yellow, 
the surface of the carrier in grey, the covalent linkage in black, the cross-linking agent in 
red, the gel matrix in green and the semipermeable membrane in blue. 
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modifying the enzyme chemically. Enzyme performance (i.e., selectivity and 
stability) can be significantly improved using this method in comparison with native 
enzyme or other immobilisation methods. Generally, the multiple linkages in 
covalent binding decrease the activity of immobilised enzyme compared with free 
enzyme.  
The performance of the biocatalyst can be affected for different properties of the 
components of the composite system (Figure 2.10) [66]. Table 2.2 summarises these 
properties and the thesis Sections where information about them can be found. 
Enzyme conformation, orientation and distribution on immobilised systems are 
discussed in the Summary Chapter of this thesis (Chapter 8). Chapter 8 also contains 
further discussions for some of the other properties included in Table 2.2. 
2.5.2 System 
2.5.2.1 Carrier 
Physical and chemical properties of the carrier are significant in the process of the 
attachment of the enzyme. Since the 1960s, it was recognised that the success of 
immobilising an enzyme was largely dependent on the physical and chemical 
properties of the whole system [67]. 
 
Figure 2.10. Elements involved in the covalent binding of an enzyme to a support. RAR  
stands for reactive amino acid residue and CAG for carrier bound group. Colour scheme is 
the same used in Figure 2.9. 
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Physical properties 
The physical characteristics of the support (such as mean particle diameter, swelling 
behaviour, mechanical strength, and compression behaviour) will be of major 
importance for the performance of the immobilised systems and will determine the 
type of reactor used under technical conditions. In particular, the pore size 
determines the total surface area and thus critically affects the capacity for binding of 
enzymes. Particle size does not really affect the total surface, unless for very small 
particle sizes (about microns). Nonporous supports show few diffusional limitations 
but have a low loading capacity. Therefore, porous supports are generally preferred 
because the high surface area allows for a higher enzyme loading and the 
immobilised enzyme receives greater protection from the environment [7]. The 
Table 2.2. Properties of the components of covalent enzyme immobilisation that can affect 
the performance of the biocatalyst. 
Properties Section 
physical nature of the carrier (i.e., pore size, particle size, 
porosity, shape, etc.) 
3.1 
chemical nature of the carrier (chemical composition of the 
backbone, active functionality, other non-active functionality) 
3.1 
nature of the linkage or binding chemistry 3.3.2 
nature and the length of the spacer 3.3.1 
number of bonds formed between the enzyme and the carrier 2.5.2 
conformation of the enzyme  Chapter 8 
enzyme orientation Chapter 8 
enzyme distribution  Chapter 8 
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surface of a carrier might include external and internal surfaces. For enzyme 
immobilisation, a large internal surface is highly desirable for high loadings. 
The accessible surface is the surface area accessible to the enzymes to be immobilised 
and depends directly on the pore size of the carrier. Therefore, the pore size becomes 
a crucial physical property in order to obtain a successful immobilisation. It has been 
observed that minimum requirements exist relating to the size of the pores in the 
carrier. The pore size should be big enough to let the enzyme enter, have freedom of 
movement to change its conformation and mitigate diffusion limitations [66]. 
Previous studies reported optimum pore sizes for maximal binding capacity and 
activity retention between 5 and 10 times of the protein globular size. In general, it 
was found that when the pore size is bigger than optimum pore size, a decrease in 
the enzyme loading is expected [68]. This is because the surface available for enzyme 
occupation usually decreased with increasing the support pore size. 
Chemical properties 
The chemical nature of the carrier involves the chemical composition of the 
backbone, the surface chemistry, the nature of the spacer, active or inactive 
functional pendant groups on the surface and hydrophilicity or hydrophobicity of 
the support. 
It has been demonstrated that it is very difficult to predict which carrier bound 
binding group (CAG) is the best-suited for a given enzyme because many factors can 
affect the binding process (i.e., nature of the backbone and immobilisation 
conditions) [66]. 
The space arms that link the CAG are of crucial importance. They can affect the 
immobilisation efficiency and increase or decrease the enzyme stability. A higher 
molecular mobility in the presence of spacers can lead to an improvement in the 
performance of the immobilisation [69]. On the other hand, it is well known that 
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stability of covalently immobilised enzyme is related to the number of bonds formed 
between the enzyme and the carrier [70, 71] making the unfolding of the peptide 
chains much more difficult in this more “rigid” system than the native enzyme. 
Obviously, high binding density leads to an increase in the number of bonds 
between the support and the enzyme and therefore in a rigidification of the system 
that is not beneficial in terms of enzymatic activity. 
2.5.2.2 Reactive enzyme residues 
There are two essential requirements to achieve an efficient covalent binding 
between the enzyme and the carrier. The first one is the matching between the 
reactivity of the functional groups of the selected carrier and the enzyme residues in 
the aqueous medium and the second is ensuring that functional groups involved in 
the immobilisation are sterically accessible to each other in the medium chosen 
(aqueous or organic).  
Not all free side chain (R) residues of the 20 amino acids can be used in covalent 
binding. Only half of them have a reactive group that can be involved in this type of 
immobilisation. The most important residues involved in immobilisation through 
covalent binding are lysine (lys), glutamic acid (glu), aspartic acid (asp), tyrosine 
(tyr), cysteine (cys), N-terminus and C-terminus of proteins (Table 2.3). 
Lysines bear a primary amine moiety and although their side chains are protonated 
under physiological pH, they can still react as nucleophiles. (ε)-amino groups of 
lysine and amino groups of N-terminal amino acids can react with a variety of 
reagents bearing reactive amino acid residues (i.e., N-hydroxysuccimide esters, 
isothiocyanates, aldehydes) producing a covalent bond [72].  
Another approach relies on the selective modification of carboxylic groups present 
on glutamic acid, aspartic acid and C-terminus of a protein. This method uses a 
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pre-activation of the carboxylic groups in order to produce an amide bond between 
the terminal functionality and pendant amines on a support [73].  
Phenol groups present on tyrosine can also react as nucleophiles. The addition of a 
diazonium salt produces an azo bond, that can be further reduced and transformed 
into a stable benzoxazine [74]. Cysteine residues can be covalently bonded to a 
support using the thiol side chain. The thiol moiety is more nucleophilic than a 
primary amine, especially at a pH below 9, where the amine is protonated. However, 
free thiols are relatively rare in proteins (Table 2.3) and they are often found as an 
oxidised dimer, known as a disulfide form. There are other factors, besides reactivity, 
to consider as possible determinants of which groups might be more involved in 
covalent attachment to a solid support. One factor is the relative content of the amino 
acids in the protein molecule. Table 2.3 shows the average amino acid composition of 
proteins [75] for some of those amino acids with reactive groups.  
There also exists a difference in the hydrophobic nature among amino acids. A 
ranking of hydrophobicity of the most important reactive amino acid in covalent 
binding2 is shown in Table 2.3. 
The position of the active amino acids on the enzyme is an important factor to 
consider. In general, hydrophobic amino acids are located in the core of the protein 
or buried zone, and less hydrophobic residues are preferentially in an exposed zone. 
However, the extent of exposure of the amino acids can be varied, depending on the 
properties of the medium and the enzyme itself. More frequently used reactive 
amino acid residues (RARs) are in general located on the surface of the enzyme in an 
aqueous environment as Lys, Glu, Asp, Arg, N- and C-terminal amino acids.  
                                                
2 These values represent the mean ranking of amino acids polarities according 38 published 
hydrophobicity scales [75]. The lower ranking numbers represent the most hydrophobic amino acids, 
and higher values represent the most hydrophilic amino acids.  
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2.5.3 Evaluation of immobilised enzyme 
The aim of the present section is to give an overview of available methodologies that 
have been utilised to gain knowledge on different aspects of immobilised enzymes. 
2.5.3.1 Immobilisation process 
In general, the process of covalent immobilisation of an enzyme consists basically in 
two main elements; the free enzyme (external solution) and the support or carrier. 
The most common method to monitor the protein immobilisation is to retrieve 
samples from the external solution (supernatant) at different times during 
immobilisation process and measure the amount of enzyme remaining in the 
surrounding solution commonly by absorption spectroscopy (see Section 4.3). This 
indirect approach usually requires manual sampling and results in a low time 
resolution. Also, if only a small fraction of protein is immobilised, the loading 
measured will be extremely inaccurate because it is a difference measurement. 
                                                
3 Frequency of occurrence of each amino acid residue in the primary structure of 105,990 protein 
sequences [75].  
Table 2.3. Properties of amino acids involved in covalent binding3. 
Amino acid Occurrence in 
proteins / % 
Ranking of amino acid 
hydrophobicity 
Glu 6.3 3 
Lys 5.8 5 
Asp 5.2 4 
Tyr 3.3 2 
Cys 1.8 1 
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There are not many studies whose aim is to measure the amount of the protein 
directly. Fluorescence microscopy has been used for this purpose [76]. There are also 
examples of the use of thermogravimetric analysis (TGA) to determine protein 
immobilised [77]. TGA is a common method to characterise materials by measuring 
changes in physical and chemical properties, such as phase transition, dehydration 
and decomposition, as function of temperature. With this technique the loss of 
weight upon heating a dried sample is used to determine the protein loading. By 
increasing the temperature protein degradation is induced, leading to the 
evaporation of organic material from the inorganic support.  
Recently, Quartz Crystal Microbalance with Dissipation monitoring (QCM-D) have 
been used to study the immobilisation process with much higher time resolution 
than the indirect approach. The QCM-D technique measures the mass added to the 
quartz crystal with a time resolution in the sub-second range [78]. 
2.5.3.2 Location of immobilised enzyme 
Some techniques can allow information to be obtained about where the enzyme is 
located (inside the pores or external surface) after the process of immobilisation. 
Techniques used for this purpose on immobilised enzymes are N2 adsorption [79, 80] 
and X-ray diffraction (XRD) [79]. For N2 adsorption, the pore volume can be 
evaluated before and after the immobilisation and pore occupation can be 
determined. XRD can give qualitative information about changes in the pore 
interiors before and after immobilisation. These techniques are referred as indirect 
techniques. There are also direct techniques that measure enzyme molecules 
localised inside the material. These techniques are fluorescence microscopy [81] and 
transmission electron microscopy in combination with immunogold staining 
(TEM-IGS) [82]. 
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The results from indirect techniques should be carefully interpreted. For example, in 
the case of nitrogen adsorption the reduced pore space after immobilisation process 
is not necessarily due to proteins occupying the pores but may also be explained by 
proteins blocking the pore openings, which in turn may hinder the nitrogen gas to 
enter. 
2.5.3.3 Conformational changes 
The conformational stability of protein structures can easily be affected by 
immobilisation as a consequence of the interactions with the support surface which 
often lead to enhanced or lowered enzyme activity [83]. Some methods can detect 
overall changes in protein structure, which can be an indicative measures of both 
unfolding and changes in enzyme activity.  
Circular dichroism (CD) is a well established method for studying conformational 
changes in protein secondary structures. The results are generally presented as 
changes in the percentages of the protein composed of α-helix, β-sheets, turns and 
random coils [84]. The presence of solid particles in samples may cause absorption 
flattening and differential light scattering perturbing the typical CD peaks. Different 
approaches have been applied to overcome these problems in the study of 
immobilised enzymes such as computational simulation corrections [85], use of 
nanosized supports [86, 87] and soluble polymers as carriers [88]. 
Fourier transform infrared spectroscopy (FTIR) has been widely used to study 
changes in protein secondary structure [89, 90]. Deconvolution of the spectra allows 
the determination of the fractions of organised secondary structures similar to the 
information given from CD spectra. FTIR has also been applied to immobilised 
enzymes confirming a maintained enzyme structure upon immobilisation [91, 92] or 
defining a α-helix/β-sheet ratio as a function of temperature [93]. 
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Fluorescence spectroscopy has also been used to study conformational changes on 
immobilised enzymes, specifically tryptophan fluorescence. The fluorescence 
spectrum of the amino acid tryptophan is dependent on the polarity of the 
surrounding solution [94]. Due to the hydrophobicity of tryptophan, the aromatic 
amino acid residue is often buried inside the protein. Therefore, unfolding of the 
protein will expose tryptophan to the surrounding solution, which can be detected as 
a shift in the fluorescence spectrum. Tryptophan fluorescence spectra have been used 
to prove a stabilising effect of immobilised enzymes compared to free enzyme [95, 
96]. 
2.5.3.4 Enzyme-surface interactions 
There are three important aspects in terms of protein-surface interactions on 
immobilised enzymes: structure, orientation and dynamics. Orientation and 
three-dimensional structure of immobilised enzymes are crucial to ensure high 
enzyme stability and activity. Most immobilisation procedures do not actively 
control the orientation of the enzymes, resulting in the inevitable burying and 
inaccessibility of some active sites. Some methods address the study of these aspects 
such as FTIR, computational simulations and solid-state NMR. 
FTIR is not only useful detecting conformational changes, but can also be used for 
detecting bond formation to the surface, therefore can be used to characterise 
formation of protein-surface interactions after immobilisation [97-100].  
Computer simulations of molecular dynamics have been used to model surface 
interactions on immobilised enzyme systems. These studies are focused in protein 
modeling of the enzyme structure and calculation of charge distribution on the 
surface at different pH [101-103]. This information can partly be used to predict how 
strongly enzymes can bind to the surface and how the strength depends on the 
environmental conditions upon immobilisation [101]. Some attempts to simulate the 
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interactions of proteins in confined environments such as nanotubes or micelles had 
been explored [104, 105]. Other approaches have been focused on modeling enzymes 
on surfaces where information of enzyme orientation can be retrieved [99, 106]. 
However, it remains to further develop the models to better mimic those systems 
allowing a better prediction of how enzyme structure is affected by the confinement 
into pores. With this requirement in mind, several studies have attempted modeling 
pore shaped nanostructures using molecular dynamics [107, 108]. 
Solid-state NMR is a popular technique to characterise supports used for enzyme 
immobilisation [109-111]. These studies do not include characterisation after the 
immobilisation process. To our knowledge, so far only one study had covered the 
analysis of enzyme-surface interactions by solid-state NMR after the process of 
immobilisation [1]. This publication derives from work included in this thesis in 
Chapter 5.  
Potentially, solid-state NMR can study immobilised enzyme dynamics indirectly 
indicating the strength of the interaction between the enzyme and the support, based 
on the hypothesis that proteins that bind strongly will be less mobile than those that 
are not tightly associated with the surface. Side chain and backbone dynamics can be 
studied using a combination of relaxation measurement (T1, T2, T1ρ and 
cross-polarisation efficiency) as well as 2H dynamics. Some reviews about the study 
of membrane proteins [112] and biomineralisation proteins [113, 114] show the 
potential capabilities of solid-state NMR for the study of immobilised enzymes. 
2.5.3.5 Enzyme-ligand interactions 
The most popular methodologies to study protein-ligand interactions were discussed 
in Section 2.4. Many of these methodologies are not possible to apply to 
heterogeneous systems such as immobilised enzymes. However, ITC has been 
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successfully applied in the activity analysis of different enzymes in the free state [115, 
116] and immobilised on solid supports [117, 118].  
Frontal affinity chromatography (FAC) has been used to study binding properties of 
several molecules to immobilised trypsin [119, 120]. Frontal analysis is a 
chromatographic method where the sample is continuously infused over a stationary 
phase, rather than injected in a low-volume plug. FAC has the advantage that it is 
extremely reproducible and could be able to identify strong (nM range) as well as 
weak-binding molecules (mM range).  
Solid-state NMR is a promising technique to monitor enzyme-ligand interactions on 
immobilised enzymes. By detecting spectral changes, residue-specific details of the 
enzyme-ligand interaction can be obtained. Interactions between ligand and labelled 
membrane proteins have been described in the past using solid-state NMR [121-123]. 
Until now, no solid-state NMR studies of ligand interactions on immobilised 
enzymes have been reported in literature.  
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CHAPTER 3 
 
Selection of the system of study 
To attain the objectives outlined in Chapter 1 it is imperative, as a first step, to define 
a system of study. The model systems studied in this thesis must comply with certain 
requirements. These requirements are primarily based on defining the immobilised 
enzyme system as simply as possible. The different elements of such a systems are 
discussed in this section. 
3.1 Type of Support 
Certain desirable features exist for the selection of the type of support, which should 
be: 
• Inorganic; because they generally have no carbon atoms, a lower 
concentration of hydrogen atoms and a higher mechanical strength than 
organic supports – these features directly affect the execution of NMR 
experiments.  
• Widely used as an enzyme support. 
• Well characterised through solid-state NMR. 
The selected supports were silica and alumina to comply fully with these three 
requirements. 
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The carrier bound group (CAG) selected was the epoxide group. The oxirane 
functionality is reactive with several amino acid residues (e.g., amino, carboxyl, 
hydroxyl, mercapto, phenol, imidazole and indole groups). 
Inconveniently, the silica and alumina supports were found to catalyse the 
hydrolysis of one of the inhibitors of interest (a R-BF3K salt − see Section 3.2.2.3); 
therefore a third support was selected: Eupergit®, a synthetic organic polymer was 
used for the studies of interactions between immobilised enzyme and ligands (see 
Chapter 7). 
3.1.1 Porous support materials 
Porous supports have received significant attention in enzyme immobilisation as a 
result of their high surface areas together with their ability to encapsulate enzymes 
within the pores, providing a stable environment. 
Figure 1.1 illustrates the scale and the level of complexity of an enzyme immobilised 
on a porous support material (approximate scale). The diagram shows a support 
particle of 15 µm of diameter (Figure 1.1a) and a pore size of 20 nm (Figure 1.1b). The 
diameter of the enzyme molecule in Figure 1.1c  is around 5 nm. 
An ideal support behaviour for a catalyst is one where the rate of the catalysed 
reaction is directly proportional to the surface area available for catalysis, assuming 
that all the surface is catalytically active. In addition to the surface area, it is essential 
to establish the pore diameter and the distribution range of the pore diameters, as 
part of the internal surface may not be accessible if the pore diameter is too small 
[124].  
The surface area of porous material can be classified into internal surface and 
external surface. The former is the total surface including that contributed by the 
pores, while the latter refers only to the outer surface. The internal surface is 
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generally about 100 to 1000 times the external surface for macroporous carriers, 
depending on the diameter of the particles and the pores. Thus, for such supports the 
enzyme loading on the external surface can be neglected in comparison with the 
overall enzyme loading [125]. 
Numerous methods currently exist for determining properties in porous materials. 
Pore size distributions can be obtained using gas adsorption [126, 127], differential 
scanning calorimetry (DSC) thermoporosimetry [128], mercury intrusion 
porosimetry (MIP) [129] and NMR cryoporometry [130]. 
The most commonly used methods for determining pore size distributions are gas 
adsorption and MIP. Often non-destructive testing is preferred and mercury 
intrusion fails in this regard because the measurement process damages the pore 
matrix and makes it impossible to reuse the sample. Gas adsorption, NMR 
cryporometry and DSC have the immediate advantange in that the samples remain 
undamaged and therefore can be measured again and recovered. All three methods 
rely on placing a liquid in the pores and measuring the change in the thermodynamic 
properties [131]. 
Gas adsorption relies on the Kelvin relationship. The surface area of a porous 
material is determined by determining the volume of a monolayer of an inert gas 
(typically N2, He or Ar) adsorbed by the support, usually using the BET method 
described by Brunauer, Emmett and Teller [126]. The adsorption-desorption 
isotherms obtained can be classified into six types, I-VI [132]. The shape of the 
isotherm can be used to provide details of the structure of the material being 
analysed. These details can include pore geometry, internal pore diameter, and pore 
size distribution and pore volume of the material. The results obtained by adsorption 
methods can be confirmed or clarified using X-ray diffraction (XRD) or transmission 
electron microscopy (TEM) [133]. Adsorption methods have been adopted as the 
principal methods to characterise porous materials. IUPAC [132] classify porous 
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materials by pore width as microporous, mesoporous or macroporous when the pore 
diameter are less than 2 nm, between 2 and 50 nm and greater than 50 nm, 
respectively.  
Both NMR cryoporometry and DSC thermoporosimetry rely on the Gibbs-Thomson 
equation concerning the relationship between the characteristic pore length scale and 
the change in the freezing point of the liquid, or melting point of its solid crystal, due 
to confinement within the porous matrix. 
NMR cryoporometry is a method suitable for measuring pore sizes and pore size 
distributions in the range of less than 30 Å to over 3000 Å pore diameter. The 
technique involves freezing a liquid in the pores and measuring the melting 
temperature by NMR. Since the melting point is depressed for crystals of small size, 
the melting point depression gives a measurement of pore size. Accurate 
measurements of the sample temperature are necessary for this approach [131].  
3.1.2 Metal-oxide-based supports 
From the early days of enzyme immobilisation oxide-based materials have been used 
[134]. Some of the advantages of using these types of support are their tunable 
physical features (e.g., porosity, particle size). Also, inorganic supports in general are 
not susceptible to biological attack and usually their morphology remains unchanged 
under different conditions of solvent or pH [135].  
3.1.2.1 Silica 
Silicon dioxide (SiO2) usually exists as a three-dimensional polymer with regular 
units of tetrahedral SiO4 sharing vertices with each other in an infinite lattice of 
siloxane bridges Si-O-Si. The most abundant form of SiO2 is in crystalline 
arrangement (i.e., quartz) forming a tetrahedral structure [136].  
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Conventional oxide-based supports possess a broad pore size distribution, low 
surface area and low thermal stability. These carriers were used extensively for more 
than seven decades [135]. The synthesis of ordered mesoporous materials with 
uniform pore size distribution was started as early as the 1970s [137-139] but went 
almost unnoticed. Intensive research in the area of mesoporous silica supports began 
in 1990s [140, 141]. Since then, a very large number of different mesoporous materials 
have been developed [142]. These tunable materials are generally prepared by 
controlled hydrolysis of tetraethyl orthosilicate or sodium silicate in the presence of 
surfactants in a solvent solution. The surfactants act as templates of the pores and 
help in the formation of a highly ordered organic-inorganic liquid-crystal phase 
(mesophase or mesostructure). The removal of the surfactant from the mesostructure 
by calcination at high temperatures or other physical or chemical treatments results 
in the formation of mesopores in the structure [143]. 
The use of this type of material as a support for enzyme immobilisation results in 
high enzyme loadings. In addition, the enzyme molecules inside the pore channels 
are protected from microbiological attack as well as from physical and mechanical 
damage [144]. 
Usually, silica surfaces show two main chemical functions: silanols (Si-OH) and 
siloxanes (Si-O-Si). The existence of four different types of coordinated-Si are 
postulated: isolated (Q3), geminal (Q2), bulk (Q4) and Q1. This last species is 
postulated but its real existence is not yet generally accepted. Figure 3.1 shows a 
representation of the bare silica surface. The coexistence on the silica surface of both 
hydrophobic (siloxanes) and hydrophilic sites (silanols) on silica surface, particularly 
the latter, explain the adsorptive properties of many silica-based materials [144]. 
Solid-state NMR techniques can reveal the surface structure of silica-based supports 
competently [136]. 
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3.1.2.2 Alumina 
Bauxite is the major source of alumina (Al2O3) worldwide. The process of producing 
pure alumina from bauxite ore (by the Bayer process) has changed very little since 
1893. The different aluminium minerals present in bauxite (e.g., gibbsite, boehmite) 
are selectively extracted from the insoluble components (e.g., quartz, iron, clay, 
titanium oxide) [145]. 
The dehydroxylation by heating treatment of aluminium trihydrates (gibbsite, 
bayerite and nordstrandite), monohydrate (boehmite) or hydroxide gels (the most 
important is pseudoboehmite) leads through different sorts of intermediate hydrates 
(transition aluminas) to anhydrous α-alumina (Figure 3.2) [146]. At least six different 
transition alumina phases ( χ, δ, γ, η, κ, θ) have been claimed using various 
techniques, including 27Al MAS NMR [147, 148]. From these transitions, γ-alumina is 
perhaps the most extensively studied and used in catalysis because of its high 
porosity and specific surface. The structure of γ-alumina is traditionally considered 
as a cubic defect spinel type. The defective nature derives from the presence of only 
trivalent Al cations in the spinel-like structure [149]. 
From an enzyme immobilisation point of view, γ-alumina could represent an 
interesting alternative to silica-based supports [144].  
The history of controlled synthesis of mesoporous alumina has been far more 
tortuous than for mesoporous silica-based materials. In 2002, Zhang and Pinnavaia 
 
Figure 3.1. Scheme of silica surface with Q1, Q2, Q3, Q4 notation for SiO4 centers. 
!
Q 1 Q 2 Q
3
Q 4
Pa
rti
cle
 
su
rfa
ce
Bu
lk
Q1 Q2 Q3 Q4
 
 
Selection of the system of study 
 
59 
[150] reported the first successful synthesis of γ-alumina with a uniform pore size 
distribution by condensation of aluminium alkoxide in the presence of neutral 
polyethylene oxide surfactants. Since then, similar procedures have been developed 
for the synthesis of mesostructured alumina [151]. Nowadays, it is possible to find a 
wide variety of mesoporous aluminas commercially available with customised pore 
size and particle size distributions (e.g., PURALOX®, CATALOX®). 
An interesting property of aluminas is their amphoteric character. They possess 
acidic and basic properties that are controlled by the surface groups. Upon exposure 
to a moist environment at low temperature (< 500 K) the surface of a metal oxide 
undergoes a series of chemical reactions that are largely dictated by the chemistry of 
the cations. The first step in surface hydration involves the formation of surface 
hydroxyl groups followed by molecular adsorption. Protons attached to bridging 
oxygen sites behave as Brønsted acids, whereas the OH- ions adsorbed to the cation 
sites behave as Brønsted bases. Additionally, the degree of unsaturation of Al+3 ions 
sites defines the strength of their Lewis acid character on surface. 
Among the different surface model and site configurations reported in the literature, 
the model proposed by Knözinger and Ratnamasy [152] in the late 1970s is still the 
most accepted (Figure 3.3) where a minimum of five different OH configurations 
should be expected to exist on the surface of γ-alumina. 
 
Figure 3.2. Thermal transformation sequence of aluminium trihydroxides and 
monohydroxides. 
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3.1.3 Oxirane functional polymers 
Many types of polymer bearing active functionalities have been studied for enzyme 
immobilisation. They include carriers bearing the functionalities such as acyl azide, 
acid anhydride, epoxy, isothiocyanate, aldehyde, activated esters, etc. [66, 72]. 
The first examples of synthetic polymers bearing oxirane functional groups for 
enzyme immobilisation can be dated to the mid-1970s [153, 154]. Since then, their 
capabilities as supports for industrial application have been proven [6, 155-158]. 
3.1.3.1 Eupergit® 
A popular and commercially available acrylic resin with epoxide pendant groups is 
Eupergit®, widely used as enzymatic support [159]. Eupergit® is a macroporous 
copolymer of N, N’-methylene-bi-(methacrylamide), glycidyl methacrylate, allyl 
glycidyl ether and methacrylamide (Figure 3.4a) with an average particle size of 180 
µm [155]. It is a relatively hydrophilic polymer with a water retention capacity of 3 g 
 
Figure 3.3. Types of OH- groups on the surface of alumina. (a) A terminal OH group is 
coordinated to a single tetrahedral Al3+ cation, (b) the OH group is coordinated to a single 
cation in an octahedral interstice, (c) a bridging OH group links a tetrahedral and a 
octahedral cation; (d) the OH group links two cations in octahedral positions, and (e) the 
OH group is coordinated to the three cations in octahedral interstices [152]. 
(a) (b)
(d)(c) (e)
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of water per gram of polymer, and is very stable chemically over a pH range from 0 
to 14.  
Two different pore sizes have been produced by Evonik Industries (previously by 
Röhm and Haas), Eupergit® C and C 250 L (Appendix A, Table A.3). Both Eupergit® 
C and C 250 L are microporous, epoxy-activated acrylic beads with a diameter of 
100-250  µm. They differ in the content of oxirane groups and in their porosity. While 
Eupergit® C has an average pore size of 100 Å and an oxirane density of 600  µmol  
g–1 dry beads, Eupergit® C 250 L has larger pores (1000 Å) and a lower oxirane 
density (300  µmol g–1 dry beads) [159]. The main advantages of immobilisation on 
Eupergit® is the increase in resistance to thermal and pH denaturation, and to the 
shear forces under reactor condition (i.e., stirred tank). Changes in pH and salt 
concentration have no effect on matrix swelling and it is therefore a good support 
candidate for fixed bed reactors. The enzyme loading is usually 10-100 mg protein   
g–1 carrier with activity retention usually below 50% [159].  
3.2 Enzyme 
α-Chymoptrypsin was chosen as a convenient enzyme model in this thesis on which 
to test out methods used in Chapter 5 to Chapter 7. Also the availability of known 
fluorinated inhibitors was one factor (see Section 3.2.2.3). 
 
Figure 3.4. Eupergit® support before (a) and after (b) immobilisation. 
!
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The enzyme immobilisation methodology selected must be a well studied process. 
Therefore, the immobilisation of α-chymotrypsin onto silica particles was chosen as 
the primary system. The immobilisation of the enzyme to the solid support is via 
covalent binding with the selected graft molecule (GOPS). 
3.2.1 α-Chymotrypsin 
3.2.1.1 General features of structure and action 
α-Chymotrypsin (Figure 3.5) has been extensively studied because it is small (25 
kDa), easily obtainable in large quantities and relatively stable. α-Chymotrypsin is 
produced in the pancreas and plays a role in digestion by hydrolysing polypeptide 
chains that contain aromatic amino acids. This enzyme was one of the first four 
enzyme structures to be solved by X-ray crystallography [160] and NMR studies 
[161] of these proteases were underway by the early 1970s. The polypeptide chain of 
α-chymotrypsin comprises 245 amino acids arranged in two six-stranded beta 
barrels. The active site is located between the two barrels [162, 163]. The active site is 
generally divided into catalytic, substrate recognition and zymogen activation 
domain component that are common to all chymotrypsin-like serine proteases [164]. 
These three processes involve many of the same structural features and are 
intricately interlaced. 
The α-chymotrypsin possesses its optimum activity at pH 8.2 and its isoelectric point 
is 9.1. The molecule is a compact ellipsoid of dimensions 51 × 40 × 40 Å [165].  
α-Chymotrypsin is a serine protease, one of the most widely studied groups of 
proteases. These enzymes cleave peptide bonds by the attack of an activated serine 
residue on the carbonyl group of the bond. Serine proteases are classically 
categorised by their substrate specificity: trypsin-like (Lys/Arg preferred), 
chymotrypsin-like (large hydrophobic residues such Phe/Tyr/Leu) or elastase-like 
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(small hydrophobic residues such as Ala/Val) [166]. Serine proteases that do not 
belong to any of those categories are the subtilisins, which possess a broad 
specificity. α-Chymotrypsin belongs to the chymotrypsin-like family, the largest 
group, and contains a deep hydrophobic pocket as is shown in Figure 3.5, which 
results in the enzymes specifically binding to substrates/inhibitors containing an 
aromatic and/or hydrophobic group that can fit into this pocket. The catalytic triad 
consists of His57, Asp102 and Ser195 [167] (Figure 3.6). In Figure 3.5 these three 
residues are labelled in yellow. 
Currently, there are three different catalytic mechanism theories of how the triad 
works in serine proteases: the conventional (Figure 3.7), the low-barrier H-bond and 
 
Figure 3.5. Structure of α-Chymotrypsin (PDB code 1CHG) [168]. This figure was 
produced with iMol v 0.4. 
!
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more recently the imidazole ring flip theory. The strongest theory to explain the 
mechanism of the catalytic triad of serine proteases is the charge-relay model of Blow 
et al. [162] (see Figure 3.7). 
Since 1969 [162] there have been more than forty years of studies in this field and yet 
a detailed picture is still not completely clear about the structure and chemical 
properties of the triad. At that time all the theory around serine active site was 
supported by X-ray diffraction data. X-ray crystallography has been essential to 
unveil the mechanism of the catalytic triad on serine proteases but controversies in 
this field have arisen, some of them deriving from a major big pitfall of the 
technique; the high salt concentrations needed. 
Further NMR studies supported the theory of Blow et al. (see Section 3.2.1.4) which 
postulates that the triad functioned as a ‘charge relay system’ where protons were 
relayed towards a buried aspartic acid in the hydrophobic interior of the protein 
(Asp102) and where electrons were relayed towards the serine residue 195 producing 
the net effect of a strong nucleophile (Ser195). 
 
Figure 3.6. Scheme of catalytic triad of resting serine protease at low pH proposed by 
reference [162]. 
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Figure 3.7. Conventional mechanism of hydrolytic cleavage of a peptide bond by 
chymotrypsin. 
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3.2.1.2 Conventional mechanism 
Figure 3.7 summarises the conventional hydrolytic cleavage mechanism [169] of a 
peptide bond by chymotrypsin. First (step ) the substrate binds the active site of 
the enzyme; the side chain of the residue adjacent to the peptide bond to be cleaved 
nestles in a hydrophobic pocket on the enzyme; the peptide bond is positioned for 
attack. After this (step ), the interaction of Ser195 and His57 generate a strong 
nucleophilic alkoxide ion on Ser195 and the ion attacks the peptide carbonyl group 
forming a tetrahedral intermediate enzyme. This is accompanied by formation of a 
short-lived negative charge on the carbonyl oxygen of the substrate that is stabilised 
by hydrogen bonding in the oxyanion hole. 
Afterwards (step ) the instability of the negative charge on the substrate carbonyl 
oxygen leads to collapse of the tetrahedral intermediate; re-formation of a double 
bond with carbon displaces the bond between carbon and the amino group of the 
peptide linkage thereby breaking the peptide bond and forming an acyl-enzyme 
intermediate. The amino leaving group is protonated by His57, facilitating its 
displacement. In step  an incoming water molecule is deprotonated, generating a 
strongly nucleophilic hydroxide ion. A second tetrahedral intermediate is generated 
by an attack of hydroxide on the ester linkage of the acyl-enzyme, with oxygen in the 
oxyanion hole again taking on a negative charge. The deacylation, step  and , 
collapses the tetrahedral intermediate and forms a carboxylate anion and displaces 
Ser195. Finally in step  the release of the second product is followed by the 
regeneration of the active site [169]. 
3.2.1.3 Catalytic components  
The Oxyanion Hole 
The oxyanion hole was first noted by Henderson [170]. The hole is formed by the 
backbone NHs of Gly193 and Ser195. These atoms form a pocket of positive charge 
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that activates the carbonyl of the scissile peptide bond and stabilises the negatively 
charged oxyanion of the tetrahedral intermediate (Figure 3.7) [170, 171]. Crystal 
structures of several transition state analogue complexes confirm this interaction 
[172-174]. 
The Substrate Recognition Sites 
The active site of proteases contains several S pockets, which accommodate 
consecutive amino acids (called P sites) towards the N-terminal of the peptide. In a 
similar way, S’ and P’ sites exist towards the C-terminal from S1’ and P1’, 
respectively (Figure 3.8). These sites determine the substrate specificity through the 
size, shape and charge of the side chains involved. The compatibility and fit between 
the S sites in the substrate-binding pocket and the substrate P sites are influenced by 
the three-dimensional structure of the substrate when it is bound to the enzyme. 
The S1 site is a pocket adjacent to Ser195, formed by residues 189-195, 214-220 and 
225-228. The residues at positions 189, 216 and 226 usually determine specificity [175, 
176]. The specificity of chymotrypsin correlates with the hydrophobicity of the P1 
residue, with P1 as Phe preferred over Ala by 50000 times [177]. The combination of 
Ser189, Gly216 and Gly226 create a deep hydrophobic pocket (Figure 3.7) in 
chymotrypsin [163]. 
Enzyme-substrate interactions are not restricted only to the S1 site. Often in serine 
proteases there are additional binding pockets for the backbone of the peptide 
substrate. In chymotrypsin hydrogen bonds are formed between the peptide 
substrate and polypeptide binding site formed by residues 214-216. The polypeptide 
binding site also forms one wall of the S1 site and the residue 214 (Ser) forms a 
hydrogen bond to His57 showing the intertwined connection between all processes 
on the active site. 
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Zymogen Activation Domain 
Chymotrypsin is synthesised as an inactive precursor or zymogen where the latter 
has different segments deformed. These deformed regions include the S1 site and the 
oxyanion hole, which explains the low activity of the zymogen. A proteolytic process 
activates the zymogen releasing the N-terminal Ile16 [178]. The new N-terminus 
forms a buried salt bridge with Asp194 that induces a conformational change 
activating the enzyme. An interesting fact is that loss of activity at high pH is 
attributed to the deprotonation of the N-terminus and the disruption of the 
Ile16-Asp194 salt bridge changing the conformation to an inactive zymogen-like 
conformation [179, 180]. 
3.2.1.4 NMR observation of active site 1H signals  
The current understanding of active site H-bonding in serine proteases has been 
revealed principally by NMR and X-ray crystallography. This section summarise the 
most important contributions in the study of hydrogen bonds in the active site of 
serine proteases − focused on chymotrypsin-like proteases − by NMR spectroscopy.  
 
Figure 3.8. The substrate recognition sites of proteases. The active site of a protease (blue) 
is composed of several substrate-binding subsites (S). The nomenclature of the S sites (S1, 
S2, S1’ and S2’) is concordant with the P sites of the peptide substrate (yellow). Sn sites 
are amino-terminal to the scissile bond (indicated by scissors) and Sn’ sites are 
carboxy-terminal to the scissile bond. 
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Asp102-His57 H-bond 
An important discovery was made in 1972 by Robillard and Shulman [161]: the first 
direct observation of a single proton signal from the active site of chymotrypsin and 
chymotrypsinogen (zymogen or precursor of chymotrypsin), using continuous-wave 
(CW) solution-state 1H NMR. The signal was titrated from ~ 18 to ~ 15 ppm with 
increasing pH, exhibiting a pKa value of 7.5. They assigned this signal to the proton 
in the Asp102-His57 H-bond [162] due to two observations: the signal seems 
invariable in serine proteases (e.g., trypsin, trypsinogen, subtilisin) but not in other 
proteins, and alkylation of His57 at Nε2 causes the signal to become pH independent. 
This assignment was supported by subsequent NMR studies [181-183]. 
His57-Ser195 H-bond 
As has been mentioned previously, the tetrahedral intermediate formation is crucial 
for the catalytic activity of serine proteases. One of the players in this configuration is 
the His57-Ser195 couple. When Robillard and Shulman [161, 184, 185] discovered the 
Asp102-His57 H-bonded proton resonance at low field, they failed to detect a 
corresponding high frequency signal for the His57-Ser195 H-bond. 
Markley and Westler [186] accomplished the direct observation, more favourable at 
low pH, of the His57-Ser195 H-bonded proton. This proton resonates at a chemical 
shift of ~ 13 ppm [187]. Its visibility is favoured at low, rather than high, pH. 
Probably, this effect is due to slowing or preventing of acid-base mechanisms at low 
pH.  
His57-Ser214 H-bond 
Among chymotrypsin-like proteases, a backbone amino acid − Ser214 − contributes 
to the substrate binding. In Figure 3.9 it is possible to observe that this residue does 
not belong to the catalytic triad. 
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The proton donor in an H-bond is thought to be very electronegative, e.g., O or N. 
Although carbon is not particularly electronegative, the idea that carbon-bound 
protons can act as H-bond donors was first proposed more than 60 years ago [188, 
189] starting the controversy about the existence of this type of H-bond. In the early 
1960s evidence of this kind of bond was provided in biological molecules [190]. 
Finally, after several years of debate, the belief that carbon-bound protons can act as 
H-bond donors has now become widely accepted [191, 192]. 
Derewenda et al. [193] proposed the existence of an additional H-bond in the serine 
proteases triad between the Cε1-H proton of His57 and a backbone carbonyl oxygen 
atom from the residue 214 (Figure 3.9) after analysis of more than 30 X-ray structures 
of different serine hydrolases. In 2000, Ash et al. [194] linked an unusual high 
frequency proton resonance with the interpretation that such chemical shift reflected 
the existence of carbon-H donated H-bonds. This proton signal resonates at 9.22 ppm 
for a protonated His57 in a α-lytic protease. Not many further studies have been able 
to prove the existence of this bond. 
 
Figure 3.9. Scheme of current model of active site of resting serine protease. 
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3.2.2 Enzyme interactions 
3.2.2.1 Water  
To perform their functionalities, enzymes require certain levels of water to sustain 
their conformational structures and this affects the ionisation and mobility of groups 
at the protein surface. Water molecules are also important in the interaction of 
enzymes with their reactants and products, either because they must be displaced in 
the process, or in some cases when they make bridging interactions. The presence of 
water does not always lead to positive results as regards enzyme performance. It is 
well known that extra water contributes to a decrease in the thermostability of the 
enzyme [195].  
To understand from a mechanistic point of view the importance of water on an 
enzyme it would be ideal to know the amount of water bound to the enzyme 
molecules and, if possible, their location [196]. This task is not an easy one. Also it 
depends of the medium used: aqueous or organic.  
Karl-Fischer analysis can give some information about the water in the system in an 
organic solution. The experiment has a restricted sensitivity and should be carefully 
designed so as to obtain information from real bound state water and not from the 
whole system [195]. Crystallography has been proven to be a useful technique for 
observing water in proteins [197] but with the usual drawbacks of the technique (e.g., 
high concentrations of salts on the structure and rigid conformation).  
The extent of interaction between protein and water can also be monitored by  
studying the dynamic processes affecting proteins (see Section 2.3). Molecular 
dynamics simulations [198-200], supported by fluorescence spectroscopy [201, 202], 
inelastic neutron scattering [203] and NMR [204] experiments report rotational 
correlation times ranging for water-protein interactions from a few picoseconds for 
bulk water [199], up to nanoseconds for surface, and tens of nanoseconds for buried 
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water [204]. NMR provides several tools for examining events that occur on these 
different time scales, based on relaxation approaches, that are discussed in Section 
2.3.1. 
NMR methods can give qualitative and/or quantitative information about the water 
in both liquid and solid systems without the requirement of a crystalline order. 
Among the many different approaches used in NMR to study protein hydration, 
three interesting examples are: multiple-quantum relaxation of 17O nuclei [205-208] 
(discussed in Section 6.3), magnetic relaxation dispersion of 2H and 17O [209] and 
intermolecular 1H-1H nuclear Overhauser effects (NOEs)[210].  
The type of support used for enzyme immobilisation can also have a role in the water 
dependent properties of a reaction system. This is due to the properties of the matrix, 
such as pore size, surface area and hydrophobicity of the support. 
3.2.2.2 Ions 
Role of Ca2+ in α-Chymotrypsin function 
Calcium ions are involved in a variety of important biological functions, many of 
which are accomplished through interactions with proteins. Ca2+ interacts with a 
number of extracellular proteins to confer thermal stability, protection against 
autolysis and is required for the activity of a number of enzymes. It has been known 
for many years that calcium ions stabilise chymotrypsin towards autolysis and 
denaturation [211, 212]. 
The existence of monomeric and polymeric forms of α-chymotrypsin in solution is 
well established. The dimerisation of α-chymotrypsin inactivates the enzyme since 
this binding involves the active site (acyl-enzyme dimers) [213]. Calcium ions have 
an inhibitory effect on this process impeding the dimerisation. Some evidence shows 
[214] that this effect is due to a displacement of the  monomer-dimer equilibrium by 
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the specific interaction of the metal ion with a single site on the monomeric enzyme. 
Therefore, it is recommended, when free enzyme is used, that a relatively low 
concentration of CaCl2 (20 mM) is included to prevent dimerisation of the enzyme 
and therefore autolysis. 
Role of Na+ in α-Chymotrypsin function 
In Chapter 6, a TQF (triple quantum filtered) NMR experiment is used to study ion 
binding to biological molecules in solution [215]. Regulation of activity through 
metal ion complexation plays a key role in many enzyme-catalysed reactions. 
Na+ is the most abundant metal ion in extracellular fluids and second highest in 
abundance in ocean water after Cl−. Molecular evolution has driven the incorporation 
of selective cation binding sites into many enzymes to enhance the activity, diversity, 
and/or stability of many enzymes [216]. 
Some experimental evidence exists to suggest that ion binding in enzymes 
substantially influences the enzyme-catalysed reaction. Ion binding may stabilise 
surface-exposed residues to increase overall thermal stability with little or no effect 
on catalysis. Cation binding has been noted to enhance the stability of a number of 
enzymes of mesophilic origin [216]. 
It is known that for S1 peptidases, a group of which α-chymotrypsin is a member, the 
Na+ site lies immediately adjacent to Asp189 in the hydrophobic pocket (S1) of the 
enzyme and establishes a direct link with substrate binding. Furthermore, the Na+ 
binding influences the extended binding site of the enzyme [216]. 
Dang et al. [217] report that the catalytic activities of several serine proteases are 
enhanced allosterically by Na+ binding. This allosteric effect is due to the nature of 
residue 225 [217, 218]. Residue 225 is either a proline or tyrosine in the vast majority 
of serine proteases [219]. In the case of α-chymotrypsin the residue 225 is proline, 
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and it is found in more ancestral proteases and practically all chymotrypsin-like 
proteases [220]. 
3.2.2.3 Inhibitors 
Any compound that decreases the catalytic activity of an enzyme is by definition an 
inhibitor. In terms of inhibitor kinetics there are two large groups of inhibitors: 
reversible and irreversible.  
Reversible inhibitors can bind to enzymes through weak non-covalent interactions 
such as ionic bonds, hydrophobic interactions and hydrogen bonds. Reversible 
inhibitors are properly classified according to the catalytic step with which they 
interact: competitive, uncompetitive and mixed type inhibitors. A competitive 
inhibitor competes with the substrate for the active site of an enzyme. While this type 
of inhibitor occupies the active site no substrate can bind to the enzyme. Increasing 
the concentration of substrate can overcome this type of inhibition. Uncompetitive 
inhibitors affect the chemical processing of the bound substrate in the active site 
without interfering with substrate binding. A mixed inhibitor binds at a site distinct 
from the substrate active site but also it binds at the active site.  
The irreversible inhibitors are those that bind covalently causing chemical changes to 
the active site of enzymes and cannot be reversed. They often contain electrophilic 
groups (i.e., aldehydes, alkenes or phenyl sulphonates) that are able to react with 
amino acid side chains to form covalent adducts. The amino acid residues act as 
nucleophiles such as hydroxyl or sulfhydryl groups (e.g., amino acids serine, 
cysteine, threonine or tyrosine).  
In general, non-covalent reversible inhibitors are preferred candidates for inhibiton 
studies because they provide better selectivity and should cause fewer side effects 
than covalent inhibitors [221]. Non-covalent inhibitors are much more difficult to 
design. Possible methods for generating non-covalent inhibitors include designing 
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transition-state analogues (mimicking the transition state during substrate 
hydrolysis) or substrate variants (structures that retain functionality and scissile 
bond of the substrate destabilising transition states), but not substrate analogues, 
which generally produce covalent inhibitors [222]. 
The strength of the binding between an enzyme and a reversible inhibitor is defined 
by the dissociation constant,  
 
 
3.1 
where ,  and  are the concentrations of the free enzyme, free 
inhibitor and enzyme-inhibitor complex, respectively. 
Serine protease inhibitors 
Serine proteases are ubiquitous in many biological processes and their deregulation 
is linked to many diseases (e.g., cancer, cardiovascular diseases, AIDS, hepatitis C) 
[223]. Therefore, there is significant interest in the area of protease-targeted therapies 
focused on drug discovery of inhibitors targeting serine proteases [221]. 
Organophosphates, sulphonyl fluorides, coumarins and boronic acids are some of 
the most widely used inhibitors of proteases. In this section boronic acids and their 
derivatives will be reviewed as inhibitors of chymotrypsin-like proteases.   
Boron-containing inhibitors 
In the 1970s, boronic acids were first used as enzyme inhibitors for serine proteases 
[224-227]. The boron atom in boronic acid is usually sp2 hybrised (neutral, trivalent 
and planar) with an empty p-orbital. When the acid is in an aqueous solution, oxygen 
from water fills the empty orbital of boron and releases a proton to generate sp3 
hybrised boron (tetravalent and tetrahedral), making it a Lewis acid (Figure 3.10a). 
 Kd !
 
Kd =
Efree⎡⎣ ⎤⎦ I free⎡⎣ ⎤⎦
EIbound⎡⎣ ⎤⎦
 Efree
⎡⎣ ⎤⎦  I free
⎡⎣ ⎤⎦  EIbound⎡⎣ ⎤⎦
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Only in exceptional cases do boronic acids act as Brønsted acids (Figure 3.10b) (e.g., 
coordination of hydroxide ion to boron in heterocyclic boronic acids) [228].  
The tetrahedral geometry of sp3 hybrised boron in boronic acids is the one that can 
mimic the enzyme-catalysed substrate tetrahedral transition state and the reason 
why boronic acid compounds can be used as enzyme inhibitors. 
Aryl and arylakyl boronic acids were the first boronic acids reported to be strong 
competitive inhibitors of chymotrypsin [183, 224, 226, 229-231] with dissociation 
constants,  Kd , in the millimolar order. 
Robillard and Shulman [184] in 1974 reported the first study of different boronic 
acids (boric acid, phenylboronic acid and 2-phenylethylboronic acid) complexes with 
the active site of serine proteases by 1H NMR. They observed that the high frequency 
proton in the Asp102-His57 H-bond moved to an intermediate position (15-16 ppm) 
between low and the high pH chemical shifts. 
The design and synthesis of more potent, reversible and selective boronic acids 
possessing specific peptide moieties have been developed since.  Some of these 
successful transition state analogues of α-chymotrypsin are 
benzamidomethaneboronic acid (Figure 3.11a) [232] and 
1-acetamido-2-phenylethaneboronic acid (Figure 3.11c) [233], with dissociation 
constants,  Kd , of around the nanomolar range. Matesson et al. [233] found that R 
 
Figure 3.10. Ionisation equilibrium of boronic acids in water as a (a) Lewis acid or as a (b) 
Brønsted acid. 
(a)
(b)
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isomers of the phenylalanine derivative inhibitor (Figure 3.11c) bind tighter than S 
isomers. The performance of this analogue as inhibitor of α-chymotrypsin was 
slightly better than benzamidomethane boronic acid at same pH.  
Some years later, Bachovchin et al. [234] observed that not all boronic acids inhibitors 
behave in the same way as transition state mimics. Using 15N NMR they examined 
the active site of α–lytic protease in presence of different boronic acids. They 
concluded that boronic acids that resemble the structure of natural substrates of 
serine proteases, such as phenylalanine, form complexes in which the imidazole ring 
of the active site is protonated. In these complexes both N-H protons are strongly 
hydrogen bonded – type 1 complexes – and tend to have high affinities for the 
enzyme (Figure 3.12a). Boronic acids with structures that are not well related to that 
of the substrate tend to coordinate covalently between Nε2 of His57. These boronic 
acids form type 2 complexes with the active site, resulting in a histidine-boronate 
adduct with lower binding affinities (Figure 3.12b) [234]. 
 
Figure 3.11. Structure of some boron-containing inhibitors of α-chymotrypsin. (a) 
benzamidomethaneboronic acid, (b) 1-acetamido-2-(4-fluorophenyl)ethane-1-boronic acid,  
(c) 1-acetamido-2-phenylethane-boronic acid, and (d) potassium 
4-fluorophenyltrifluoroborate. Aromatic protons are not included for structure simplicity. 
(a)
(c)
(b)
(d)
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Type 1 complexes should exhibit two signals in the low-field region of the 1H NMR 
spectrum. On a α-lytic protease, using BoroVal (MeO-Suc-Ala-Ala-Pro-boro-Val-OH) 
as inhibitor, the Nδ1-H and Nε2-H protons for type 1 complexes resonate at ~ 16.0 and 
~ 16.5 ppm, respectively. Both signals were assigned unambiguously by 15N NMR 
[234]. The fact that Nε2-H resonates further at higher frequency than Nδ1-H indicates 
that Nε2-H forms the stronger of the two H-bonds. In 1995, Zhong et al. [235] 
observed similar results for BoroPhe (MeO-Suc-Ala-Ala-Pro-boro-Phe-OH) and 
BoroVal-chymotrypsin complexes with two pH invariable chemical shifts. They 
assumed the assignment by Bachovchin et al. [234] of Nδ1-H and Nε2-H protons at      
~ 16.0 and ~ 17.0 ppm, correspondingly. In 1998, Bao et al. [236] studied the 
complexes of chymotrypsin and subtilisin with BoroPhe. This research exposed the 
fact that the assignments adopted in the study of Bachovchin and co-workers’s for α-
lytic protease [234] for Nδ1-H and Nε2-H protons were probably confused with other 
serine proteases complexes [235]. Bao et al. conclude that the higher frequency proton 
signal belongs to Nδ1-H and the lower frequency signal to Nε2-H, reversing previous 
beliefs for chymotrypsin-peptideboronate serine adducts complex. 
Type 2 inhibitors gave rise to a single pH independent resonance at low frequency  
(~ 15.5 ppm) for α-lytic protease inhibited by benzeneboronic acid [234]. These 
results are consistent with Robillard and Shulman’s early 1H NMR work [184] on a 
 
Figure 3.12. Scheme of serine protease boronic acid complexes. (a) Type 1 (serine adduct) 
and (b) type 2 (histidine adduct). 
!
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boric acid-chymotrypsin complex. This showed a single high frequency resonance at 
~ 15 ppm, confirming that this complex behaves as a His adduct. 
19F NMR has been proven as an effective probe for biological interactions. The 19F 
nucleus has excellent NMR properties that are comparable to those of the proton 
NMR (Table 2.1). Strong dipolar coupling allows 19F-19F and 1H-19F nuclear 
Overhauser effects to be measured [237]. One of the most useful and simple features 
of 19F nucleus is the intrinsic sensitivity of its chemical shift to changes in the local 
chemical environment, with a range of ~ 400 ppm against 15 ppm for the 1H nucleus 
[238]. 
Sylvia and Gerig [239, 240] were among the promoters of an interesting approach to 
studying boronic acids interacting with serine proteases. They attached a fluorine 
atom to the phenyl ring of 1-acetamido-2-phenylethaneboronic acid (Figure 3.11b) so 
that information could be conveniently obtained from the fluorine-containing 
α-chymotrypsin-inhibitor complex. The 19F NMR spectrum of such a system 
exhibited two resonances, one at the chemical shift characteristic of the inhibitor in 
the absence of the protein and another 2.34 ppm to higher frequency. They assumed 
that the high frequency signal arose from inhibitor molecules bound to the enzyme.  
Fluorine relaxation in labelled proteins is dominated by proton-fluorine dipolar 
interactions which can be studied using heteronuclear {19F, 1H} NOE [241]. With this 
in mind, Sylvia and Gerig [239] carried out a two-dimensional {19F, 1H} NOE 
experiment of α-chymotrypsin in the presence of the fluorine-containing inhibitor 
(Figure 3.11b). H-F cross peaks were observed with the fluorine signal representing 
the bound inhibitor (Figure 3.13). The highest frequency cross peak at ~ 6.9 ppm in 
Figure 3.13, is very likely to be a result of an intra molecular NOE effect between the 
aromatic protons of the fluoroaromatic ring of the inhibitor. Similar results were 
obtained by Hammond, using a fluorine-containing carbazate [242], for an acylated 
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form of α-chymotrypsin. These results suggest that the other cross peaks on the 
twodimensional spectrum are possibly related to the hydrophobic pocket. 
The studies by Sylvia and Gerig [240] of the enzyme-inhibitor complex at different 
pHs by 1H NMR gave similar results to those obtained by Zhong et al. [235] with 
another type 1 boronic acid inhibitor. 
Organotrifluoroborates are a new class of air-stable boronic acid derivatives. They 
are not sensitive to oxygen or moisture and are more stable than their corresponding 
organoboronic acid or ester [243]. The majority of the applications of 
organotrifluoroborate are located in the area of organic synthesis [244]. Recently, it 
 
Figure 3.13. Two-dimensional {19F, 1H} spectrum of 
α-chymotrypsin-(R)-1-acetamido-2-(4-fluorophenyl)ethane-1-boronic acid complex from 
reference [239] at 282 MHz. The concentrations of enzyme and inhibitor were 1.5 and 3.0 
mM, respectively. The mixing time was 200 ms. 
!
330 
Pex was found to have only minor influence on the 
values for the other parameters obtained in the analy- 
sis; the optimum value Of Pex was found to vary with 
rb, as would be expected since the importance of 
relaxation of this proton to relaxation of the fluorine 
will vary with r b. 
Other experimental observations made with this sys- 
tem support the essential features that emerge from 
this analysis of the data: the exchange rates deduced by 
analysis of the relaxation data agree in magnitude with 
that suggested by saturation-transfer experiments and 
the magnitude of the r b parameter indicates direct 
contacts between protein protons and the fluorine of 
the inhibitor, consonant with 2D 19F{~H} NOE experi- 
ments discuss d below. 
Two-dimensional 19F{1H} NOE experiments were 
carried out at 282 MHz using a variety of mixing times 
in order to characterize dipolar interactions between 
the fluorine atom of the bound inhibitor and protons 
of the amino acids that define the binding site. Fig. 7 
shows a typical result; H-F cross peaks were observed 
with the fluorine signal representing the bound in- 
hibitor but only at mixing times longer than 400 ms 
were cross-peaks to the signal of the free inhibitor 
detected. However, cross-peaks to the 'free' inhibitor 
fluorine signal were at the same proton shifts as the 
cross peaks to the 'bound' signal, as would be expected 
for a system in which exchange between the two forms 
of the inhibitor is reasonably rapid. A study of mixing 
time-dependence of the intensity of cross peaks to the 
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Fig. 7. Contour  plot of  a 19F{IH} 2D N OE  experiment at 282 MHz with a sample in which the fraction of bound II is 0.64. The  mixing time was 
200 ms. An  exponential apodization was used in both dimensions that  broadened the lines by 35 Hz. The  proton shift axis was referenced to an 
external s tandard containing sodium 2,2-dimethyl-2-silapentane sulfonate, cross peaks to the fluorine resonance at the position of the unbound 
boronic acid (0 ppm) are not observed until the mixing time is greater  than 400 ms. 
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has been discovered that trifluoroborates can play a role in therapeutic applications 
such as analgesics [245], for the treatment of thyroid dysfunctions [246], and as 
inhibitor of serine proteases [247]. A disadvantage of R-BF3K salts is their instability 
in the presence of silica-gel [248] or other “fluorophiles” such as alumina [249]. There 
is a rapid equilibrium with free fluoride ions and the fluorophile binds the free 
fluoride ions pulling the equilibrium over towards hydrolysis. 
In 2005, Smoum and co-workers [247] evaluated the inhibitory activity of different 
boronic acids and their respective salts on serine proteases. The salts were found to 
be noncovalent, competitive and reversible inhibitors of serine proteases. They 
exhibited an increase of inhibition by at least an order of magnitude over the 
corresponding boronates for α-chymotrypsin and trypsin, with dissociation 
constants in the millimolar order. One of these organoborate salts, 
trifluoro-4-fluorophenylboronate (Figure 3.11d), was studied by 19F NMR in the same 
contribution (Figure 3.14). Four signals arise from a mixture of α-chymotrypsin and 
the organotrifluoroborate. They assigned two of these signals to the fluorines in the 
unbounded inhibitor: –136 (F-B) and –114 ppm (aromatic). 
The other two resonances were assumed as the bound inhibitor to the enzyme at       
–133 (F-B) and –107 ppm (aromatic). These assignments are not supported with 
complementary NMR data. Smoum et al. [247] postulate that the high frequency shift 
between the free and the bound state of the inhibitor arise from the formation of a 
hydrogen bond between the oxyanion hole and N-H and O-H groups from the active 
site (Figure 3.15). 
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3.3 Method of Immobilisation 
As seen in section 2.5.1, there are many methods of immobilisation. The covalent 
binding method was selected to be the method by which the enzyme is directly 
attached to the support. Being an irreversible method, there is no risk of enzyme 
leaching during experimentation. In this section, the method of immobilisation will 
be discussed, including the surface functionalisation of silica and alumina supports 
and the mechanism of immobilisation between the enzyme and the selected carrier 
bound group − CAG (oxirane group).  
3.3.1 Functionalisation of metal-oxide-based supports 
The method most often used to functionalise inorganic support surfaces is to silanise 
an organosilane onto the surface of the support. The modification of silica surfaces by 
 
Figure 3.14. 19F NMR spectrum of α-chymotryspin and trifluoro-4-fluorophenyl-boronate 
from reference [247] at 282 MHz. The concentration of enzyme and inhibitor used were 
0.08 mM and 0.602 mM, respectively. 
!
for trifluoropotassium borates, which cannot be found for the
fluorine free compound. The different proteolytic stabilities of
the compounds seem to result froma specific interactionbetween
the substrate and the enzyme induced by the high electron
density of the BF3K group.
19F NMR studies on enzyme–inhibitor complex
Fluorine NMR is a useful tool for investigating enzyme–
inhibitor interactions owing to its high sensitivity and lack of
background interference from protein.23,24 The high sensitivity
of the fluorine chemical shift to their local environment can be
used to probe details of a receptor–ligand complex. In order
to investigate the structure of the enzyme–inhibitor complex
of a sample compound (trifluoro-4-fluorophenylboronate), we
determined the 19F NMR spectra of inhibitor alone and of
inhibitor and the enzyme. In the former case, two signals were
observed at −136.366 and −114.189 ppm for the −BF3K group
and for the aromatic fluorine, respectively. Upon addition of
a-chymotrypsin/trypsin to the sample, two new broad signals
appeared at −133.435 and −107.803 ppm for the −BF3K and
the aromatic fluorine respectively (Fig. 3). These two new peaks
were downfield shifted from the original peaks. The peak at
−133.435 is consistent with the formation of an enzyme-bound
complex derived from the hydrogen-bond formation between the
fluorine atoms and the serine protease. On the other hand, the
−107.803 ppm signal is assigned to other noncovalent enzyme-
bound aromatic fluorine atoms with the hydrophobic pocket. As
can be seen in Fig. 3, the broad signals for the bound-inhibitor
are in relatively rapid equilibrium with the free inhibitor. The
increased linewidths for the signals of the enzyme-bound species
are consistent with other 19F NMR studies on chymotrypsin
bound inhibitors and are attributed to the slower tumbling
of the macromolecular complex.25,26 Saika and Slichter27 have
developed a quantitative theory for the 19F chemical shifts and
these shifts have been related28 to changes in ionic character,
bond order and degree of hybridization of the bond involving
the fluorine atom. In general, an increase in electronegativity of
the atom attached to fluorine decreases the ionic character of the
fluorine, which thereby increases the paramagnetic contribution
to shielding, i.e. causes a downfield shift. Hence, the downfield
shift seen for the fluorine atoms of the salt arise from the
formation of hydrogen bond between two fluorine atoms and
the N–H and O–H groups in the active site. The amide N–
H groups that constitute the oxyanion hole are believed to
contribute to catalysis by stabilizing the tetrahedral substrate
oxyanion formed during catalysis. The third fluorine atom is
hydrogen bonded to the N–H in the oxyanion hole (Fig. 4).
Fig. 3 19F NMR (282 MHz) spectrum of a-chymotrypsin and triflu-
oro-4-fluorophenyl-boronate (0.602 M inhibitor, 0.08 mM enzyme in
0.1 M KCl with 10% D2O).
The downfield shift of the 19F signal of an enzyme-bound
species is consistent with other studies. The 19F signals of various
p-fluorophenylalanine inhibitors are shifted 1–2 ppm downfield
Fig. 4 A trifluoroborate inhibitor forming hydrogen bonding with
a-chymotrypsin which is subsequently inhibited from further activity.
upon binding to chymotrypsin.29,30 Current 19F chemical shift
theory attributes these downfield shifts to Van der Waal
interactions with protein protons and thus to binding of the
p-fluorophenyl ring into the aromatic ring pocket. Gorenstein
and Shah31 observed∼4 ppmdownfield shift forN-acetyl-DL-p-
fluorophenylalinal and this is one of the largest protein-induced
shifts observed for a reversibly bound inhibitor to chymotrypsin.
Conclusion
The potassium trifluoro(organo)borates show high stability
toward air and water, which is not the case for the vast majority
of other organoboron compounds. The compounds were found
to be simple noncovalent, competitive and reversible inhibitors
of the serine proteases a-chymotrypsin and trypsin. If the pos-
tulated hydrogen bonding interactions are formed in the active-
site of the target enzyme and are responsible for the inactivation,
our concept would be useful for further development of selective
noncovalent type inhibitors. The potency and/or selectivity can
be improved by taking advantage of binding interactions at the
S subsites of the protease. This is the first example of protease
inhibition by KRBF3 compounds. While more potent inhibitors
are known, our intent was to show a concept and not to optimize
inhibition at this stage.
Experimental
General procedures
1H, 13C, 11B and 19F NMR were recorded on a Varian 300 MHz
instrument at frequencies of 300, 75.9, 96.29 and 282.23 MHz,
respectively. Shift values were reported with respect to TMS (1H
and 13C), BF3·OEt2 (11B) and CCl3F (19F). Coupling constants
are reported in Hertz and refer to apparent peak multiplicities.
Biological assays were performed on a UVIKONxs-BIO-TEK
instrument. All chemicals and enzymes were purchased from
Sigma-Aldrich. Solvents were purchased as analytical reagent
grade.
General procedure for preparation of trifluoroborate salts
The boronic acid (1 mmol) dissolved in 4 ml of THF was
treated with excess aqueous KHF2 (6 mmol) and allowed to
stir overnight at room temperature. The THF solvent was
removed under a reduced pressure using a rotary evaporator
and water was removed by lyophilization. The resultant solid
was extracted with acetone, the combined acetone fractions
concentrated under a reduced pressure and the residue washed
with ether to obtain trifluoroborate salt.
Potassium butyltrifluoroborate. Yield 90%. (Found: C,
29.01; H, 5.42%. Calc. for C4H9BF3K: C, 29.29; H, 5.53%);
dH(300 MHz; d6-DMSO) 0.08 (2 H, t, J 7.6, CH2B), 0.77 (3 H,
t, J 7.05, CH3), 1.12 (4 H, m, CH2CH2); dC(75.9 MHz;
d6-DMSO) 15.07, 26.67, 28.81; dF(282.23 MHz; d6-DMSO)
−137.23; dB(96.29 MHz; d6-DMSO) 4.09.
Potassium 4-chlorophenyltrifluoroborate. Yield 86%. (Found:
C, 32.60; H, 5.21%. Calc. for C6H4BClF3K: C, 32.99; H,
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silanisation is a well established and widely used technology in enzyme 
immobilisation. The literature shows endless options of surface functionalisation for 
silica-based supports and these findings, in general, can be extended to other oxides 
with good results [250]. 
Figure 3.16 summarises the silanisation reaction, which consists of a nucleophilic 
attack of a silanol group on the support to the silicon atom of the organosilane with 
differents functionalities represented by X, giving off methanol or ethanol depending 
on whether group R if is –C2H5 or –CH3, respectively. 
The reaction could take place in bulk (without any added solvents) or in the presence 
of an organic solvent such as toluene [250]. Moderate heating or reflux are useful to 
volatilise methanol or ethanol in order to drive the reaction towards completion. In 
principle, all three alkoxy substituents on the silicon atom of the organosilane are 
eliminated upon reaction with the silanol groups on the surface. Various studies 
have concluded that not all alkoxy substituents are removed. It has been observed 
that some of them remain, probably for sterical reasons [251, 252]. However, during 
the immobilisation process, inevitability these remaining groups will hydrolise 
becoming silanols which can condensate with other neighbor silanols (silanisation 
under aqueous conditions). Silanisation undertaken in organic conditions is 
 
Figure 3.15. Scheme of a trifluoroborate inhibitor forming hydrogen bonding with 
α-chymotrypsin. From reference [247]. 
!
for trifluoropotassium borates, which cannot be found for the
fluorine free compound. The different proteolytic stabilities of
the compounds seem to result froma specific interactionbetween
the substrate and the enzyme induced by the high electron
density of the BF3K group.
19F NMR studies on enzyme–inhibitor complex
Fluorine NMR is a useful tool for investigating enzyme–
inhibitor interactions owing to its high sensitivity and lack of
background interference from protein.23,24 The high sensitivity
of the fluorine chemical shift to their local environment can be
used to probe details of a receptor–ligand complex. In order
to investigate the structure of the enzyme–inhibitor complex
of a sample compound (trifluoro-4-fluorophenylboronate), we
determined the 19F NMR spectra of inhibitor alone and of
inhibitor and the enzyme. In the former case, two signals were
observed at −136.366 and −114.189 ppm for the −BF3K group
and for the aromatic fluorine, respectively. Upon addition of
a-chymotrypsin/trypsin to the sample, two new broad signals
appeared at −133.435 and −107.803 ppm for the −BF3K and
the aromatic fluorine respectively (Fig. 3). These two new peaks
were downfield shifted from the original peaks. The peak at
−133.435 is consistent with the formation of an enzyme-bound
complex derived from the hydrogen-bond formation between the
fluorine atoms and the serine protease. On the other hand, the
−107.803 ppm signal is assigned to other noncovalent enzyme-
bound aromatic fluorine atoms with the hydrophobic pocket. As
can be seen in Fig. 3, the broad signals for the bound-inhibitor
are in relatively rapid equilibrium with the free inhibitor. The
increased linewidths for the signals of the enzyme-bound species
are consistent with other 19F NMR studies on chymotrypsin
bound inhibitors and are attributed to the slower tumbling
of the macromolecular complex.25,26 Saika and Slichter27 have
developed a quantitative theory for the 19F chemical shifts and
these shifts have been related28 to changes in ionic character,
bond order and degree of hybridization of the bond involving
the fluorine atom. In general, an increase in electronegativity of
the atom attached to fluorine decreases the ionic character of the
fluorine, which thereby increases the paramagnetic contribution
to shielding, i.e. causes a downfield shift. Hence, the downfield
shift seen for the fluorine atoms of the salt arise from the
formation of hydrogen bond between two fluorine atoms and
the N–H and O–H groups in the active site. The amide N–
H groups that constitute the oxyanion hole are believed to
contribute to catalysis by stabilizing the tetrahedral substrate
oxyanion formed during catalysis. The third fluorine atom is
hydrogen bonded to the N–H in the oxyanion hole (Fig. 4).
Fig. 3 19F NMR (282 MHz) spectrum of a-chymotrypsin and triflu-
oro-4-fluorophenyl-boronate (0.602 M inhibitor, 0.08 mM enzyme in
0.1 M KCl with 10% D2O).
The downfield shift of the 19F signal of an enzyme-bound
species is consistent with other studies. The 19F signals of various
p-fluorophenylalanine inhibitors are shifted 1–2 ppm downfield
Fig. 4 A trifluoroborate inhibitor forming hydrogen bonding with
a-chymotrypsin which is subsequently inhibited from further activity.
up n binding to chymotrypsin.29,30 Current 19F chemical shift
theory attributes these downfield shifts to Van der Waal
interactions with protein protons and thus to binding of the
p-fluorophenyl ring into the aromatic ring pocket. Gorenstein
an Shah31 observed∼4 ppmdownfield shift forN-acetyl-DL-p-
fluorophenylalinal and this is one of the largest protein-induced
shifts observed for a reversibly bound inhibitor to chymotrypsin.
Conclusion
T p tassium triflu ro(organo)borates show high stability
toward air and water, which is not the case for the vast majority
of ther org noboro compounds. The comp und were found
to be simple noncovalent, competitive and reversible inhibitors
of the serine proteases a-chymotrypsin and trypsin. If the pos-
tulated hydrogen bonding interactions are formed in the active-
site of e target enzyme and are responsible for the inactivation,
our concept would be useful for further development of selective
noncovalent type inhibitors. The potency and/or selectivity can
be improved by taking advantage of binding interactions at the
S subsit s of the prote se. This is the first example of prot ase
inhibition by KRBF3 compounds. While more potent inhibitors
are known, our intent was to show a concept and not to optimize
inhibition at this stage.
Experimental
General procedures
1H, 13C, 11B and 19F NMR were recorded on a Varian 300 MHz
instrument at frequencies of 300, 75.9, 96.29 and 282.23 MHz,
respectively. Shift values were reported with respect to TMS (1H
and 13C), BF3·OEt2 (11B) and CCl3F (19F). Coupling constants
are reported in Hertz and refer to apparent peak multiplicities.
Biological assays were performed on a UVIKONxs-BIO-TEK
instrument. All chemicals and enzymes were purchased from
Sigma-Aldrich. Solvents were purchased as analytical reagent
grade.
General procedure for preparation of trifluoroborate salts
The boronic acid (1 mmol) dissolved in 4 ml of THF was
treated with excess aqueous KHF2 (6 mmol) and allowed to
stir overnight at room temperature. The THF solvent was
removed under a reduced pressure using a rotary evaporator
and water was removed by lyophilization. The resultant solid
was extracted with acetone, the combined acetone fractions
concentrated under a reduced pressure and the residue washed
with ether to obtain trifluoroborate salt.
Potassium butyltrifluoroborate. Yield 90%. (Found: C,
29.01; H, 5.42%. Calc. for C4H9BF3K: C, 29.29; H, 5.53%);
dH(300 MHz; d6-DMSO) 0.08 (2 H, t, J 7.6, CH2B), 0.77 (3 H,
t, J 7.05, CH3), 1.12 (4 H, m, CH2CH2); dC(75.9 MHz;
d6-DMSO) 15.07, 26.67, 28.81; dF(282.23 MHz; d6-DMSO)
−137.23; dB(96.29 MHz; d6-DMSO) 4.09.
Potassium 4-chlorophenyltrifluoroborate. Yield 86%. (Found:
C, 32.60; H, 5.21%. Calc. for C6H4BClF3K: C, 32.99; H,
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generally preferred because it achieves higher loadings of functionalised surface than 
aqueous silanisation [250]. 
When a non-silica-based support is used instead, such as Al2O3, a quite similar 
reaction takes place and a covalent organosilane coating is formed [144]. An 
exceptional case is represented by ZrO2, which under those conditions is incapable of 
forming Zr-O-Si bonds [253]. 
3.3.1.1 Oxirane functional metal-oxide-based supports 
Some of the most widespread organosilanes used for functionalisation of inorganic 
supports for protein immobilisation are represented in Figure 3.17. Functionalised 
supports are usually not capable of reacting directly with the proteins. Only 
epoxy- or aldehyde-functionalised supports can directly couple with reactive amino 
acid residues (RARs) from the enzyme. In all the other cases, the support needs to be 
activated. Commonly, the activation consists of inserting an electrophilic function on 
the support surface [144].  
A popular and commercially available organosilane used in surface modification is 
3-(glycidoxypropyl)trimethoxysilane. Figure 3.18 shows a representation of the 
different species expected on functionalised surface with GOPS. A similar surface is 
expected when the same organosilane is tethered to an Al2O3 surface. All these 
 
Figure 3.16. Scheme of surface functionalisation of metal-oxide-based supports using 
trialkoxyorganosilanes. (a) Before and (b) after  silanisation. 
!
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species can be observed by 29Si NMR, and by 13C NMR it is possible to observe the 
different carbons on the chain. 
3.3.2 Mechanism of covalent binding via epoxide groups 
The reaction type between epoxide groups and reactive amino acid residues (RARs) 
from the protein is a nucleophilic substitution. Protonation makes the epoxide group 
more electrophilic and creates a better leaving group. This makes the ring more 
susceptible to nucleophilic attack.  
Epoxide groups can react with three different RARs: sulphydryl group of cysteine, 
phenolic hydroxyl groups of tyrosine and amino groups of N-terminal amino acids 
and ε-amino groups of lysine. Epoxy groups are quite stable especially at neutral pH 
 
Figure 3.17. Organosilanes used in the functionalisation of metal-oxide-based supports. (a) 
(3-Aminopropyl)triethoxysilane, (b) (3-glycidyloxypropyl)triethoxysilane, (c) 
(3-mercaptopropyl)trymethoxysilane, (d) 3-(trimethoxysilyl)propyl methacrylate, (e) 
(3-choloropropyl)triethoxysilane, and (f) trimethoxy(2-phenylethyl)silane. 
(a) (b)
(c) (d)
(e) (f)
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and consequently are not highly reactive in mild conditions. Due to this, original 
epoxy supports hardly immobilise large amounts of protein. To overcome this 
problem, immobilisation in the presence of high ionic strengths has been used [254-
258]. This is because the immobilisation occurs in two steps. Firstly, the enzyme is 
hydrophobically adsorbed on the surface due to a salt-induced hydrophobic 
interaction, followed by the covalent attachment between the nucleophile groups of 
the enzyme and the epoxy groups. The increase in protein concentration near the 
reactive epoxy groups leads to an increase in the rate of reaction. 
In general, the most targeted reactive amino acid residue (RAR) in proteins for 
covalent binding is undeniably –NH2, both N-terminal α-amino group and lysine 
ε-amino group. This is for several reasons: it is widespread in almost all proteins, 
reactivity is optimal, lysine usually has a minor mechanistic relevance and is 
therefore not fundamental for retention of catalytic activity, a preferential exposed 
distribution of lysine residues (especially in an aqueous system) [259]. 
At the end of the immobilisation process, the remaining carrier bound group (CAG) 
can be easily blocked, if necessary, with thiol or amino compounds in mild 
conditions [260]. 
 
Figure 3.18. Scheme of epoxide-silica surface with T1, T2, T3 notation for R-SiO3 centers, 
where R is an aliphatic carbon side chain. 
! T1 T2 T3T1 T2 T3
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CHAPTER 4 
 
Experimental 
This chapter covers the analytical and experimental protocols used. Appendix F 
contains a list of the chemicals utilised in the protocols described in this section. 
4.1 Quantification of Epoxide Groups 
The amount of epoxide content (epoxy equivalent weight, EEW) on organosilane 
modified support and Eupergit® was determined by the non-aqueous titration of 
oxirane groups according the modified Dubertaki method. In 1956, Durbetaki [261] 
reported an analytical procedure to titrate α-epoxy compounds with hydrogen 
bromide (HBr) in glacial acetic using crystal violet as an indicator. The method 
involves a two-step electrophilic addition: protonation and secondly anion addition 
(Br−). Despite this method being rapid and capable of good results, the reagent HBr, 
which fumes profusely in air, requires special handling and frequent 
restandardisation for accurate analysis. The problem of HBr storage is avoided in a 
useful variation of the Dubertaki method [262, 263]. In this modification HBr is 
prepared in situ by treatment of a quaternary ammonium halide with standard 
perchloric acid (HClO4). 
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4.1.1 Preparation of reagents 
• Crystal violet indicator solution (0.1 %): 0.1 g of crystal violet was dissolved in 
100 ml in a 250 ml beaker. 
• Perchloric acid solution: A solution of 0.1 M perchloric acid was prepared in 
glacial acetic acid (CH3COOH) by adding 8.5 ml of 72% perchloric acid and 20 
ml of acetic anhydride ((CH3CO)2O) to 400 ml of glacial acetic acid in a 1000 
ml volumetric flask. The mixture was diluted to full mark with glacial acetic 
acid. 
• Tetraethylammonium bromide solution: The indicator solution was prepared 
by dissolving 100 g of of tetraethylammonium bromide (NEt4Br) in 400 ml of 
glacial acetic acid. Finally, 3-5 drops of the crystal violet indicator solution 
were added to the previous mixture. 
4.1.2 Procedure 
Standardisation of perchloric acid solution: potassium hydrogen phthalate 
(HOOCC6H4COOK) was dried overnight at 100 °C (0.2 g). The dry salt was weighed 
on an analytical balance and recorded with accuracy to four decimal places, and 
finally placed into a 150 ml beaker. Glacial acetic acid (50 ml) was added on low heat 
until the sample was dissolved. After cooling, another 50 ml of acetic acid was added 
to wash down the sides of the beaker. Crystal violet indicator was added (3-5 drops). 
The mixture was titrated under magnetic stirring with the perchloric acid until a 
yellow green end point was reached. The amount of tritant added was recorded to 
the nearest 0.05 ml. 
Molarity of perchloric acid was calculated according to  
 
 
N = K ∗1000
MWK ∗VP
 4.1 
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where  K  is the weight of potassium hydrogen phthalate (g),  MWK  is the molecular 
weight of potassium hydrogen phthalate (204.2 g mol–1),  VP  is volume of perchloric 
acid solution added (ml) and  N  is molarity of perchloric acid solution. 
Determination of epoxy equivalent weight (EEW): Approximately 1 g of sample was 
weighed in a 50 ml beaker. The sample weight was recorded on an analytical 
balance. Next, 5-6 drops of crystal violet indicator were added. The mixture was 
titrated under magnetic stirring with standarised perchloric acid until the color 
changed from crystal violet to green. The volume of perchloric acid used was 
recorded to the nearest 0.1 ml. 
Epoxy equivalent weight was defined according to 
 
 
4.2 
where  S  is weight of the sample (g),  VS  is perchloric acid titer volume (ml) and EEW 
is epoxy equivalent weight (kg sample/mol epoxide group). 
4.2 Protein Analysis 
Quantification of proteins has been carried out using the colourimetric method of 
Bradford [264], which involves the binding of Coomassie Brilliant Blue G-250 to the 
residues of arginine and hydrophobic aminoacids present in protein. This union 
produces a change in the absorption maximum and can be monitored at 595 nm. It is 
a quick and reproducible method, and does not experience interference due to the 
presence of amino acids in the media. The process is complete in fifteen minutes and 
is stable for up to one hour. 
Protein concentration is obtained by interpolation with a calibration curve calibrated 
with bovine serum albumin (BSA), which relates the concentration of albumin to the 
!
 
EEW = SVS ∗N
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absorbance at 595 nm. The concentration of BSA used for the calibration curve 
should be between 0.01 and 0.1 mg/ml (Appendix B, Figure B.1). 
4.2.1 Preparation of reagents 
• BSA stock solution (1 mg/ml): BSA (250 mg) was dissolved in 250 ml of 
distilled water. Subsequently, the solution was aliquoted in Eppendorf vials 
using small volumes of approximately 500 µl and stored at –20 °C. 
• Bradford reagent: 100 mg Coomassie Brilliant Blue G-250 (≥ 90%) were 
dissolved in 50 ml of ethanol 95%. 100 ml of orthophosphoric acid 85% (w/w) 
were added slowly and diluted to 1 L with deionised water. The Bradford 
reagent was stored at room temperature protected from light.  
4.2.2 Procedure 
Standard curve: From BSA stock solution (1 mg ml–1) several dilutions were 
prepared using 0.010 M potassium phosphate buffer (pH = 7.0), with concentrations 
between 0.02 and 0.14 mg protein per ml. For each dilution, 5 ml of Bradford reagent 
was added per 0.5 ml of BSA stock solution diluted. The mixtures were well mixed 
and after 15 minutes the absorbance was measured at 595 nm in a spectrophotometer 
against a blank reagent prepared with 0.010 M potassium phosphate buffer (pH = 
7.0) to finally build the standard curve. 
Sample: Bradford reagent (5 ml) was added to 0.5 ml of a sample solution suitably 
diluted with buffer in order to be within the range of protein concentration of the 
standard curve. The mixture was well mixed and after 15 minutes the absorbance 
was measured at 595 nm in a spectrophotometer against a reagent blank prepared 
with buffer. 
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4.3 Immobilised Protein Determination 
The immobilised protein quantity was determined by measuring the difference 
between the total protein content in the initial enzyme solution contacted and soluble 
protein at the end of immobilisation process in the supernatant. The enzyme solution 
and the support were separated by centrifugation at 5000 rpm. 
4.4 Enzyme Activity Determination 
The determination of hydrolytic activity of α-chymotrypsin was carried out 
according to methodology developed by Vandermeers, Lelotte and Christophe [265] 
who described an automated method by constant pH titration using a pHstat to 
measure the reaction. α-Chymotrypsin hydrolyses the synthetic substrate 
N-acetyl-L-tyrosine ethyl ester (ATEE) releasing acid (N-acetyl-L-tyrosine). The 
amount of acid liberated (at pH = 7.0 and 25 °C) is measured by titration with 
sodium hydroxide, recorded as a function of time. 
An international unit (IU) is defined as the amount of enzyme able to hydrolyse 1 
µmol of ATEE at 25 °C per minute under the assay conditions indicated.  
4.4.1 Preparation of reagents 
• ATEE solution (50 mM): ATEE (134.6 mg) was dissolved in 3 ml of ethanol 
and diluted to 10 ml with 5 mM Tris-HCl buffer (pH = 7.0) containing 20 mM 
CaCl2. 
• Titration solution: A 50 mM NaOH standarised solution was prepared.  
• Free enzyme solution: A 0.1% (w/v) α-chymotrypsin solution in 1 mM HCl 
(in order to avoid autolysis phenomena) was prepared. 
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• Immobilised enzyme suspension: A suspension of immobilised enzyme with 
an amount that has the same amount of protein as the free enzyme solution, 
according to section 4.2 and 4.3, was prepared. The suspension was diluted 
properly with 1 mM HCl. 
4.4.2 Procedure 
A 10 ml volume of 50 mM ATEE in 5 mM Tris-HCl, pH = 7.0, containing 20 mM 
CaCl2, was placed into a reaction vessel under magnetic stirring at 25 °C. The 
reaction was started by addition of 50  µl of free enzyme solution or immobilised 
enzyme suspension, in 1 mM HCl, and the pH was maintained constantly at 7.0 by 
continuous addition of 50 mM NaOH as titrant. One unit of activity was defined as 
the amount of enzyme that hydrolyses 1 µmol ATEE per min under standard 
conditions of assay (pH = 7.0, 25 °C). 
Enzyme activity was calculated according to  
 
 
A = S∗CNaOH
Cenz ∗Venz
 4.3 
where  A  is the specific activity of free enzyme (E) solution or immobilised enzyme 
(IE) suspension (IU/mg E or IU/mg IE),  S  is the slope obtained in the titration curve 
(ml NaOH/min),  CNaOH  is the concentration of titration solution (mM),  Cenz  is the 
concentration of free enzyme solution or immobilised enzyme suspension (mg E/ml 
or mg IE/ml), and  Venz  is the volume of free enzyme solution or immobilised enzyme 
suspension added (ml). 
4.5 Immobilisation Procedure 
Daiso kindly donated for this project porous silica with different pore sizes 
(Appendix A, Table A.1). It was primarily decided to use the support with greater 
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surface area because this condition might be expected to allow the immobilisation of 
an increased amount of enzyme than supports with a lower area. Therefore, most of 
the experiments shown in this report so far have been developed with the support 
with pore size of 60 Å or 100 Å.  
Alumina supports were donated by SASOL Germany (Appendix A, Table A.2). 
4.5.1 Activation of Support 
4.5.1.1 Synthesis of epoxide-activated silica  
The epoxide-activated silica was prepared essentially according to a procedure 
described by Herman et al. [260]. Daisogel silica with various pore sizes (10 g) was 
dried for 24 h at 200 °C. The dry silica was suspended in 160 ml of dry toluene and 
degassed by sonication under vacuum for half hour. A tenfold theoretical excess of 
GOPS was added. This excess was calculated assuming four silanol groups per 
square nanometer of silica surface using the surface area data supplied by Daiso Co., 
Ltd (Appendix A, Table A.1). The mixture was refluxed gently for 4 hr. After cooling 
and filtration of the reaction mixture the silica was washed with 500 ml of toluene, 
250 ml of tetrahydrofuran (THF) and 500 ml of methanol, and then dried under 
vacuum at 40 °C overnight.  
4.5.1.2 Synthesis of epoxide-activated alumina 
An identical protocol as that used for the silica-based supports was used for the 
preparation of epoxide-activated alumina supports. SASOL aluminas are provided in 
boehmite form. The desired transition phase is  γ-alumina, therefore it is necessary to 
dehydrate the support before the functionalisation. The supplier advises calcination 
of the sample at 550 °C (823 K) for 3 hours to obtain the γ transition. 
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4.5.2 Covalent Binding of the Enzyme 
Essentially, the same protocol was used to immobilise the enzyme onto epoxide 
silica, onto epoxide alumina, and onto Eupergit®. 
The protocols described in this section are based on the work of Wheatley and 
Schmidt [254] and Felix and Descorps [256], which reveal that high salt concentration 
during immobilisation increases the amount of protein immobilised onto an epoxy 
silica support, as mentioned in Section 3.3.2. This enhancement is thought to occur 
because of a salt-induced hydrophobic interaction between the protein and the 
surface of the stationary phase. The increase in concentration of the protein near the 
reactive epoxy groups leads to an increase in the rate of reaction between the 
nucleophilic groups on protein and the epoxide [255].  
4.5.2.1 Procedure 
Protein immobilisation was performed based on the work of Wheatley and Schmidt 
[254] and Felix and Descorps [256]. α-Chymotrypsin from bovine pancreas (Type II) 
was dissolved in 0.010 M potassium phosphate, pH 8.0 and 1.88 M ammonium 
sulfate, resulting in 10 mg ml−1 protein solution. A 500 µl volume of the above 
solution was combined with 50 mg of support4 in a 1.5 ml capped vial. The mixture 
was agitated for 40 h by orbital rotation at room temperature. The conjugated 
support was centrifuged at 3000 rpm for 1.5 min and washed twice with 500 µl of 
0.010 M potassium phosphate, pH = 7.0, subsequently with 1 ml of 0.010 M sodium 
acetate, pH 4.5, containing 0.3 M sodium chloride, and ultimately the immobilised 
enzyme was equilibrated with 1 ml of 0.10 M potassium phosphate, pH = 6.0. 
As is discussed in Section 3.3.2, the process of immobilisation involves two steps: 
adsorption of the protein followed by a covalent reaction between reactive amino 
                                                
4 Epoxide silica, epoxide alumina or Eupergit® 
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acid residues (RARs) and epoxide groups. It is logical to assume that not all protein 
molecules will be immobilised covalently; some of them will be loosely adsorbed and 
washed out after completion of the immobilisation. For this reason, the protein 
content was measured in the washings after the end of the immobilisation (last part 
of the procedure in Section 4.5.2). Measurements were conducted for the epoxide-silica 
and alumina systems but the amounts of protein in the washings were negligible 
(less than 1% of the total protein contacted). Only the measurements for immobilised 
enzyme on Eupergit® were included in this thesis (Section 5.3.3) because they 
presented a significant amount of protein in the washings.  
For the immobilisation process, the use of ammonium sulfate was evaluated for all 
different types of supports (epoxide silica, epoxide alumina and Eupergit®). The 
enzyme loading was estimated in order to obtain a high yield of immobilisation 
(protein and activity yield) and high specific activity. 
At the end of the immobilisation, wet samples were dried under vacuum at room 
temperature overnight. 
Immobilisation yields are defined according to the Equations 4.4 and 4.5. 
 
 
4.4 
 
 
4.5 
where  is the concentration of proteins in solution at the beginning of 
immobilisation (mg ml–1), and  is the concentration of proteins in solution at the 
end of immobilisation (mg ml–1). 
where  is the specific activity of the immobilised enzyme (IU/mg support),  is 
the mass of support contacted (mg support),  is the specific activity of the free 
!
 
Protein yield (%) = Ci −CfCi
∗100
!
 
Activity yield (%) = AEI ∗MSA∗ME
∗100
 Ci
 Cf
 AEI  MS
 A
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enzyme (IU/mg enzyme commercial powder), and  is the mass of enzyme 
contacted per mass of support (mg protein/mg support). 
A third parameter was included: retention of activity, defined according to 
 
 
Retention of activity (%) = AEI MEIA Pc
*100  4.6 
where  MEI is the mass of immobilised enzyme per mass of support (mg protein/mg 
support) and  is the protein fraction content of the commercial enzyme powder. 
4.6 Sample storing 
Samples were stored in plastic boxes with moisture indicator silica beads at −20 °C. 
The silica is used as a desiccant to control the environment humidity to avoid the 
degradation of the samples. The moisture indicator in the silica consists in the 
impregnation of silica beads with cobalt chloride, which changes from blue to pink as 
the desiccant becomes saturated with water. These silica beads are available 
commercially under the name silica gel blue. After becoming saturated (pink), the 
desiccant can be reactivated for reuse by heating at 100 °C overnight. 
4.7 Nuclear Magnetic Resonance  
General details are provided in this section. Further information can be found at the 
start of Chapter 5 to Chapter 7 where experimental details for the samples 
investigated in the chapter are presented. 
4.7.1 Solution-State  
The spectra were recorded on two spectrometers: a Bruker Avance 400 MHz 
spectrometer equipped with a narrowbore 9.4 T and a Bruker Avance III 600 MHz 
spectrometer equipped with a narrowbore 14.1 T magnet; these provide 1H 
 ME
 Pc
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resonance frequencies of approximately 400 and 600 MHz, respectively. Samples 
were held in borosilicate glass (Type 1 Class A) NMR tubes. Samples that release 
fluoride anions were held in PTFE-FEP copolymer tubes inserts to avoid interactions 
(etching) with the NMR glass tube. Studied nuclei were 1H, 19F, 11B and 13C (Table 
2.1). Chemical shifts are recorded in ppm relative to tetramethylsilane (TMS) for 13C 
and 1H, trichlorofluoromethane (CFCl3) for 19F and trimethyl borate (C3H9BO3) for 
11B. 
4.7.2 Solid-State with Magic Angle Spinning  
The spectra were recorded on three spectrometers: a Bruker Avance 400 MHz 
spectrometer equipped with a widebore 9.4 T magnet, a Bruker Avance III 600 MHz 
spectrometer equipped with a widebore 14.1 T magnet, and a Bruker Avance III 850 
MHz spectrometer with a widebore 20 T magnet; these provide 1H resonance 
frequencies of approximately 400, 600 and 850 MHz, respectively. Probe assemblies 
support the transmitter/receiver coil, tuning circuits and sample, and are inserted 
directly into the magnet bore. The dry powder samples were packed into a 
conventional MAS rotor and samples containing liquid into a CRAMPS rotor with a 
polytetrafluoroethylene (PTFE) spacer to avoid sample leakage. The rotors and caps 
are made from zirconium oxide and Kel-F (polymerised FClC=CF2), respectively. 
Studied nuclei were 1H, 19F, 29Si, 13C, and 23Na (Table 2.1). Chemical shifts are 
recorded in ppm relative to tetramethylsilane (TMS) for 29Si, 13C and 1H and 
trichlorofluoromethane (CFCl3) for 19F.  
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CHAPTER 5 
 
Structural Characterisation of the 
Immobilised Enzyme and its Supports 
The systems of study chosen (Chapter 3) were: α-chymotrypsin covalently 
immobilised on functionalised silica and alumina particles 
(glycidoxypropyltrimethoxysilane, GOPS, grafted onto the surface of inorganic 
supports), and Eupergit®. Inorganic supports (silica and alumina) are studied both 
before (Section 5.2) and after (Section 5.3) functionalisation with the chosen 
organosilane (GOPS). Eupergit® is included from Section 5.3 onwards because it is 
an activated support and it is not necessary to use any additional treatment before 
immobilising the enzyme onto it. The results for the three systems after 
immobilisation are discussed in Section 5.4. 
5.1 Experimental details 
5.1.1 NMR experiments 
All NMR spectra presented in this Chapter were recorded from solid samples. 
Experiments were performed on either a Bruker Avance I 400 MHz spectrometer 
equipped with a widebore 9.4 T magnet or a Bruker Avance III 850 MHz 
spectrometer with a widebore 20 T magnet, yielding 1H resonance frequencies of 
approximately 400 and 850 MHz, respectively.  
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Powdered samples (dry samples) were packed into 4 mm and 1.3 mm ZrO2 rotors. 
Samples were rotated at rates between 10 and 15 kHz in a 4 mm MAS probe or 60 
kHz in a 1.3 mm MAS probe.  
When liquids needed to be added to the powder (wet sample), then a 4 mm 
“CRAMPS-type” MAS rotor was used with a PTFE spacer to help contain the fluid. 
For containment of liquids in 1.3 mm ZrO2 rotor, soft silicone plugs were used in the 
top and bottom of the rotor, in addition to the normal end caps.  
Chemicals shifts are quoted relative to TMS for 29Si, 13C and 1H and to Al(H2O)63+ for 
27Al. For 13C, 27Al or 29Si NMR, cross-polarisation was generally used, with a 50-100% 
linear ramp on the 1H channel for variable contact times between 1 to 5 ms (Figure 
2.6b). Further experimental details such as pulse length, recycle delay and number of 
transients can be found in the text and figure captions. 
5.1.2 Sample preparation 
Preparation of the supports and the immobilised enzyme is explained in detail in 
Chapter 4. Wet samples were stored at 3 ºC and discarded after one week of 
preparation. Dry samples were stored in the conditions described in Section 4.6. 
Immobilised enzyme samples were discarded after six months of preparation.  
5.2 Characterisation of the Supports 
5.2.1 Bare silica 
Daiso Co. Ltd kindly donated silica supports of different pore sizes used in this 
thesis. The technical data supplied for these silica supports by Daiso is summarised 
in Table A.1 (Appendix A). 
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Figure 5.1 shows 29Si MAS NMR spectra of bare silica without and with 
cross-polarisation, with 15 and 2.5 hours of collection time, respectively. The 29Si 
MAS NMR spectrum (Figure 5.1a) reveals three different resonances that belong to 
silicon species expected in bare silica: Si-coordinated Q2, Q3 and Q4 (Figure 3.1). 
According to Maciel and Sindorf [266] the peak at –90 ppm corresponds to surface 
silicon atoms with two siloxane bonds and two silanol groups (Q2); similarly, the 
resonance at –100 ppm is attributed to surface silicon atoms with three siloxane 
bonds and one silanol group (Q3); while the peak at –110 ppm is attributed to silicon 
atoms with four siloxane bonds (Q4). 
As the current understanding of the structure of silica is that hydrogen atoms occur 
almost exclusively on the surface [267], cross-polarisation (1H → 29Si) can be 
considered to be a surface-selective method. The 29Si CPMAS spectrum (Figure 5.1b) 
confirms the presence of Q2, Q3 and Q4 29Si species. An enhancing effect by 
magnetisation transfer from nearby dipole-dipole-coupled protons is observable for 
those 29Si species which are in close contact with protons. These species are Q2 and 
Q3 and a smaller proportion of Q4 species that are close to the surface. 
For the spectrum recorded using a single 90° pulse (Figure 5.1a), the area A under a 
29Si peak will be approximately quantitative and it is possible to note that            
A(Q4) > A(Q3) > A(Q4), as expected, with the bulk of the silica comprising Q4 units. In 
contrast, in the spectrum recorded using 29Si CPMAS experiment, the signal 
intensities reflect the homo- and the heteronuclear dipolar couplings, H-H and H-Si, 
as well as the numbers of each species.  
One obvious advantage of cross-polarisation with respect to direct polarisation is the 
time gain because interval times are now governed by the longitudinal relaxation 
times of 1H rather than of 29Si. This effect is observed in the lengths of the relaxation 
intervals used to obtain the spectra in Figure 5.1; 180 seconds of relaxation delay for 
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the direct polarisation experiment (Figure 5.1a) and 3 seconds in the case of the 
cross-polarisation experiment (Figure 5.1b). 
5.2.2 Bare alumina 
Alumina supports with different pore size were donated by Sasol, Germany. The 
technical data for these alumina supports are given in Table A.2 (Appendix A). The 
aluminas were supplied in the form of boehmite, needing a further calcination to 
become γ-alumina. 
Dehydration of pore-variable boehmites gives rise to different transition aluminas 
(Figure 3.2) where the most useful of them for the purpose stated in this thesis is 
 
Figure 5.1. 29Si (a) simple 90º pulse MAS (90º pulse length of 3 µ s, relaxation interval of 
180 s, averaging of 300 transients) and (b) CPMAS spectra of dry bare silica (100 Å) (90º 
pulse length of 6.2 µ s, contact time of 5 ms, relaxation interval of 3 s, averaging of 3000 
transients) at  B0  = 9.4 T and a MAS rate of  ωR 2π  = 10 kHz. 1H decoupling was not used. 
-180-160-140-120-100-80-60-40-20 ppm
Cross 
polarisation 
Simple 90 
pulse
(b)
(a)
Q2
Q3
Q4
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γ-alumina. This is because it has a favourable combination of various characteristics 
such as surface area, pore size and pore-size distribution. The dehydration of 
boehmites supplied by Sasol was studied using 27Al MAS NMR, before and after 
calcination at 550 ºC for 3 hours (Figure 5.2). The use of direct- and cross-polarisation 
was evaluated. 
Figure 5.2a and Figure 5.2c show 27Al MAS NMR spectra of bare boehmite (TH-80) 
before calcination without and with cross-polarisation, respectively. The spectra 
reveal a single resonance at 10 ppm that is attributed to octahedrally coordinated 
aluminium sites (AlVI), where it is possible to note that boehmite is composed 
exclusively of AlVI within the bulk and surface [268].  
Compared to silica, the γ-alumina structure is much more complex, as seen in Section 
3.1.2. Bearing in mind that only aluminium that is coupled to the hydroxyl group, 
will give signals in the 1H → 27Al CPMAS experiment, it is important know the 
predominant location of the H-species in alumina. Controversies arise about the 
location of hydrogen in the γ-alumina structure, with the majority of these studies 
claiming that a considerable amount of hydrogen is present in the bulk of γ-alumina 
as protons trapped in octahedral and tetrahedral vacancies within the bulk anion 
lattice [269-272]. Contrarily, a more recent study claims that no interstitial hydrogen 
can be found in γ-alumina [273].  
As a consequence of the discussion above, the results of cross-polarisation 
experiments applied to alumina materials should be interpreted cautiously and the 
CPMAS technique should not be referred to as “surface-selective” because there is no 
certainty of this. However, a preferential surface distribution has been observed for 
these materials [274] where over 60% of H-species are located on the surface and the 
rest in the bulk. 
In terms of cross-polarisation efficiency, the application of 1H → 27Al CPMAS NMR is 
more complicated when compared to 1H → 29Si CPMAS, as it involves transfer 
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between a half-integer nucleus (1H) and a quadrupolar nucleus (27Al). Only a small 
fraction of the quadrupolar nuclei can be Hartmann-Hahn matched with protons, 
therefore signal enhancements in the CPMAS NMR spectra for quadrupolar nuclei 
are generally poor or even insignificant [275]. This effect is observed in the spectra 
shown in Figure 5.2 where a higher number of transients is needed for CPMAS 
compared with the direct polarisation experiments to obtain a desirable 
signal-to-noise ratio.  
After the thermal treatment, it is expected that the specific surface of the alumina will 
increase and therefore there will be an increase in aluminium species with a different 
 
Figure 5.2. 27Al simple 90° pulse MAS NMR spectra of dry TH-80 alumina (a) before and 
(b) after calcination (90° pulse length of 5 µ s, relaxation interval of 5 s, averaging 4 
transients). 27Al CPMAS NMR spectra of dry TH-80 alumina (c) before and (d) after 
calcination (90° pulse length of 5.6 µ s, contact time of 0.5 ms, relaxation interval of 2 s, 
averaging 1024 transients). All spectra were recorded at  B0  = 9.4 T and a MAS rate of 
 ωR 2π  = 10 kHz. 1H decoupling was not used. Spinning sidebands are indicated by 
asterisks. 
(a) (b)
(c) (d)
AlVI
Before  
calcination
After 
calcination
AlVI
AlIV
AlV
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coordination geometry. The spectrum recorded using a single 90° pulse (Figure 5.2b), 
shows two aluminium species, AlIV and AlVI, at 68 and 10 ppm, respectively, whereas 
the spectrum recorded using 27Al CPMAS experiment also shows pentacoordinated 
aluminium (AlV) at 35 ppm (Figure 5.2d). These resonances are in agreement with 
other 27Al MAS NMR alumina studies [276, 277]. From Figure 5.2b is possible to note 
that the dominant species in γ-alumina are tetrahedral and octahedral where    
A(AlVI) > A(AlIV). The bulk of γ-alumina contains both hexacoordinated (AlVI) and 
tetracoordinated (AlIV) alumina sites, with the former being more abundant than the 
latter. [278, 279]. Around only 1.5% of Al atoms are pentacoordinated in γ-alumina 
[280]. This coordination number, AlV, is not yet well understood, but many authors 
refer to it as being caused either by substitution of lattice oxygens in octahedral 
symmetry by hydroxyl groups or by oxygen defects adjacent to an aluminium centre 
[269, 281]. Other researchers have tentatively assigned Al atoms at the external 
surface of alumina particles to pentahedral sites [282]. 
In the cross-polarisation experiment (Figure 5.2d) the AlV peak is well separated and 
clearly resolved suggesting that this type of Al atom is preferentially located on the 
surface of γ-alumina. In 2007, Kwak et al [283] found strong evidence that 
pentacoordinated aluminium is exclusively located on the surface of γ-alumina. 
Recently, De Paëpe’s research group confirmed these results using dynamic nuclear 
polarisation [284]. It is possible to conclude that AlV sites are exclusively located in 
the surface of γ-alumina with the data presented in Figure 5.2 and the recent 
literature mentioned above. 
Identical spectra were obtained for SB-1, TH-100 and TH-200 aluminas before and 
after calcination. Therefore, only TH-80 spectra were included in this thesis. 
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5.3 Characterisation of the Immobilised Enzymes 
5.3.1 Epoxide-silica 
After the functionalisation with GOPS, a modified surface with epoxide groups is 
obtained (Figure 3.18). As can be seen from Figure 5.3, the smaller the pore size 
(larger surface area) the greater the epoxide content, with the exception of 60 Å 
where the activation process could have been affected by diffusional restrictions due 
to the small pore size. 
Figure 5.4a shows the 29Si CPMAS NMR spectrum of functionalised silica. The new 
species were assigned according to those previously reported by Bayer et al. [285] for 
chemically modified silica gels where all new Si species have one alkyl group but 
siloxane and silanol vary. The peak at –48 ppm corresponds to surface silicon atoms 
with one siloxane bond and two silanol groups (T1), similarly the resonance at –56 
ppm is ascribed to surface silicon atoms with two siloxane bonds and one silanol 
group (T2), while the resonance at –67 ppm is assigned to surface silicon atoms with 
three siloxane bonds and no silanol group (T3).  
It must be remember that the success of cross-polarisation depends on the dipolar 
coupling interaction between proximate protons and the nucleus observed. 
Therefore, in the case of 1H → 29Si CPMAS, it is plausible to suggest that the 
efficiency of the cross-polarisation experiment will decrease after grafting organic 
moietes on to the surface (GOPS silanisation). 
13C CPMAS NMR spectra of epoxide-silica (100 and 300 Å pore size) are presented in 
Figure 5.5a and Figure 5.5c, respectively. The new species related with GOPS 
tethered to silica surface were assigned in agreement with previous studies [285, 
286]. Figure 5.5a shows the carbon labels for each epoxide-silica species. Figure 5.6 
shows the notation that was used here for the carbon assignments. 
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The addition of liquid D2O (10 ml of D2O per 0.5 g epoxide-silica, at least 3 h prior to 
NMR measurements) to the powdered epoxide-silica (100 Å pore size) sample (in the 
CRAMPS-type rotor) has a very significant effect on the 1H MAS spectrum, as shown 
in Figure 5.7. There is displacement of bound H2O and exchange of acidic protons 
(i.e., in Si-OH groups) for deuterons, leading to the disappearance of some of the 
broad and intense 1H peaks in the spectrum of the dry epoxide-silica.  
Furthermore, a narrowing of the remaining 1H resonances is very noticeable, 
especially in the expansion in Figure 5.7b, which is presumably a result of the greater 
mobility of the GOPS linker in the presence of a solvent. As expected, the protons 
closest to the surface (H1 and H2) are narrowed less than those further away, which 
have greater mobility. It should be noted that this addition of a solvent is significant 
as it mimics the environment in which a solid biocatalyst will be utilised in practice. 
The epoxide-silica sample has been treated with D2O (see Figure 5.7) so that only 
non-exchangeable 1H nuclei related with the grafted linker remained. This treatment 
 
Figure 5.3. Epoxide content after functionalisation with GOPS for silica with 60, 100, 200 
and 300 Å pore size. 
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avoids getting broad and large peaks, principally, due to residual water and Si-OH 
groups (Figure 5.7). 
The immobilisation of the enzyme was conducted under the conditions mentioned in 
section 4.5 for different pore sizes of silica particles (60, 100, 200 and 300 Å). The 
commercial enzymatic powder used in all immobilisations had a protein content of 
78.1% and its hydrolytic activity was 412.3 IU/mg powder. 
 
Figure 5.4. 29Si CPMAS NMR spectra of (a) dry epoxide-silica (100 Å) and (c) dry 
immobilised enzyme (90° pulse length of 3 µ s, contact time of 5 ms, relaxation interval of 3 
s, averaging 512 transients). All spectra were recorded at  B0  = 20 T and MAS rate of 
 ωR 2π  = 10 kHz, using 90 kHz SPINAL-64 1H decoupling during acquisition. The blue 
lines represent deconvoluted 29Si CPMAS NMR spectra of (b) dry epoxide-silica and (d) 
dry immobilised enzyme fitted using Gaussian line shape analysis. Results of 
deconvolution analysis are presented in Table 5.3. 
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Immobilisation results are presented in Table 5.1 and Table 5.2. Differences in the 
protocols in the literature [254, 256] lead to different suggested immobilisation pHs 
(pH 7.0 and 8.0). Table 5.1 summarises the results without and with ammonium 
sulfate at pH 7.0 and 8.0 where it is very clear that the addition of salt highly favours 
an increase in the amount of protein immobilised. Loading is also higher at pH 8.0. 
As has been mentioned in Section 3.3.2, immobilisation in presence of high ionic 
strengths increases the reactivity of epoxide groups with reactive amino acid 
residues (RARs).  
It is important to note that small values of immobilised protein (e.g., 13.77 mg prot/g 
sup in Table 5.1) may include large error values because the protein quantification is 
 
Figure 5.5. 13C CPMAS NMR spectra with 1H decoupling of (a) dry epoxide-silica 100 Å, 
(b) dry immobilised enzyme on epoxide-silica 100 Å, (c) dry epoxide-silica 300 Å and (d) 
dry immobilised enzyme on epoxide-silica 300 Å (90° pulse length of 3 µ s, contact time of 
1 ms, relaxation interval of 3 s, averaging 20000 transients). All spectra were recorded at 
 B0  = 20 T and a MAS rate of  ωR 2π  = 14 kHz, using 90 kHz SPINAL-64 1H decoupling 
during acquisition. Spinning sidebands are indicated by asterisks. 
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obtained as a difference between supernatant concentrations at the start and the end 
of the immobilisation procedure. 
The principal issue for studying immobilised enzymes using solid-state MAS NMR is 
the low sensitivity, which on the one hand is due to the relatively small quantity of 
protein present – relatively – in the sample, and consequently in the rotor, and on the 
other to the low 13C abundance. 13C enrichment is not considered in this thesis, for 
the reasons discussed in Chapter 1, therefore samples with the highest amount of 
protein are preferred.  
The highest amount of immobilised protein in Table 5.1 was achieved at pH 8.0 and 
in presence of salt. For these conditions the immobilisation takes around 20 min to be 
completed. In contrast, without ammonium sulfate the process takes more than 40 
 
Figure 5.6. (a) Scheme of α-chymotrypsin covalently immobilised in epoxide-silica. (b) 
Scheme of GOPS grafted on to silica surface. (c) Scheme of opened epoxide ring. 
Subscript ie: immobilised enzyme, ep: epoxide and or: open ring. 
!
(a)
(b)
(c)
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hours finish. The kinetics of immobilisation on epoxide-silica (60 Å pore size) are 
shown in Figure C.1 (Appendix C).  
Table 5.2 shows the results of immobilisation at pH 8 and with ammonium sulfate 
(previous conditions selected) for the four different pore sizes available. The highest 
amount of protein achieved was for a pore size of 100 Å with 68.52 mg/g sup and 
95% of retained activity.  
The protein yield parameter can be very useful to determine if the biocatalyst 
produced is close to reaching the maximum amount of protein possible (saturation 
point). For example, in Table 5.2 it is possible to notice that, excluding 60 Å pore size 
support, all immobilised enzymes reach around a 100% of protein yield. This means 
that the maximum of protein is not reached yet with a contacted load of around 70 
mg prot/g support. An important suggestion for future studies using this support is 
to evaluate a higher contact loading. 
Table 5.1. Immobilisation results of α-chymotrypsin on epoxide-silica 60 Å. 
Immobilisation 
procedure 
Contacted 
load / (mg 
prot/g 
support) 
Immobilised 
protein / (mg 
prot/g 
support) 
Protein 
yield / % 
Immobilised 
enzyme 
activity / 
(IU/g) 
Activity 
yield / % 
Retention 
activity / 
% 
pH 7.0 without 
ammonium 
sulfate 
80.8 ± 2.1 13.7 ± 7.2 17.0 ± 8.3 1360 ± 30 3.23 ± 0.13 18.7 ± 1.2 
pH 7.0 with 
ammonium 
sufate (1.88 M) 
79.1 ± 2.4 36.6 ± 4.3 46.3 ± 2.4 19040 ± 23 45.1 ± 0.2 98.3 ± 1.4 
pH 8.0 with 
ammonium 
sulphate (1.88 
M) 
81.6 ± 2.3 44.2 ± 3.4 54.2 ± 3.5 18850 ± 20 44.6 ± 0.2 80.6 ± 1.3 
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Figure 5.4c and Figure 5.5b show 29Si and 13C CPMAS NMR spectra of immobilised 
enzyme on epoxide-silica (100 Å pore size), respectively. A scheme of 
α-chymotrypsin covalently immobilised on epoxide-silica is shown in Figure 5.6a. 
Carbonyl groups and, probably, ε-carbon from lysine residues (C6ie) from enzyme 
can be observed in the immobilised α-chymotrypsin spectrum (Figure 5.5b). 
The 29Si CPMAS NMR spectra (Figure 5.4a and Figure 5.4c) were deconvoluted by 
fitting Gaussian lineshapes, adjusting their intensity, width and frequency shift 
(Figure 5.4b and Figure 5.4d). Table 5.3 presents the results of the deconvoluted and 
integrated Gaussian curves for epoxide-silica and immobilised enzyme spectra. 
These results are reported as percentages. 
Unexpectedly, the 29Si CPMAS NMR spectra shown in Figure 5.4b reveal changes in 
the surface species of epoxide-silica after the enzyme immobilisation, a process that 
is distant from silicon atoms. These changes are confirmed by the results obtained 
from the deconvolution of the spectra (Table 5.3). 
On the basis of the 29Si CPMAS NMR spectra, it is possible to calculate the degree of 
polycondensation of Qn or Tn species by deconvolution which may be estimated 
using the formulae 
Table 5.2. Immobilisation results of α-chymotrypsin on epoxide-silica with different pore 
size at pH 8 with ammonium sulfate (1.88 M). 
Pore size / Å 
Contacted load /      
(mg prot/g support) 
Immobilised protein / 
(mg/g support) 
Protein yield / 
% 
60 69.3 ± 3.4 31.2 ± 2.3 54.8 ± 3.5 
100 69.0 ± 3.8 68.5 ± 3.1 99.6 ± 4.3 
200 69.3 ± 4.2 67.7 ± 4.7 99.4 ± 6.2 
300 69.3 ± 2.5 66.4 ± 3.3 97.8 ± 4.7 
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Degree of condensation Tn(%) =
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∑
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5.2 
where  Qi  and  Ti  are the percentages of the corresponding sites obtained from 
deconvolution of the 29Si CPMAS NMR spectra (Table 5.3) and  i  is the respective 
number of condensed siloxane groups.  
After the immobilisation procedure, it can be observed that the T1 peak is negligible, 
T2 is significantly increased and T3 has appeared for the first time; small changes can 
 
Figure 5.7. (a) 1H MAS NMR of dry epoxide-silica and wet epoxide-silica in D2O recorded 
at 9.4 T (20 kHz MAS rate, 90° pulse length of 5.5 µ s, relaxation interval of 6 s, averaging of 
64 transients). (b) Close section 1H MAS NMR of wet epoxide-silica in D2O at  B0  = 9.4 T. 
The full linewidth at half-height is 289 Hz for H1, 238 Hz for H2, 51 Hz for H6epa and 68 
Hz for H6epb. 
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also be observed in the Si-coordinated Q2, Q3 and Q4 species. The degree of 
condensation for Tn and Qn species confirm these observations (see Table 5.4). A 
condensation increase of 30% was obtained for Tn species after immobilisation and 
just 1% for Qn species. 
These changes are because residual Si-OH groups become cross-linked to give 
Si-O-Si. The same changes were observed if GOPS-modified silica was incubated in 
aqueous conditions, as in the immobilisation procedure, but with no enzyme present. 
The hydrolysis and condensation (cross-linking process) of organofunctional 
alkoxysilanes is a well-known process used in industry to increase adhesive strength 
[287]. However, it has not been extensively studied on surfaces and not at all in the 
type of system studied here. It is interesting that silanol groups do not condense to 
the maximum possible extent during the initial GOPS modification but require the 
extended aqueous incubation during immobilisation. 
Another reaction promoted by the aqueous conditions of the immobilisation is the 
nucleophilic attack by water molecules on the oxirane functional groups [288], 
thereby yielding a diol (see Figure 5.6c); this can be noted from the relative increase 
in intensity of C6or and the decrease of oxirane carbons (the C5ep and C6ep decrease is 
Table 5.3. Results of deconvolution analysis of 29Si CPMAS NMR spectra before and after 
immobilisation on epoxide-silica. 
Sample Q2 / % Q3 / % Q4 / % T1 / % T2 / % T3 / % 
Epoxide-silica 
7.82± 0.11 
8.80 ± 0.12a 
51.9 ± 0.7 
58.4 ± 0.7a 
29.1 ± 0.4 
32.7 ± 0.4a 
6.70 ± 0.97 
70.82 ± 0.99b 
2.76 ± 0.04 
29.1 ± 0.4b 
- 
- 
Chymotrypsin 
on Epoxide-
silica 
4.04± 0.04 
4.89 ± 0.05a 
50.60 ± 0.52 
61.3 ± 0.6 a 
27.9 ± 0.2 
33.8 ± 0.3 a 
- 
- 
9.39 ± 0.09 
82.0 ± 0.8 b 
2.06± 0.02 
17.9 ± 0.1 b 
a percentages are normalised to 100% for Qn species (Q2, Q3 and Q4) 
b percentages are normalised to 100% for Tn species (T1, T2 and T3) 
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also due to the immobilisation of the enzyme) (Figure 5.5a and b). The same 
behaviour has been observed also in absence of the enzyme. Also, the epoxide group 
can be opened by nucleophilic attack by ammonia (NH3) from the immobilisation 
buffer, yielding primary amines.  
13C CPMAS NMR spectra before and after immobilisation of α-chymotrypsin are 
presented in Figure 5.5 for both 100 and 300 Å silicas. It can be seen from Figure 5.5a 
and c that the NMR results confirm the difference in the epoxide content found by 
the modified Dubertaki method (Figure 5.3), which were 0.40 and 0.18 mol kg−1 for 
100 and 300 Å, respectively. Furthermore, after immobilisation of the enzyme, the 13C 
spectra of 100 and 300 Å silicas show similar intensity to the α-chymotrypsin 
carbonyl groups at 175 ppm (Figure 5.5b and d). The area under the carbonyl peak 
for the immobilised enzyme on epoxide-silica of 100 Å pore size has an absolute 
value of 3.7 × 106 and for 300 Å pore size an absolute value of 3.4 × 106. These results 
are in agreement with the results for biochemical quantification of the immobilised 
protein (Table 5.2), where both pore sizes achieved similar protein content at the end 
of the immobilisation procedure. Although CPMAS signal intensities are generally 
not quantitative, it should be noted that here we are comparing 13C intensities of 
samples that differ only in the silica pore size; we are comparing absolute intensities 
in Figure 5.5a and c and, separately, in Figure 5.5b and d. The 13C signals from the 
GOPS tethered to the epoxide-silica (100 Å pore size) in Figure 5.5a and b have been 
Table 5.4. Degree of condensation of Qn and Tn. 
Sample 
Degree of 
condensation Qn / % 
Degree of 
condensation Tn / % 
Epoxide-silica 80.9 ± 1.1 43.0 ± 0.6 
Chymotrypsin 
on Epoxide-
silica 
82.2 ± 0.8 72.5 ± 0.7 
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assigned with the aid of a {1H, 13C} HETCOR experiment and are in agreement with 
previous studies [286, 287]. Figure 5.6 shows the notation used here for the carbon 
assignment.  
To aid assignment of 1H and 13C MAS NMR spectra, two-dimensional {1H, 13C} 
HETCOR spectra of the epoxide-silica and solid biocatalyst samples (both 100 Å pore 
size) were recorded and are shown in Figure 5.8 (only 13C shifts below 100 ppm are 
displayed). Two-dimensional correlation peaks here indicate the presence of a 
dipolar coupling and hence spatial proximity between 1H and 13C pairs. The 13C 
projections of the two spectra are also shown, and to aid assignment, the 1H MAS 
spectrum of the epoxide-silica sample with added D2O from Figure 5.7 is also 
presented. Analysing the results of the support system and solid biocatalyst jointly, it 
was possible to assign the 13C and 1H NMR spectra in Figure 5.5 and Figure 5.7 as 
shown, according to the numbering schemes in Figure 5.6.  
5.3.2 Epoxide-alumina 
The functionalisation of calcined alumina was conducted using the same protocol as 
for silica. A set of aluminas with various pore sizes were grafted on the surface with 
GOPS in a non-aqueous reflux system (Section 4.5.1). The epoxide content for 
different alumina supports after the functionalisation with the organosilane are 
summarised in Figure 5.9. The trend is similar to that found using silica supports; the 
smaller the pore, the greater the epoxide content. Apparently, alumina with a pore 
size of 50 Å does not show diffusional restrictions, unlike that found for silica with 60 
Å pores size. This effect could be possible due to a better pore distribution (i.e., a 
narrower range of pore sizes) on the alumina support. These parameters were not 
provided by the suppliers of silica and alumina and not measured in the present 
thesis. It is strongly recommended that future studies include the characterisation of 
the supports by methods such as BET, TEM or XRD.  
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Figure 5.10 shows 27Al MAS NMR spectra of epoxide-alumina (TH-80) without 
cross-polarisation (Figure 5.10a) and with (Figure 5.10c). There is no visible 
difference between the cross-polarisation experiment and the simple 90° pulse. 
Pentacoordinated alumina sites are no longer present on the surface after the 
immobilisation procedure. The disappearance of AlV after immobilisation is probably 
because of the interaction of water molecules from the immobilisation buffer with 
pentacoordinated alumina sites converting these sites to octahedral aluminium. This 
result supports the idea of the exclusive presence of AlV on the surface of alumina, 
discussed in Section 5.2.2, since the interaction of water and AlV is restricted to the 
surface only.  
 
Figure 5.8. Two-dimensional {1H, 13C} HETCOR spectra with 1H decoupling of (a) dry 
epoxide-silica and (b) dry immobilised enzyme 100 Å at  B0  = 20 T and a MAS rate of 
 ωR 2π  = 14 kHz, using 90 kHz SPINAL-64 1H decoupling during acquisition. Spectra 
were recorded with the pulse sequence shown in Figure 2.7 by averaging 128 transients for 
each of the 24 t1 increments of 150 µ s (90° pulse length of 3 µ s, contact time of 1 ms, 
relaxation interval of 3 s). 
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29Si CPMAS NMR spectra of GOPS-treated alumina are presented in Figure 5.10b. It 
is possible to note that the signal-to-noise ratio is much lower than for epoxide-silica 
systems (Figure 5.4), even using a 20 T magnet. This is not a surprise because in the 
alumina epoxide system the only source of silicon atoms is from the molecules of 
GOPS tethered to the surface.  
13C CPMAS NMR spectra before and after immobilisation of α-chymotrypsin on 
epoxide-alumina are shown in Figure 5.11. The same species as were found for 
epoxide-silica were identified in this system (Figure 5.5a and b).  
The addition of liquid D2O (100 ml D2O per 0.5 g of epoxide-alumina, at least 3 h 
prior to NMR recording) was also studied for epoxide-alumina with 80 Å of pore size 
(Figure 5.12). No difference was observed in the proton species between 
epoxide-silica (Figure 5.7) and epoxide-alumina. 
The immobilisation of enzyme on epoxide-alumina with different pore sizes (50, 80, 
100 and 200 Å) was achieved. The initial conditions used were the optimum 
conditions obtained for epoxide-silica discussed in Section 5.3.1 (pH 8.0 with 
 
Figure 5.9. Epoxide content after functionalisation with GOPS for alumina 50 Å(SB-1), 80 
Å (TH-80), 100 Å (TH-100) and 200 Å( TH-200) pore size. 
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ammonium sulfate). Table 5.5 and Table 5.6 summarise the results for these 
immobilisations. In Table 5.5 it is possible to note that the highest amount of protein 
immobilised was obtained for an alumina pore size of 80 Å (TH-80).  
The immobilisation kinetics for all different pore sizes are shown in Figure C.2 
(Appendix C). It is noticeable that the time required to immobilise the enzyme on 
epoxide-alumina increases for smaller pores. This trend seems reasonable because 
the access of the protein will be restricted during the immobilisation process for 
smaller pores and the coverage of the surface available within these pores will be 
 
Figure 5.10. 27Al simple 90º pulse MAS (90° pulse length of 5 µ s, relaxation interval of 5 s, 
averaging 4 transients) and CPMAS NMR spectra (90° pulse length of 5.6 µ s, contact time 
of 0.5 ms, relaxation interval of 2 s, averaging 1024 transients) of (a) dry epoxide-alumina 
and (c) dry immobilised enzyme (80 Å pore size) at 9.4 T and a MAS rate of  ωR 2π  10 
kHz, 1H decoupling was not used. 29Si CPMAS NMR of (b) dry epoxide-alumina and (d) 
dry immobilised enzyme (80 Å pore size) (90° pulse length of 3.3 µ s, contact time of 5 ms, 
relaxation interval of 3 s, averaging 6057 transients) at  B0  = 20 T and a MAS rate of  ωR 2π  
= 10 kHz, using 90 kHz SPINAL-64 1H decoupling during acquisition. 
(a) (b)
(c) (d)
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hampered by internal diffusion. The procedure of immobilisation of α-chymotrypsin 
on epoxide-silica with a pore size of 50 Å pore size took approximately 50 hours, for 
a pore size of 80 Å around 20 hours, for a pore size of 100 Å about 10 hours and, 
finally, for the largest pore available (200 Å) less than 5 hours. Similar behaviour was 
observed in the immobilisation on epoxide-silica for different pore sizes. 
The enzymatic activity results for alumina systems were intriguing (Table 5.6). Very 
low activities were obtained at normal conditions of the activity assay described in 
 
Figure 5.11. 13C CPMAS NMR spectra of (a) dry epoxide-alumina and (b) dry immobilised 
enzyme on same support (80 Å pore size) (90° pulse length of 3 µ s, contact time of 1 ms, 
relaxation interval of 3 s, averaging 20000 transients) at  B0  = 20 T and a MAS rate of 
 ωR 2π  = 14 kHz, using 90 kHz SPINAL-64 1H decoupling during acquisition. Spinning 
sideband is indicated by asterisk. 
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Section 4.4 (pH 7 and 25 °C) compared with immobilised enzyme on epoxide-silica 
(Table 5.1). 
It has been reported that several mono- and divalent cations, particularly sodium 
(Section 3.2.2.2) and calcium, bind proteolytic enzymes, inducing conformational 
changes which affect the catalytic activity of proteinases and/or the recognition 
process by their protein inhibitors [289-291]. Aluminium, as other metals, can act as 
an enzyme inhibitor. Aluminium strongly influences the binding properties of 
α-chymotrypsin, affecting both substrate and the inhibitor recognition process [292]. 
The experimental data of Angeletti et al. [292] demonstrate that the modulative effect 
of aluminium is due to a simultaneous occupancy of the substrate and metal-binding 
sites. The substrate binding brings about a modification of the ionic environment of 
 
Figure 5.12. 1H MAS NMR spectra of (a) dry epoxide-alumina, (b) wet epoxide-alumina in 
D2O and (d) wet enzyme immobilised on epoxide-alumina at  B0  = 20 T (90° pulse length 
of 1.8 µ s, relaxation interval of 4 s, averaging 256 transients). (c) Expanded region of 1H 
MAS NMR spectrum of wet epoxide-alumina in D2O at  B0  = 20 T. The MAS rate was 
 ωR 2π  = 60 kHz. 
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the enzyme molecule, favouring aluminium binding. This situation induces a 
threefold decrease in the affinity of the enzyme for the macromolecular protein 
inhibitor bovine pancreatic trypsin inhibitor (BPTI) in presence of Al3+. In the same 
study the pH effect was studied. They observed that upon increasing the pH from 7.0 
to 8.5, the dissociation constant between Al3+ and the enzyme increases too. With this 
background the results shown in Table 5.6 seem plausible. 
With the purpose of observing if the inhibition of aluminium is dependent or not on 
pH, different pH values were evaluated in the activity assay. Table 5.6 shows the 
enzymatic activity that took place at pH 7.0, 9.0 and 10.0 for all immobilised enzymes 
on epoxide-alumina. The results show a clear pH dependence on the enzymatic 
activity of enzyme immobilised on alumina-based supports, suggesting that 
protonated residues on the protein modulate the aluminium-linked effect. 
Another contribution that could explain the pH dependence on the enzymatic 
activity could be a negative charge on the alumina surface in aqueous media. This 
attracts H+ ions and leads to a lower microenvironmental pH, and therefore an 
apparent shift in the enzyme pH profile to a higher pH. 
Similarly to silica systems, cross-linking between residual Al-OH and alkyl silicon 
atoms (T1, T2 and T3) on epoxide-alumina surface takes place during the 
Table 5.5. Immobilisation results of α-chymotrypsin on epoxide-alumina with different 
pore sizes. 
Pore size / Å 
Contact load / (mg 
prot/g support) 
Immobilised protein / 
(mg/g support) 
Protein yield / 
% 
50 81.5 ± 3.3 47.9 ± 2.2 58.8 ± 3.3 
80 81.8 ± 2.4 64.2 ± 2.8 78.4 ± 2.2 
100 80.4 ± 2.1 61.5 ± 1.4 76.5 ± 1.7 
200 81.4 ± 3.7 59.3 ± 2.7 72.8 ± 2.4 
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immobilisation in aqueous conditions (Figure 5.10b and Figure 5.10d). The 29Si peak 
around –100 ppm (Q3) before and after immobilisation in Figure 5.10b and Figure 
5.10d can be attributed to impurities in the alumina support. 
Figure 5.11 shows 13C CPMAS NMR before and after immobilisation of 
α-chymotrypsin on epoxide-alumina (80 Å pore size). By comparison with Figure 5.5 
(silica systems) and Figure 5.11 (alumina systems), no significant differences are 
observed after the immobilisation. 
With the purpose of confirming whether the assignment for silica epoxide systems 
can be applied to epoxide-alumina systems, two-dimensional {1H, 13C} HETCOR 
spectra were recorded and are shown in Figure 5.13 (only 13C shifts below 100 ppm 
are displayed). The 13C projections of the two spectra are also shown. The 1H MAS 
NMR spectrum of the epoxide-alumina sample with added D2O from Figure 5.12 is 
also presented. For both metal-oxide supported biocatalysts, the {1H, 13C} HETCOR 
spectra (Figure 5.8 and Figure 5.13) are comparable and the assignments are identical 
for the 13C and 1H peaks. 
In general, the structural characterisation of both inorganic supports has shown quite 
similar results. In contrast, their performances as biocatalysts were completely 
Table 5.6. Activity results at different pHs for immobilised enzyme on epoxide-alumina. 
Pore 
size 
/ Å 
Immobilised enzyme activity / 
(IU/g) 
Activity yield / % Retention activity / % 
pH 7 pH 9 pH 10 pH 7 pH 9 pH 10 pH 7 pH 9 pH 10 
50 21 ± 12 276 ± 10 350 ± 20 0.07 ± 0.01 0.84 ± 0.03 1.07 ± 0.06 0.09 ± 0.01 1.12 ± 0.04 1.42 ± 0.08 
80 93 ± 15 776 ± 23 732 ± 10 0.28 ± 0.04 2.36 ± 0.07 2.23 ± 0.03 0.28 ± 0.04 2.35 ± 0.06 2.22 ± 0.02 
100 93 ± 13 1005 ± 14 1005 ± 12 0.29 ± 0.04 3.11 ± 0.04 3.11 ± 0.03 0.29 ± 0.04 3.17 ± 0.04 3.17 ± 0.04 
200 104 ± 11 1116 ± 12 420 ± 14 0.32 ± 0.03 3.41 ± 0.03 3.41 ± 0.12 0.34 ± 0.04 3.66 ± 0.03 1.38 ± 0.04 
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different. The use of alumina supports is not recommended for immobilisation of 
α-chymotrypsin if a high enzymatic activity is desirable. 
5.3.3 Eupergit® 
Eupergit® is a trademark of Evonik Industries. There are two different types of this 
support: Eupergit® C and 250 L (Appendix A, Table A.3). As a the result of a market 
driven decision, production of Eupergit® C was discontinued years ago and it is 
therefore no longer commercially available. This meant that Eupergit® 250 L alone 
was available for use in the present research. From this point onwards the term 
Eupergit® will be used to refer to Eupergit® 250 L unless otherwise stated. 
Eupergit® was generously donated by Evonik industries. 
 
Figure 5.13. Two-dimensional {1H, 13C} HETCOR spectra of (a) dry epoxide-alumina and 
(b) dry immobilised enzyme on epoxide-alumina at  B0  = 20 T and a MAS rate of  ωR 2π  = 
10 kHz, using 90 kHz SPINAL-64 1H decoupling during acquisition. Spectra were 
recorded with the pulse sequence shown in Figure 2.7 by averaging 256 transients for each 
of the 25 t1 increments of 50 µ s (90° pulse length of 3.5 µ s, contact time of 1 ms, relaxation 
interval of 3 s, averaging 20400 transients). Epoxide-alumina used had a pore size of 80 Å 
(TH-80). 
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The epoxide content of Eupergit® by the modified Dubertaki method was 0.67 mol 
kg−1 of support. This commercial support exhibits a higher amount of oxirane groups 
per mass than the metal-oxide-based supports (around 0.4 mol kg−1 sup) described 
earlier in this Chapter.  
Of the supports chosen in this thesis, Eupergit® becomes the most challenging to 
characterise by NMR due to the complexity of its nature as a polymer (3.1.3.1). The 
cross-linking agent used to manufacture the acrylic resin does not contain aromatic 
groups (personal communication with Dr Stefan Menzler who is in charge of the 
production of Eupergit® currently). 
The 13C CPMAS NMR spectra of Eupergit® are shown in Figure 5.14. The peak at 181 
ppm corresponds to carbonyl groups, whereas the resonance at 67 ppm is assigned 
to carbon singly bonded to an oxygen atom (C-O) and the peak at 56 ppm relates to 
not-terminal epoxide carbon (CEp). The resonance at 46 ppm corresponds to either a 
terminal epoxide carbon, a carbon bonded to nitrogen atoms or methyl carbons (CEpT, 
C-N or CH3). The broad peak at 20 ppm is attributed principally to backbone carbons 
in the polymer (CBB).  
As observed before with epoxide-silica and epoxide-alumina, the addition of D2O to 
Eupergit® has a significant effect on the 1H spectrum in narrowing signals and 
exchanging acidic protons (100 ml of D2O per 0.5 g of Eupergit®, at least 3 h prior to 
NMR recording) (Figure 5.15). The proton resonances from the epoxide ring (Hep) are 
visible after the addition of heavy water (Figure 5.15b) at 3.8 and 3.2 ppm. In the 
same spectrum a very sharp signal arises at 1 ppm, probably corresponding to 
methyl protons. 
The immobilisation of α-chymotrypsin on Eupergit® was optimised. Some of the 
factors studied were the presence of ammonium sulfate at different concentrations 
and contacted loads of enzyme. 
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Again, the presence of ammonium sulfate shows favourable effects on the amount of 
protein immobilised (Table 5.7), almost doubling the protein yield. The 
immobilisation kinetics for these two immobilisations are shown in Figure C.3 
(Appendix C). More than 60 hours are needed to complete the immobilisation 
without the use of ammonium sulfate. When ammonium sulfate was used the 
immobilisation process only took around the half of the time.  
 
Figure 5.14. 13C CPMAS NMR spectra with 1H decoupling of (a) dry Eupergit® and (b) dry 
immobilised enzyme on Eupergit® (90° pulse length of 3.5 µ s, contact time of 1 ms, 
relaxation interval of 3 s, averaging 20400 transients) at  B0  = 20 T and a MAS rate of 
 ωR 2π  = 15 kHz, using 90 kHz SPINAL-64 1H decoupling during acquisition. Spinning 
sidebands are indicated by asterisks. 
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The use of different concentrations of ammonium sulfate was evaluated (Table 5.8) 
showing no clear optimum concentration. The contacted load used is still far from a 
concentration indicating saturation, even using over 100 mg of protein per g of 
support. This effect is possibly because of the higher oxirane density of Eupergit® 
compared with epoxide-silica or epoxide-alumina. An increase in the immobilised 
 
Figure 5.15. 1H MAS NMR spectra (a) of dry Eupergit®, (b) wet Eupergit® in D2O and (c) 
wet immobilised enzyme on Eupergit® in D2O (90° pulse length of 1.8 µ s, relaxation 
interval of 4 s, averaging 256 transients) at  B0  = 20 T and a MAS rate of  ωR 2π  = 10 kHz. 
The solvent peak has been truncated. 
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enzyme content can be due to an increase in the binding density [293]. However, the 
same positive effect can have negative repercussions in the form of a reduction of in 
activity retention, presumably because of rigidification of the conformation of the 
enzyme [294]. The multipoint covalent attachment has shown a significant increase 
in the thermostability of α-chymotrypsin immobilised on Eupergit® C [295] but, 
intriguingly, in the same publication the retention of activity for this biocatalyst is 
not provided. 
Interestingly, in Table 5.8 it is possible to observe that the activity of the immobilised 
enzyme at pH 8 decreases when a higher salt concentration has been used during the 
immobilisation. This is probably for the same reasons stated above: an increase of the 
Table 5.7. Immobilisation results of α-chymotrypsin on Eupergit® at pH 8. 
Immobilisation 
procedure 
Contacted load /     
(mg prot/g support) 
Immobilised protein / 
(mg/g support) 
Protein yield / 
% 
without ammonium 
sulfate 
52.8 ± 4.2 26.7 ± 2.7 50.7 ± 4.3 
with ammonium 
sulphate (1.88 M) 
56.7 ± 3.6 55.1 ± 3.5 94.7 ± 5.1 
 
Table 5.8. Immobilisation results of α-chymotrypsin on Eupergit® at different salt 
concentrations at pH 8.0. 
Salt 
concentration 
/ M 
Contacted 
load /     
(mg prot/g 
support) 
Immobilised 
protein / 
(mg/g 
support) 
Protein 
yield / % 
Immobilised 
enzyme 
activity / 
(IU/g) 
Activity 
yield / % 
Retention 
activity / % 
1.5 116.5 ± 5.2 111.4 ± 5.7 95.6 ± 4.3 571 ± 13 0.95 ± 0.02 1.00 ± 0.02 
2.0 122.1 ± 4.4 115.8 ± 4.5 94.8 ± 3.1 399 ± 11 0.63 ± 0.01 0.67 ± 0.02 
2.5 136.9 ± 4.1 135.8 ± 4.8 99.1 ± 3.9 402 ± 17 0.57 ± 0.02 0.58 ± 0.02 
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binding points between the enzyme and the support, leading to an observable 
decrease in the retention of activity.  
As was mentioned in Section 4.5.2, the results for Eupergit® for the evaluation of the 
protein content in the washings were measured. The washings correction was 
significant in this case, and has been used. The immobilisation results for this system 
are summarised in Table 5.9. 
Bearing in mind the points above, not all the protein adsorbed was immobilised by 
covalent binding because at least 6% of the protein is lost during the washing 
procedure. Non-covalent adsorption was higher for this support than for epoxide-
silica and epoxide-alumina. 
Figure 5.14 shows 13C CPMAS NMR spectra before and after immobilisation of 
α-chymotrypsin at pH 8.0 with a protein loading of 152 mg prot g−1 support. No 
significant differences can be percieved because the high complexity of the 
Eupergit® spectrum obscures the signals from the protein. The parameters for both 
experiments in Figure 5.14 are the same, and thus are comparable. Presumably, the 
signal from the protein is very small compared with the significant background from 
the support, hence impeding observation of any differences in the spectra. This effect 
is noted, for example, in the signal from carbonyl groups, where at least some 
increase in intensity was expected but not found. 
The effect of the addition of D2O to an immobilised enzyme on Eupergit® was 
studied. Figure 5.15 shows 1H MAS NMR spectra before and after immobilisation 
with D2O (5% w/v, at least 3 h prior to NMR recording). It is noticeable that the 
intensity of epoxide protons decreases after the immobilisation. This could be an 
effect of the immobilisation of the protein through the epoxide or the nucleophilic 
attack of water during the immobilisation procedure (as was noted earlier for silica 
and alumina systems). 
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5.4 Discussion 
Solid-state NMR has certain limitations as a characterisation tool of porous supports. 
One drawback of this technique is that it is not possible  to obtain information about 
the size or distribution of pores. Gas adsorption analysis is the more conventional 
technique used for this purpose (see Section 3.1.1). Additional studies using 
adsorption methods could be beneficial in order to compare the metal-oxide systems 
and make better conclusions about the performance of these supports. Conclusions 
could be drawn that derive from information gained from examining the relative 
activity performance  of the biocatalyst and the pore size distribution. 
Another limitation of the use of solid-state NMR is the absence of information about 
the location of the immobilised enzyme. However, it is usually assumed for these 
types of systems that the majority of the enzyme is inside the pores because the 
internal surface is much larger than the external surface. The use of complementary 
techniques such as gas adsorption, XRD, FTIR or TEM could be extremely beneficial 
in providing further insights about the distribution of the protein within the 
supports.  
Table 5.9. Immobilisation results of α-chymotrypsin on Eupergit® at pH 8 and with ammonium 
sulfate (2.0 M). 
Contacted 
load /  
(mg prot/ 
g support) 
Immobilised protein / 
(mg/g support) 
Protein yield / % Immobilised 
enzyme 
activity / 
(IU/g) 
Activity 
yield / % 
Retention activity / % 
Before After Before After Before After 
54.6 54.3 ± 3.1 53.0 ± 2.3 99.4 ± 5.6 96.9 ± 4.3 180 ± 12 0.64 ± 0.04 0.64 ± 0.04 0.66 ± 0.04 
105.2 103.0 ± 4.6 96.3 ± 3.7 97.9 ± 4.4 91.5 ± 3.8 508 ± 14 0.94 ± 0.02 0.96 ± 0.02 1.02 ± 0.03 
152.4 131.1 ± 2.3 108.6 ± 3.2 85.9 ± 2.7 71.2 ± 2.5 379 ± 20 0.48 ± 0.04 0.56 ± 0.03 0.68 ± 0.03 
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Despite these pitfalls, solid-state NMR has proven its capabilities as a useful 
technique for characterising the surface interaction before and after silanisation of the 
oxide-metals supports used in this thesis. In addition, the use of FTIR and TGA could 
be used as complementary techniques to analyse the grafting procedure. 
The use of solid-state NMR to characterise Eupergit® systems is less informative 
when compared to its use for silica and alumina systems. The main reason is the 
organic nature of Eupergit®. Future solid-state NMR studies of enzymes 
immobilised on polymers (and also on inorganic supports) should explore 
approaches other than cross-polarisation. In the cross-polarisation method, 
enhancement of 13C magnetisation is effective for immobile components in a polymer 
where there are relatively strong dipolar couplings. Therefore, there is a chance that 
mobile regions of the polymer have been missed in the CPMAS NMR spectra. Other 
solid-state NMR methods such as pulse saturation transfer under MAS or low 
decoupling under MAS can enhance the 13C signal of the mobile components in this 
type of system [296].  
An interesting approach, not explored in this thesis, is the study of the 
enzyme-surface interactions by relaxation measurements using solid-state NMR. 
Potentially, solid-state NMR can be used to study the immobilised enzyme dynamics 
by indicating the strength of the dipolar interaction through relaxation 
measurements (e.g., T1 or Τ1ρ) performed on the both the protein backbone and its 
side chains. This approach is based on the hypothesis that proteins that bind strongly 
will be less mobile than those that are not tightly associated with the surface. This 
tactic has been exploited for analogous systems to immobilised enzymes, such as 
membrane proteins and biomineralisation proteins (see Section 2.5.3.4). 
Computer simulation methods such as molecular dynamics can also provide 
information about enzyme-surface interactions. Some work has been done for 
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immobilised proteins on surfaces (see Section 2.5.3.4). However, further development 
is needed to obtain more accurate predictions for such systems. 
In addition to the NMR studies, the protein quantitation is an important step to fully 
characterise these systems after immobilisation. Here, the protein quantition was 
conducted by a traditional difference method. This indirect method is not suited for 
fast immobilisation processes (see Appendix C, Figure C.2d) because it requires 
manual sampling and results in a low time resolution, typically tens of minutes. 
Table 5.10 shows other methodologies that can quantify protein concentration 
directly in real time. The additional use of these direct methods for protein 
quantification could be beneficial but not essential for future studies. 
5.5 Conclusions 
It has been shown that solid-state NMR can be used to characterise the 
metal-oxide-based supports (silica and alumina) used in an immobilised enzyme 
model biocatalyst and can also be used to follow changes in the surface environment 
upon coupling of the covalent linker (GOPS) and the enzyme (α-chymotrypsin). In 
particular, 29Si CPMAS NMR spectra reveal changes in the surface species upon 
immobilisation, arising from cross-linking between silanol groups. Using one- and 
two-dimensional 13C CPMAS NMR, it was possible to achieve a full assignment of 
13C and 1H species from the linker before and after covalent immobilisation of the 
enzyme. Although most of the focus of the work described in this Chapter has been 
upon the characterisation of the metal-oxide-based support and covalent linker, it 
was possible to observe carbonyl groups in the α-chymotrypsin enzyme using 13C 
CPMAS NMR. 
On the other hand, the information from the structural characterisation of the 
Eupergit® system by solid-state NMR was not as useful as for the other two 
metal-based biocatalysts. The complexity of the polymer, with an abundance of 13C 
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species from the support, makes it very difficult get a deep insight into the system. 
However, information on 1H signals from the epoxide ring was noticeable before and 
after the immobilisation. 
Finally, although the primary goal of this Chapter was the characterisation of the 
systems by solid-state NMR, some results from biochemical assays about the 
optimisation of the immobilisation process provided interesting information. For 
example, the effect of a high ionic strength during the immobilisation of protein is 
not a well known effect for metal-oxide-based supports, despite the popularity of the 
same approach for immobilisation on oxirane functional polymers. 
Table 5.10. Methods for quantification of immobilised protein. 
Method References 
Difference Method [264], [297], [298] 
QCM-D1 [78] 
Fluorescence Microscopy [76] 
1 Applicable only to immobilised enzyme on Quartz crystals 
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CHAPTER 6 
 
Quadrupolar Relaxation Studies of 
Immobilised Enzymes 
There has been widespread interest in using NMR of spin  I = 3/2  nuclei, such as 7Li, 
23Na, 35Cl and 39K, and spin  I = 5/2  nuclei, such as 17O, 25Mg, 67Zn, 85Rb and 127I, to 
study the vital roles played by ions in many important biological processes.  
The two main areas of interest have been the study of these nuclei in intracellular 
environments [299] and of their binding to biological molecules in solution [215]. In 
both cases the nuclei often exhibit multiexponential transverse and longitudinal 
quadrupolar relaxation [300] if the extreme narrowing condition is not fulfilled (i.e., 
if conditions of restricted mobility exist), 
  ω0τ c ≥ 1   6.1 
As was mentioned in Section 2.3.1, the quadrupolar relaxation mechanism normally 
dominates the relaxation process and, therefore, the line shapes and widths of the 
NMR peaks observed from such nuclei. To a certain extent, quadrupolar NMR is 
advantageous because, effectively, only a single relaxation mechanism is in 
operation. 
Multiple-quantum NMR experiments have been used to investigate multiexponential 
relaxation since 1986 [301, 302] when it was first discovered that multiple-quantum 
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coherences could be excited in liquid samples whose spectrum consisted only of a 
single resonance at a chemical shift characteristic of the aqueous ion.  
In this chapter the study of the relaxation behaviour for different immobilised 
enzymes in the presence of sodium cations and water is explored. The theory behind 
multiple-quantum experiments for spins  I = 3/2  and  I = 5/2  will be outlined.  
Principally, our interest in the study of quadrupolar relaxation lies in the study of 
water interactions with immobilised enzymes. It is generally assumed that in the 
presence of macromolecules, water can be located in the bulk, surface or buried (see 
Section 3.2.2.1). When immobilised enzymes are employed in non-aqueous media at 
low water activity, with bulk phases based on organic liquids, supercritical fluids or 
gas phases, residual water molecules bound to the enzyme are crucial in this case for 
the continuing function of the enzyme. The importance of these enzyme interactions 
is discussed in Section 3.2.2. The potential users of the methods developed in this 
chapter will be interested in determining the number of bound water molecules and 
the strength of their interaction with the immobilised enzyme at low water activity. 
Consequently, the fractions of free and bound water represent interesting 
information and potentially could be addressed using MQ-filtered 17O NMR. It is 
important to note that the systems tested here correspond to aqueous systems, where 
this is a matter of definition as well as of experimental measurement.  
We decided to start with 23Na NMR – cheaper, more sensitive, and theoretically 
simpler than for spin  I = 5/2  – before moving on to 17O NMR. However, 23Na NMR 
relaxation study of sodium ions with immobilised enzyme is also an interesting 
system to evaluate. 
The application of the techniques presented in this chapter to solid-liquid hybrids 
samples (see Section 6.1.2) using solid-state MAS NMR is completely novel. 
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6.1 Experimental details 
6.1.1 NMR experiments 
All NMR spectra presented in this chapter were recorded using the methodology of 
solid-state NMR, although many of the samples were solid-liquid composites. 23Na 
NMR experiments were performed on a Bruker Avance I 400 MHz spectrometer 
equipped with a widebore 9.4 T magnet and 17O NMR experiments on a Bruker 
Avance III 850 MHz spectrometer with a widebore 20 T magnet, yielding 1H 
resonance frequencies of approximately 400 and 850 MHz, respectively. All samples 
treated in this chapter contain liquids, therefore samples were packed into a 4 mm 
“CRAMPS-type” MAS rotor with a PTFE spacer to help contain the fluid. Samples 
were rotated at 10 kHz in a 4 mm MAS probe. Further experimental details such as 
pulse sequence, pulse length, free-precession delay, recycle delay and number of 
transients can be found in the text and figure captions. 
6.1.2 Sample preparation 
Samples were approximately 50% biocatalyst and 50% liquid by weight. The liquid 
was a solution of aqueous NaCl (0.03 M) for 23Na NMR experiments (Section 6.2) and 
70% 17O enriched water for 17O NMR experiments (Section 6.3). The biocatalyst used 
in these experiments was immobilised enzyme (α-chymotrypsin) on epoxide-silica of 
different pore sizes. Samples were stored at 3 °C and discarded after one week in 
case of possible microbiological contamination. Biocatalyst samples were the same 
preparations as the ones characterised in Chapter 5: immobilised-enzyme on 
epoxide-silica. 
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6.2 The Triple-Quantum Filter Experiment for 23Na (Spin  I = 3 / 2 ) 
The most frequently studied spin  I = 3/2  nucleus, especially in vivo, is 23Na because 
of its 100% natural abundance, high biological concentration and favourable 
gyromagnetic ratio (see Table 2.1).  
The regulation of activity through metal ion complexation plays a key role in many 
enzyme-catalysed reactions [216]. In serine proteases there exists a specific site where 
Na+ binds to the enzyme, affecting positively the activity of these enzymes (Section 
3.2.2.2). Although our main interest in 23Na TQF NMR experiments is to perform a 
trial run before moving on to 17O NMR experiments, the obtention of information 
about the behaviour of sodium cations in the presence of immobilised enzyme, also 
provides us with information that could potentially be of interest to us.  
The Na+ interaction with the enzyme can be catalogued as an allosteric effect. 
Allostery can be defined as the regulation of protein function, structure and/or 
flexibility induced by the binding of a ligand, at a site away from the active site. The 
timescales of dynamics implicated in allostery often range from nanoseconds to 
milliseconds (see Figure 2.8) [303]. Here, a novel approach to the study of the 
quadrupolar relaxation behaviour of Na+ in the presence of a solid-liquid composite 
sample (i.e., immobilised enzyme in presence of a solution of NaCl) by solid-state 
MAS NMR, using a solution-state NMR method [49], is presented. 
When 23Na is transiently bound to the protein (i.e., under conditions of restricted 
mobility), electric field gradients created at the 23Na nucleus act as an effective 
relaxation mechanism and the outer transitions ( mI = −3 /2  ↔  mI = −1/2  and 
 mI = +1/2  ↔  mI = +3 /2 ) relax more quickly than the inner transition ( mI = −1/2  ↔ 
 mI = +1/2 ). Jaccard et al. [301] and Pekar and Leigh [302] have independently shown 
that, when Na+ has two distinct relaxation rates for the inner and the outer 
transitions, the normal coherence transfer selection rule can be violated and MQ 
transitions become possible. 
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It has been shown that biexponentially relaxing spin  I = 3/2  nuclei can be filtered 
through a state of multiple-quantum coherence, therefore providing unambiguous 
evidence of the presence of biexponential relaxation [301, 302]. NMR studies 
employing 23Na triple-quantum filter experiments have been used in the past to 
study sodium ion binding to biological molecules in solution [205, 304, 305]. 
The published theory behind triple-quantum filter experiments for  I = 3 /2  nuclei is 
written in terms of irreducible spherical tensor operators. A full description of these 
is beyond the scope of this section, which is the application of multiple-quantum 
experiments to the systems of interest (i.e., immobilised enzymes). Further details 
about the theory behind the study of relaxation for spin  I = 3 /2  through 
multiple-quantum techniques can be found in reference [301]. 
In brief, in the irreducible tensor operator basis the density operator  – the “state 
of the spin system” – for an isolated spin of quantum number  I  can be expressed as a 
linear combination of tensor operators 
 
 
6.2 
where  denotes an irreducible spherical tensor operator of rank  and order . The 
expansion of Equation 6.2 is especially useful in the description of multiple-quantum 
NMR experiments since the ranks ( l ) and coherence order ( p ) are readily 
identifiable. 
If a number of uninteresting constants are ignored, the tensor operators for a spin 
 I = 3/2  nucleus immediately after a 90° excitation pulse (“at  t = 0 ”) are: 
  σ (t = 0) = (T1,−1 −T1,+1)  6.3 
That is, the initial transverse magnetisation is single quantum ( p = ±1) and in phase   
( l = 1). If the time evolution of the density operator occurs as a result of 
 σ (t)
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biexponential transverse relaxation then, after time  t , the new density operator  σ (t)  
is given in tensor operator form by [301] 
  σ (t) = f11
(1)(t)(T1,−1 −T1,+1)+ f31(1)(t)(T3,−1 −T3,+1)  6.4 
where 
 
 
f11(1)(t) =
1
5 3exp{−Rf
(1)t}+ 2exp{−Rs(1)t}( )  6.5 
 
 
f31(1)(t) =
6
5 exp{−Rf
(1)t}− exp{−Rs(1)t}( )   6.6 
Note that doubly-antiphase single-quantum magnetisation (represented by  T3,±1 ) has 
appeared and can be used to excite MQ coherences (pulses can change the order of a 
tensor but not its rank). For pure quadrupolar relaxation in the absence of exchange, 
the fast ( Rf ) and slow ( Rs ) transverse relaxation rate constants can be calculated as 
  Rf
(1) = C(J0 + J1)  6.7 
  Rs
(1) = C(J1 + J2 )   6.8 
where the spectral densities  Jn  and the constant  C  are given by 
 
 
6.9 
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where  τ c  is the motional correlation time,  ω0  is the Larmor frequency,  e  is the 
electronic charge,  q  is the magnitude of the EFG,  Q  is the nuclear quadrupolar 
moment,  !  is the reduced Planck constant and η  is the quadrupolar asymmetry 
parameter that can take values between 0 and 1. 
!
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Since the constant  C  depends not only on the nuclear quadrupolar moment  Q , but 
also on the chemical environment of the nucleus, quadrupole couplings can vary 
greatly for the same nucleus. The quadrupolar coupling constant is intimately 
connected with the type of valence surrounding the nucleus. Moreover, the nuclear 
quadrupole constant tensor (see Equations 2.12 and 2.13) contains useful chemical 
information on the disposition of bonding and nonbonding electrons which 
determine the electric field gradient [306]. 
In a normal, “one-pulse” NMR experiment only the relaxation function  f11(t)  can be 
measured, which corresponds to the sum of two decaying exponentials. In contrast, a 
multiple-quantum filtration experiment (Figure 6.1), by filtering the magnetisation 
through  T3,±2  or  T3,±3 , additionally allows the transverse relaxation function  f31
(1)(t)  to 
be measured [301, 302]. This function is the difference of two decaying exponentials, 
which can permit their easier deconvolution. Chung and Wimperis [49] have shown 
that the triple-quantum filter (TQF) experiment (filtration through  T3,±3 ) is 50% more 
sensitive than the double-quantum (DQF) experiment (filtration through  T3,±2 ). 
6.2.1 TQF 23Na NMR relaxation study of sodium ions with immobilised 
chymotrypsin 
Having considered our interest in first testing 23Na multiple-quantum NMR, here 
TQF experiments were evaluated for various immobilised enzymes of different pore 
sizes. A solution of aqueous NaCl (0.03 M) was added to our sample, where the 
binding of the sodium ions to α-chymotrypsin leads to long correlation times, so that 
the transverse relaxation becomes biexponential. 
The pulse sequence shown in Figure 6.1 (triple-quantum filtration) was used to 
measure spin  I = 3/2  transverse relaxation.  
Figure 6.2a-c shows the TQF 23Na MAS NMR spectra of immobilised α-chymotrypsin 
on epoxide silica 100, 200 and 300 Å with 0.03 M NaCl. Fixed evolution times  τ e  of 3, 
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7.2 and 13.8 ms were used, respectively, and 32768 acquisitions were taken for all 
samples. These TQF spectra correspond to  F31
(1)(ω ) , the Fourier transform of the 
time-domain function  f31(t) , and are the differences of two Lorentzian line shapes. 
Further experiments using TQF showed no signal from samples of epoxide silica 
without protein. 
Figure 6.2d-f show the time-domain results obtained for immobilised 
α-chymotrypsin with different pore sizes using the TQF pulse sequence. They show 
the peak amplitude plotted against  τ e . The amplitudes of TQF spectra were 
measured for a range of values of  τ e  between 0 and 150 ms. This allows 
measurement of the time-domain function  f31(t)  directly and, as a consequence of 
the 180° pulse in the middle of the  τ e  period, is free of most of the adverse effects of 
 B0  inhomogeneity. The experimental time-domain data presented in Figure 6.2d-f 
were fitted to a biexponential model (Equation 6.11) using Mathematica software 
(Appendix E). 
 
Figure 6.1. Pulse sequence and coherence pathway diagram for multiple-quantum 
filtration of spin  I  = 3/2 nuclei to study biexponential transverse relaxation. Pulse phase 
 is stepped through the values the values 0° , 90° , 180°  and 270°  for double-quantum 
filtration (dashed coherence pathways) and through 30° , 90° , 150° , 210° , 270°  and 330°  for 
triple-quantum filtration (solid pathways). 
!
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6.11 
where  is an amplitude factor. 
The Fourier-Laplace transform was used to provide the matrix  F(1)(ω )  directly, 
yielding the analytical frequency-domain lineshapes  F11
(1)(ω )  and  F31
(1)(ω ) , starting 
from the transverse relaxation matrix  Rtensor
(1) in the spherical tensor operator basis 
(Appendix D). The spectra presented in Figure 6.2a-c were fitted to the lineshape 
function  F31
(1)(ω )  (Equation 6.12) using a Mathematica routine (Appendix E). 
 
 
F31(ω ) = −
6C(J2 − J0 )
5(CJ1 +CJ2 + iω )(CJ1 +CJ0 + iω )
  6.12 
where  and  are defined in Equations 6.9 and 6.10, respectively. Only the real 
component of Equation 6.12,  F31
(1)(ω )real (Appendix D, Equation D.8), was used.  
For convenience, the parameters extracted from the Mathematica routines were  Rf
(1)  
and  Rs
(1)  for the time-domain data and  τ c  and  C  for frequency-domain. The 
calculation of the remaining dependent parameters was achieved using Equations 6.7 
to 6.10. 
Substantial differences in the values for  Rs
(1)  between the two method – 
frequency- and time-domain – were observed. Frequency and time-domain methods 
should converge to provide identical results within a negligible margin of error; 
nonetheless significant differences were found. A probable explanation for these 
differences might be the impact of  B0  inhomogeneity, which will affect only the line 
shape fitting results, in particular the line width of the central component. For this 
reason, only the results obtained by the time-domain fitting are presented here (Table 
6.1). 
!
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Although difficult to interpret, the correlation time  τ c  of motion associated with 
relaxation is a parameter that is potentially of interest for our research. This 
parameter contains information about the dynamics of the protein as well as the bulk 
 
Figure 6.2. TQF 23Na MAS NMR spectra of immobilised enzyme of pore size (a) 100 Å, (b) 
200 Å and (c) 300 Å with fixed  τ e  values of 10, 15 and 20 ms, respectively, recorded in 
presence of NaCl (0.03 M). TQF time-domain peak amplitude against  τ e (s) plots of 
immobilised enzyme of pore size (d) 100 Å, (e) 200 Å and (f) 300 Å in presence of NaCl 
(0.03 M). All spectra were recorded with the pulse sequence shown in Figure 6.1 at  B0  = 
9.4 T and MAS rate of  ωR 2π  = 10 kHz (90° pulse length of 5.5 µ s,  τm of 2 µ s, relaxation 
interval of 0.2 s, averaging 4096 transients). Computer fittings (dashed lines) were 
performed to experimental data (solid line in spectra and circles for time-domain plots).  
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physical characteristics of the solvent. A novel aspect of the experiments performed 
in this chapter is that the protein is tethered to a solid. Therefore the correlation time 
should not reflect rotational diffusion of the protein molecule, because the protein is 
“static”. It is usually assumed that sodium ions are in fast exchange between free 
solution and the bound state. In this case the obtained  τ c  values are more likely due 
to the distortion of the water coordination sphere that takes place as the Na+ binds 
and unbinds – this will cause a fluctuation of the quadrupolar coupling that will be 
“rotation-like” and so will possess a definable correlation time. Of course, there is the 
possibility of a contribution from local motion in the protein or perhaps a rocking 
motion on the surface.  
As can been seen from Table 6.1, the correlation times  τ c  obtained show a decreasing 
trend when the pore size is increased. When the protein is immobilised, the 
relaxation effect depends instead on the internal molecule residence time rather than 
on free tumbling of protein molecules [307]. Therefore as an effect of pore size, the 
internal residence times are reduced when it is larger. However, these data must be 
interpreted with caution due to the little knowledge about relaxation phenomena on 
proteins in restricted or inhibited motion environments. The correlation times in this 
type of system will be dictated by the residence time of the ligand and also by the 
restricted movement of the immobilised protein.  
Table 6.1. Results for time-domain fitting of 23Na TQF NMR data from immobilised 
chymotrypsin with different pore sizes.  Rf
(1) ,  Rs
(1) ,  C  and  τ c  are defined in Equations 
6.7-6.10. 
Pore size 
/ Å  Rf
(1)
 / s−1  Rs
(1)
/ s−1  C / s−2  τ c / ns R
2 
100 980 ± 20 33 ± 1 (5.3 ± 0.1) ×  1010 9 ± 0.2 0.9970 
200 484 ± 18 32 ± 1 (3.7 ± 0.1) ×  1010 6 ± 0.2 0.9972 
300 226 ± 20 25 ± 2 (2.3 ± 0.2) ×  1010 4 ± 0.4 0.9974 
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The values of correlation time showed in Table 6.1 were calculated assuming no fast 
chemical exchange in the systems. It is clear that a non-chemical exchange approach 
is unrealistic. An attempt to obtain correlation time  τ c  assuming fast chemical 
exchange between bound sodium ions and free solution was performed. The values 
obtained did not make sense in terms of their magnitude (less than 1 ns) and 
therefore these results were omitted. A motional model that includes such fast 
chemical exchange is used for the spin  I = 5/2  systems in Section 6.3.1.  
6.3 Four-Quantum and Five-Quantum Evolution Experiments for 17O-
labelled (Spin  I = 5 / 2 ) 
Water plays an important role in enzyme structure and function. Water molecules 
affect the ionisation and mobility of groups or residue chains on the protein surface 
(Section 3.2.2.1). The study of the structural and dynamic details of the immobilised 
enzyme-water interaction is covered here. With this purpose, enriched 17O-water was 
used and the 17O NMR relaxation behaviour in presence of immobilised enzyme was 
studied. As was mentioned earlier in this chapter, the fractions of free and bound 
water in presence of immobilised enzyme are of interest to us and could be 
addressed using MQ-filtered 17O NMR. 
With a spin quantum number of  I = 5/2 , 17O is the only magnetic nuclide of oxygen. 
Despite its low abundance and low gyromagnetic ratio (Table 2.1), this nuclide has 
attracted considerable interest as a means of probing the environment of water in 
biological systems [308].  
In general, spin  I = 5/2  nuclei are less favourable to study than spin  I = 3/2  nuclei as 
a consequence of far more complicated relaxation dynamics. As with spin  I = 3 /2  
systems, it is possible to use multiple-quantum filtration experiments to study 
relaxation in spin  I = 5 /2 . However, to obtain quantitative parameters from such 
studies (e.g., relaxation rate constants, fraction of bound water, etc.) requires the use 
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of complex iterative fitting techniques as, unlike in the  I = 3 /2  case, both the 
amplitudes and line widths of the (now) three components depend on  τ c . A much 
simpler alternative is to monitor the relaxation of fifth-rank four-quantum and five-
quantum coherences [309]. These exhibit exponential decays under all motional 
conditions and a simple exponential fitting (see Figure 6.6) of both is all that is 
required to extract the two independent variables: correlation time and exchange-
averaged quadrupolar coupling constant.  
The scope of this section is the application of multiple-quantum evolution 
experiments to immobilised enzymes. Further details about the theory behind the 
study of relaxation for spin  I = 5 /2  through multiple-quantum techniques can be 
found in reference [50]. 
The pulse sequence used to measure spin  I = 5 /2  four-quantum and five-quantum 
relaxation is shown in Figure 6.3. In this sequence the multiple-quantum coherence is 
allowed to evolve during the mixing period  τm  so that its exponential decay can be 
measured. 
If a number of uninteresting constants are ignored, the spin  I = 5 /2  tensor operators 
at the start of the mixing period,  tm = 0  for the rank  l = 5  four-quantum and five-
quantum coherences are 
  σ 4Q(tm = 0) = (T5,−4 −T5,+4)  6.13 
  σ 5Q(tm = 0) = (T5,−5 −T5,+5)   6.14 
Thus, after a time  tm , the new density operators for four-quantum and five-quantum 
coherence can be written 
  σ 4Q(t) = f55
(4)(tm)(T5,−4 −T5,+4)  6.15 
  σ 5Q(t) = f55
(5)(tm)(T5,−5 −T5,+5)   6.16 
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where 
  f55
(4)(tm) = exp{−R2(4)t}  6.17 
  f55
(5)(tm) = exp{−R1(5)t}   6.18 
For pure quadrupolar relaxation in the absence of exchange, the two relaxation rate 
constants can be calculated as 
  R2
(4) = C '(6J0 + 2J1 + 7J2 )  6.19 
  R1
(5) = C '(10J1 + 5J2 )   6.20 
where  is given for spin  I = 5 /2  by 
 
 
6.21 
and the spectral densities  Jn  by Equation 6.9. 
Chemical exchange is an intrinsic feature of any system that involves ligand binding5 
to a macromolecule. The theory behind quadrupolar relaxation in the presence of 
chemical exchange has been treated in references [310, 311]. For quadrupolar nuclei it 
is possible to assume that there exist two exchanging populations of water molecules 
in fast chemical exchange, namely bulk water in the extreme narrowing limit and 
water bound in the slow-motion limit. The two correlation times will be very 
different; the relaxation rates of the quadrupolar nuclei at the bound site are much 
greater than at the free site, while their exchange lifetimes are much less.  
  6.22 
                                                
5 Ions, inhibitors and water can interact with macromolecules as ligands. 
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  6.23 
where  and  are the free-site relaxation rates,  and are the bound-site 
relaxation rates, and  and are the bound and free ion fractions. 
The free-site relaxation rate constants  and  can be assumed to be negligible 
compared with the bound-site relaxation rate constants [50] 
  6.24 
  6.25 
The ratio of the two bound-site relaxation rates is given by [50] 
! R2(4) = Rf(4) + (pb /pf )Rb(4)
 Rf
(5)
 Rf
(4)
 Rb
(5)
 Rb
(4)
 pb  p f
 Rf
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Rf(5) ≪ (pb /pf )Rb(5)
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Rf(4) ≪ (pb /pf )Rb(4)
 
Figure 6.3. Pulse sequence and coherence pathway diagram for multiple-quantum 
evolution sequence for spin  I = 5 / 2  nuclei to measure four-quantum and five-quantum 
relaxation functions  f55
(4)(tm )  and  f55
(5)(tm ) . Pulse phase  is stepped through the values 0° , 
45° , 90° , 135° , 180° , 225° , 270°  and 315°  for four-quantum  (dashed coherence pathways) 
and through 18° , 54° , 90° , 126° , 162° , 198° , 234° , 270° , 306°  and 342°  for five-quantum 
coherence (solid pathways). The exponential four-quantum and five-quantum relaxation 
rates are measured by monitoring the amplitude of the observed signal as a function of 
the mixing time period . 
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6.26 
With the spectral densities  given by Equation 6.9 the expression for  can be 
solved 
 
 
6.27 
With the measured quadrupolar constant  C '  from Equations 6.19 or 6.20 and 
assuming a value for the 17O quadrupolar constant of pure water , the ratio 
between the bound and free ion fraction  pb p f  can be calculated since  
 
 
pb
p f
= C 'Cw
  6.28 
6.3.1 An 17O multiple-quantum NMR relaxation study of water dynamics and 
interactions with immobilised chymotrypsin 
The MAS NMR experiments described in this section were performed on 
immobilised chymotrypsin on epoxide silica of two different pore sizes (100 and 200 
Å) in the presence of 70% 17O enriched water (added with mass approximately equal 
to that of the whole immobilised preparation).  
Four-quantum and five-quantum evolution 17O NMR experiments were performed 
using the pulse sequence in Figure 6.3. The phase of the third pulse was  φ ' = 0
!  for 
four-quantum and  φ '  = 90° for five-quantum coherences. The following phase cycles 
were used in addition to those provided in Figure 6.3: a two-step phase cycle to 
counteract any imperfections of the first  pulse; a two-step phase cycle to 
counteract any imperfections of the second pulse; and a four-step CYCLOPS 
!
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phase cycle. Overall this resulted in a 128-step phase cycle for four-quantum and a 
160-step phase cycle for the five-quantum evolution experiment [50]. 
Figure 6.4 shows the 17O NMR spectra obtained using the four-quantum and the 
five-quantum evolution experiments for chymotrypsin immobilised on epoxide silica 
with a pore size of 100 Å. Likewise, Figure 6.5 shows the spectra for chymotrypsin 
immobilised on epoxide silica with a pore size of 200 Å. The spectra are shown as a 
function of the mixing time  τm . The evolution period was fixed at the experimentally 
optimised values of  τ e = 0.62  and  τ e = 1  ms for 100 and 200 Å pore size, respectively. 
 
Figure 6.4. (a) Four-quantum and (b) five-quantum evolution 17O MAS NMR spectra of 
immobilised enzyme on epoxide silica with a pore size of 100 Å in presence of 17O 
enriched water. The spectra shown were recorded with the pulse sequence shown in 
Figure 6.3 with a variable  τm  at  B0  = 20 T and MAS rate of  ωR 2π  = 10 kHz (90° pulse 
length of 5.2 µ s,  τ e of 0.6 ms, relaxation interval of 0.1 s, averaging 2400 transients). 
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The four-quantum coherence is observed with lower sensitivity and shows a much 
faster relaxation rate. These results are in accordance with the analogous 25Mg NMR 
work of Chung and Wimperis in the solution state [50]. 
As described in Section 6.3, the correlation time and quadrupolar coupling constant 
can be extracted analytically from the exponential four-quantum and five-quantum 
 
Figure 6.5. (a) Four-quantum and (b) five-quantum evolution 17O MAS NMR spectra of 
immobilised enzyme on epoxide silica with a pore size of 200 Å in the presence of 17O 
enriched water recorded at  B0  = 20 T. The spectra shown were recorded with the pulse 
sequence shown in Figure 6.3 with a variable  τm  at  B0  = 9.4 T and MAS rate of        
 ωR 2π  = 10 kHz (90° pulse length of 5.2 µ s,  τ e of 1 ms, relaxation interval of 0.1 s, 
averaging 2048 transients).  
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relaxation rates. Peak amplitudes from Figure 6.4 and Figure 6.5 were fitted to a 
first-order decay as a function of time  (Figure 6.6). The fitting procedure was 
generated using Mathematica software to obtain relaxation rate constants.  
These values obtained are shown in Table 6.2. By combining these two relaxation 
values, and assuming the theoretical treatment of Chung and Wimperis [50] to be 
valid (Equations 6.24 to 6.28), it is possible to obtain estimates of the correlation times 
of motions associated with relaxation, and the number of water molecules perturbed 
by interaction with the immobilised enzyme. This leads to the further values in Table 
6.3 using a value of the quadrupolar coupling constant  for liquid 
17O-water of 7.7 MHz [312]. This enabled the fraction of bound  and free  water 
and the number of water molecules bound to the protein to be estimated (see Table 
6.2). The number of water molecules bound per immobilised enzyme (mol/mol) can 
be calculated since the amount of 17O enriched water and immobilised enzyme in the 
sample were measured. The numbers of water molecules bound to the enzyme are 
plausible. 
 τm
 (e
2qQ/!)(1+η2 /3)1/2
 pb  p f
 
Figure 6.6. 17O peak amplitude as a function of  τm  evolution time in (a) four-quantum 
NMR experiment and (b) a five-quantum NMR experiment. Data and fitted lines for 
immobilised chymotrypsin on epoxide silica with pore sizes 100 Å (blue circles) and 200 Å 
(red triangles). Note the change in  τm  scale between (a) and (b). 
! !m/ms !m/ms
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It is possible to obtain motional correlation times from these experiments and these 
are also given in Table 6.2. Earlier, in Section 3.2.2.1, it was mentioned that water 
molecules can be classified into three different categories according to their 
dynamical properties: bulk water with typical reorientational correlation time  τ c  of 
the order of picoseconds; water present on the surface of the protein which exhibits a 
partially restricted motion with  τ c  in the order of nanoseconds; and buried water 
molecules with  τ c  values typically of the order of 10
−8 seconds (tens of nanoseconds). 
The values for motional correlation times  τ c  obtained here (Table 6.2) fall within 
motional range for water present on the surface of the protein. 
As with the 23Na TQF experiments, a decrease in  τ c  values was observed for 
17O 
multiple-quantum experiments for immobilised enzymes with increasing pore sizes 
(Table 6.2). The idea that internal residences times are reduced when the pore of the 
support is larger, therefore reducing  τ c , is corroborated by these results.  
6.4 Discussion 
Future studies should address the possibility of interactions between the ligands (i.e., 
Na+ and H217O) and the support, which in this case is silica. Jang and Fuerstenau 
[313] observed a correlation time of 7 ns by 23Na spin-lattice relaxation studies for 
silica of pore size 100 Å in a NaCl solution. They concluded that this correlation time 
probably reflected the time needed for sodium ions to diffuse out of the pore region, 
rather than a motional restriction of the interfacial sodium ion due to binding. 
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Additional control experiments of the bare supports and ligands should be included 
to evaluate if there is any interaction between them. These can be performed in a 
similar fashion to those used in [313] for inversion time recovery  T1  experiments. 
This information will help in a better understanding of the interpretation of the 
motion times obtained. Also, it will help provide a more accurate value for the water 
molecules bound to the immobilised enzyme in the case of the 17O NMR 
experiments. 
The magnitude of the correlation times obtained – in the range of nanoseconds – by 
23Na and 17O multiple-quantum experiments is in accordance with what is expected 
for a small protein like α-chymotrypsin [314]. Shimshick et al. [315] measured  τ c  for a 
phosphonyl α-chymotrypsin with a nitroxide spin-label by Electron Paramagnetic 
Resonance (EPR), obtaining an experimental value of 12 ns. They argued that, due to 
the rigid body motion of the labelled enzyme, the correlation time must be 1.6 times 
smaller than the theoretical value predicted for a rigid sphere of the same mass and 
density as α-chymotrypsin using the Debye equation (around 7.5 ns). Despite these 
results having similar magnitudes with the  τ c values presented in Table 6.1 and 
Table 6.2, there is no a clear picture of the behaviour of the immobilised enzyme and 
the data must be interpreted with caution. This is mainly because our systems have a 
restricted mobility, where the enzyme is tethered on a solid surface.  
Table 6.2. Results for fitting and calculations for multiple-quantum evolution experiment 
of 17O NMR data from immobilised chymotrypsin with different pore sizes.  R2
(4) ,  R1
(5) , 
 C '  and  τ c  are defined in Equations 6.23-6.28.  
Pore 
size / Å  R2
(4)
/ s−1  R1
(5)
/ s−1
  C ' /  s
−2  τ c  / ns 
 
pb
p f
 
Bound 
water per 
enzyme/ 
(mol/mol) 
R2 
100 6140 ± 20 389 ± 2 (1.71 ± 0.01)×  1010 7.32 ± 0.02 (20 ± 0.12)×  10−3 345 ± 2 0.9983 
200 3610 ± 12 814 ± 3 (1.93 ± 0.01)×  1010 3.59 ± 0.01 (22 ± 0.13)×  10−3 425 ± 3 0.9997 
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The numbers of water molecules calculated by 17O NMR experiments are plausible 
for those surrounding the protein surface. For a fuller picture, it is also necessary also 
to consider the possibility of water molecules interacting with sites on the silica 
surface (ones not masked by the attached protein, silane coupling agent used as a 
first step of immobilisation or hydroxyl/amino groups on the hydrolysed epoxides). 
Another consideration is that not all the interactions between protein and water are 
the same: the binding of water to some sites on the protein is much stronger (e.g., 
around charged groups) than others. However, values between 300 and 400 water 
molecules are feasible numbers for a fully hydrated small protein like 
α-chymotrypsin. Similar values have been obtained for water bound to small 
proteins in the free state by molecular dynamics, X-ray and neutron diffraction [198, 
316, 317]. 
6.5 Conclusions 
The relaxation phenomena associated with immobilised enzymes interacting with 
Na+ and water were studied. The multiple-quantum 23Na NMR experiment trial run 
was sucessfully performed enabling us to move on to multiple-quantum 17O NMR 
experiments. The later experiments were also performed succesfully, providing us 
with the information required: the number of water molecules bound to the 
immobilised enzyme. The multiple-quantum techniques to follow transverse 
relaxation used in this Chapter have been proved to be useful for the evaluation of 
these systems. 
For studies of spin  I = 3/2  it was observed that the frequency-domain method is not 
an effective means to derive information from the relaxation behaviour because 
relaxation rates are falsified by  B0  inhomogeneity. The time-domain method 
provides a more reliable method for extracting information about relaxation 
phenomena. 
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Four-quantum and five-quantum evolution experiments were used to obtain 
information about the relaxation of spin  I = 5/2  in systems with 17O enriched water 
in the presence of immobilised enzyme. The decision to use this approach to measure 
transverse relaxation instead of TQF experiments was based on the simplicity of this 
method compared with the treatment for TQF for spin  I = 5/2 .  
Potentially, the motional correlation time  τ c  is a valuable parameter for investigating 
systems where the protein is in an environment of restricted motion.  However, it is 
important to keep in mind that this parameter does not reflect the “rotational” 
motion because the protein is tethered to the solid support. In this case  τ c  values are 
more likely due to fluctuation of the quadrupolar coupling. However, it is also 
possible that local motions in the protein make a contribution.  
Regarding the values of the correlation time  τ c  obtained here, the results provided 
by the TQF 23Na NMR experiments are in the timescale expected for allostery 
dynamics, which is in the range of nanosecond to millisecond. In the case of 
multiple-quantum 17O NMR experiments, the  τ c  values fall within the motional 
range for water present on the surface of the protein.  
It is possible to say, that the aim of determining the number of bound water 
molecules to immobilised enzyme was sucessfully attained. The numbers of water 
molecules per immobilised enzyme (mol/mol) obtained by 17O NMR experiments 
are plausible numbers. 
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CHAPTER 7  
 
Enzyme-Inhibitor Interaction Studies in 
Solution and in Solid State 
Molecular recognition lies at the core of any biological process. These ligand-binding 
interactions are central to numerous biological processes such as signal transduction, 
physiological regulation, gene transcription and enzymatic reactions. Ligand-binding 
interactions involve both macromolecular complexes (i.e., protein-protein and 
protein-DNA) and complexes of small molecules with macromolecules. As many 
proteins regulate these key biological processes via interactions with small 
molecules, these protein receptors are often prime targets for therapeutic agents. 
Since serine proteases are concerned in the deregulation of biological processes 
linked to many diseases, the study of their interactions with ligands has a 
significance for drug development programmes.  
In this Chapter, the accessibility of the enzyme active sites to ligands was measured 
by using two different fluorine-containing inhibitors of α-chymotrypsin. A ligand-
based NMR method (see Section 2.4.1.1) is evaluated here. Ligand examination has 
the technical advantage of not requiring labelled protein. 19F NMR has proven to be a 
powerful technique in the study of protein structure and dynamics because provides 
a relatively nonperturbing yet sensitive probe with no background signals. 
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The evaluation of the accesibility of the inhibitors to the biocatalysts provides insight 
into the enzyme-inhibitor interactions. The information extracted from these studies 
can lead to the delevopment of methods to evaluate the conformational state of the 
enzyme in the preparation and observe if the enzyme is active or not. 
The two chosen inhibitors are potassium 4-fluorophenyl trifluoroborate (PFPTB) and 
(R)-1-acetamido-2-(4-fluorophenyl)ethane-1-boronic acid (AFEB). They correspond to 
non-covalent reversible inhibitors. Reversible inhibitors are preferred in inhibition 
studies because they are generally less toxic than irreversible inhibitors and bind 
non-covalently to the active site of the enzyme.  
Inhibitors with an inhibition constant,  Kd , in the µm range are prefered over the mM 
range. The reason behind this is that the smaller the  Kd  value the greater the affinity 
of an inhibitor for its target. The first inhibitor selected (PFPTB) corresponds to an 
inhibitor with a  Kd  in the mM range. The second inhibitor used in this Chapter 
(AFEB) has a  Kd  in the µM range. It is in our interests the observation of differences 
in the spectra between two inhibitors with different  Kd . These differences can lead in 
a better understanding of how inhibitors interact with the enzyme. 
The characterisation of both inhibitors was conducted in this thesis by solution-state 
NMR (see Appendix G). The inhibitor utilised in Section 7.3 (PFPTB) was 
commercially available, as opposed to the inhibitor utilised in Section 7.4 (AFEB), 
which was synthesized by the research group of Professor Colin Gibson at the 
University of Strathclyde (more details in Appendix G.2) in collaboration with this 
project. 
Despite the focus on solid-state NMR studies of this thesis, the majority of the work 
presented in this Chapter was performed using solution-state NMR experiments on 
free enzyme. The reason behind this is that there is currently no complete 
understanding of these ligand-enzyme systems in the solution state. Therefore, better 
insight is needed into such systems before turning to immobilised enzymes in 
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presence of ligands. Solution-state NMR studies were conducted first to test the 
ligand-enzyme systems for eventual comparison with the solid-state results of 
ligand-immobilised enzyme systems. 
Approaches without the need of isotopic labelling were preferred for the reasons 
discussed in Chapter 1. The direct observation of low-field protons belonging to the 
active site of the enzyme by 1H NMR and a ligand-based approach were explored. 
7.1 Experimental details 
7.1.1.1 NMR experiments 
The solution-state NMR spectra presented in this Chapter were recorded on two 
spectrometers: a Bruker Avance 400 MHz spectrometer equipped with a narrowbore 
9.4 T and a Bruker Avance III 600 MHz spectrometer equipped with a narrowbore 
14.1 T magnet, providing 1H resonance frequencies of approximately 400 and 600 
MHz, respectively. The probe head was equipped to provide pulsed field gradients 
in the z direction. Solution samples were held in 5 mm borosilicate glass (Type 1 
Class A) NMR tubes. To prevent etching of the glass by fluoride anions released from 
the inhibitor, the samples were held inside PTFE-FEP copolymer tubes inserts. The 
studied nuclei were 1H, 19F, 11B and 13C (Table 2.1). Chemical shifts were recorded in 
ppm relative to tetramethylsilane (TMS) for 13C and 1H, trichlorofluoromethane 
(CFCl3) for 19F and trimethyl borate (C3H9BO3) for 11B. 1H NMR data were acquired 
by using a double pulsed field gradient spin echo (DPFGSE) approach to eliminate 
the solvent resonance. For the DPFGSE method, rectangular soft pulses were used 
for selective inversion at the solvent frequency together with sine-shaped gradient 
pulses (1 ms duration) in a ratio of 31:11. Further experimental details such as pulse 
sequence, pulse length, recycle delay and number of transients can be found in the 
text and figure captions.  
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The solid-state NMR spectra were recorded on a Bruker Avance III 600 MHz 
spectrometer equipped with a narrowbore 14.1 T magnet, providing a 1H resonance 
frequency of approximately 600 MHz. Samples were packed into 1.9 mm and 2.5 mm 
ZrO2 rotors and rotated at 38 kHz in a 1.9 mm MAS probe, and 20 kHz in a 2.5 mm 
MAS probe, respectively. To contain liquids inside rotors, soft silicone plugs were 
used. Further experimental details such as pulse sequence, pulse length, recycle 
delay and number of transients can be found in the text and figure captions. 
7.1.1.2 Sample preparation 
Two types of samples were studied in this Chapter: the free enzyme and the 
immobilised enzyme samples. Free enzyme samples (solution samples) were studied 
by solution-state NMR, and immobilised enzyme samples (heterogeneous samples) 
by solid-state NMR. Solution samples consisted of a solution of 1.5 mM of 
α-chymotrypsin and 20 mM CaCl2 (to avoid autolysis) with or without inhibitor 
(PFPTB or AFEB) in H2O/D2O (90:10). The concentration of PFPTB in the solution 
was 10 mM and 3 mM for AFEB. The dry immobilised (on Eupergit®) enzyme6 was 
suspended in 200 µl of a 10 mM HCl solution containing the inhibitor (PFPTB or 
AFEB) and then packed in the rotor. The same inhibitor concentration as for free 
enzyme samples was used in the immobilised enzyme samples. All samples were 
stored at 3 °C and discarded after one week in case of possible microbiological 
contamination. 
Table 7.1 summarise the composition of the samples for the different experiments 
conducted in this Chapter. 
                                                
6 The amount of biocatalyst was calculated on the basis to have a similar concentration of enzyme as 
for free enzyme (solution) samples. 
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7.2 Solution–state NMR studies of the free enzyme  
A 1H NMR spectrum of a protein of any size is a very complex piece of information 
to interpret as most of the signals overlap heavily. α–Chymotrypsin is no exception 
as can be observed in Figure 7.1, which shows data from α-chymotrypsin dissolved 
in distilled water (90% H2O/10% D2O) in the presence of CaCl27 at pH 2.3. This is the 
pH obtained after dissolution of α-chymotrypsin without pH adjustment. In this 
Chapter all samples with free α-chymotrypsin were prepared without adjustment of 
pH unless otherwise stated. 
In 1972 an exceptional discovery was made: the first direct observation of a single 
proton signal from the active site of α-chymotrypsin [161]. Since this discovery, the 
understanding of how the catalytic triad of serine proteases operates has improved 
enormously, as was discussed in Section 3.2.1. However, despite the large number of 
studies on the active site of serine proteases, questions relating to the catalytic 
mechanism have arisen recently (LBHB and ring-flip theory). A review about the 
story concerning the observation of H-bonding signals in the catalytic triad of 
chymotrypsin-like enzymes by solution-state NMR was included in Section 3.2.1.4.  
                                                
7 The effect of the presence of calcium ions for free α-chymotrypsin is mentioned in 3.2.2.2.  
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Figure 7.2a shows the expansion of the spectrum shown in Figure 7.1 for a specific 
high-frequency region of the one-dimensional 1H NMR spectrum of α-chymotrypsin 
between  δ 1H = 10 and 20 ppm, where it is possible to observe signals from protons 
bound in the enzyme active site. At low pH, it is possible to observe three signals in 
this region arising from the active site protons, two clearly resolved around  δ 1H = 18 
ppm (18.5 and 18.2 ppm) and a quite broad one at  δ 1H = 13.1 ppm. The signals 
arising in the 18 ppm region correspond to N δ1-H protons of the catalytic triad of 
α-chymotrypsin (see Figure 3.9). Bruylants et al. [318] concluded that the protonation 
state of Asp102 is responsible for the two signals observed for the His57 N δ1-H at low 
pH. Based on the change in the relative intensities of the observed signals with pH, 
they assigned the higher frequency signal to the N δ1-H proton of His57 in the 
presence of protonated Asp102 and the lower frequency signal to the same proton in 
the presence of deprotonated Asp102. The observation of these two signals in similar 
systems is not very common; the use of an extremely low pH helps in this respect. 
Table 7.1. Sample characteristics for experimental studies described in Chapter 7. 
Experiment Enzyme Inhibitor 
NMR 
configuration 
Figure 7.1, Figure 7.2a, 
Figure7.8a 
1.5 mM (20 mM CaCl2) in 
H2O/D2O (90:10) 
No Solution-state 
NMR 
Figure 7.2b, Figure 7.4, 
Figure 7.5 
1.5 mM (20 mM CaCl2) in 
H2O/D2O (90:10) 
10 mM PFPTB Solution-state 
NMR 
Figure 7.6 0.6 gr of IE on Eupergit® in 10 
mM HCl (200 µl total volume) 
10 mM PFPTB Solid-state   
NMR 
Figure 7.8b, Figure 7.9, 
Figure 7.10, Figure 7.11 
1.5 mM (20 mM CaCl2) in 
H2O/D2O (90:10) 
3 mM AFEB Solution-state 
NMR 
Figure 7.12 0.3 gr of IE on Eupergit® in 10 
mM HCl (200 µl total volume) 
3 mM AFEB Solid-state  
NMR 
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The signal at  δ 1H = 13.1 ppm corresponds to the Nε2-H proton (see Figure 3.9), 
which is known to resonate in this frequency range. This proton is possibly involved 
in fast exchange thereby causing the line broadening visible in Figure 7.2a. 
The Cε1-H proton signal of His57 reported previously by Ash et al. [194] at δ 1H = 9.2 
ppm (Section 3.2.1.4) was not possible to distinguish due to the strong background in 
that region. 
 
7.3 Interactions with potassium 4-fluorophenyl trifluoroborate 
7.3.1 Solution-state NMR studies of the free enzyme in presence of PFPTB 
 
Figure 7.1. 1H NMR spectrum of free enzyme recorded using DPFSGE sequence at  B0  = 
14.1 T (90° pulse length of 9 µ s, relaxation interval of 1.4 s, averaging 4800 transients). The 
free enzyme sample contains α-chymotrypsin (1.5 mM) with CaCl2 (20 mM) at pH 2.3. 
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In 2005, Smoum et al. [247] reported the inhibitory effect of a series of 
trifluoro(organo)borates. They observed that the inhibitory effect was much more 
potent than the effect associated with the corresponding boronic acids (Section 
3.2.2.3). One of these salts was potassium 4-fluorophenyl trifluoroborate (PFPTB) 
(Figure 7.3), which exhibited a reported inhibition constant,  Kd , of 1.84 mM for α-
chymotrypsin. 
The use of PFPTB as an inhibitor of α-chymotrypsin has been studied in this thesis. 
The characterisation of PFPTB by solution-state NMR has been conducted and 
 
Figure 7.2. 1H NMR spectra of (a) free enzyme (b) and free enzyme in presence of 10 mM 
of PFPTB (inhibitor) at pH 2.3 recorded using DPFSGE sequence at  B0  = 14.1 T (90° pulse 
length of 9 µ s, relaxation interval of 1.4 s, averaging 30000 transients).  
(a)
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Appendix G.1 summarises the NMR spectra of PFPTB and confirms that the 
structure of the commercial compound is the one expected. 
Figure 7.2 shows the 1H NMR spectra with and without PTPTB. As well as the free 
active site appearing at  δ 1H = 18.2 and 13.1 ppm in the presence of the inhibitor, two 
additional pairs of signals arise close to these two peaks. These two pairs of signals 
belong to the active site protons complexed to the inhibitor. The pair of signals 
arising at high frequency ( δ 1H = 17.6 and 17.5 ppm) are assigned to the N δ1-H 
proton, which is known to resonate in this frequency range. The pair of signals at the 
lower frequency ( δ 1H = 14.0 and 13.6 ppm) are assigned to the Nε2-H proton [234]. 
The observation of two signals for the inhibitor-chymotrypsin complex protons has 
not been reported before in the literature. This can be attributed to the difference in 
the environments of these two protons and could, for instance, be an effect associated 
with protonated and deprotonated residues arising from the very low pH used 
during these measurements (pH = 2.3) in the slow exchange regime. The signals from 
protonated and deprotonated N δ1-H sites have residence lifetimes of at least 16 ms 
and in the case of the Nε2-H proton of at least 4 ms. Further experiments, using a 
labelled enzyme, are necessary to lead to a clearer understanding of why these two 
sets of signals arise.  
From the information obtained from the proton NMR spectrum (Figure 7.2b) it is 
possible to conclude that PTPTB acts as a type 1 inhibitor (Section 3.2.2.3). This can 
be noted from the presence of N δ1-H and Nε2-H protons in the inhibitor-enzyme 
complex forming a Ser adduct (Section 3.2.2.3). Type 2 complexes can be recognised 
 
Figure 7.3. Structure of 4-fluorophenyl trifluoroborate (PFPTB). Aromatic protons are not 
included for structure simplicity. 
(a)
(c)
(b)
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through the absence of responses associated with the Nε2-H proton after the 
formation of a His adduct (Figure 3.12b).  
The 19F NMR spectrum of PTPTB in presence of α-chymotrypsin is presented in 
Figure 7.4. When compared with the 19F NMR spectrum of PTPTB (Appendix G, 
Figure G.4), it can be seen that two new signals arise in addition to the two expected 
signals related to the free inhibitor ( δ 19F = –115.5 and –137.4 ppm) at δ 19F = –109.4 
and –155.5 ppm. In accordance with this result, it is known that chymotrypsin forms 
a fraction complexed with PTPTB at approximately 1:5 enzyme:inhibitor ratio [247]. 
This is observed in the area of the peaks for the aromatic fluorine in the free and 
bound states. Conclusions cannot be drawn from the signals arising from the boron-
fluorine species. It is possible to observe that peak area ratios between boron-fluorine 
and aromatic fluorine species in the bound and free states are not proportional. This 
is probably due to the effect of the quadrupole moment of 11B. T1 relaxation effects on 
the intensities have been excluded. 
Smoum et al. [247] studied the same system, also by solution-state 19F NMR (Figure 
3.14).  They observed four signals in the spectrum of α-chymotrypsin (0.08 mM) in 
presence of PTPTB (0.6 M). Two signals were observed at δ 19F = –136 and –114 ppm 
for the –BF3 group and for the aromatic fluorine, respectively. They assumed that the 
signals observed in the one-dimensional 19F NMR data that did not belong to the free 
inhibitor, (those at δ 19F = –133 and –107 ppm) were from the complex 
inhibitor-enzyme. No additional evidence behind this conclusion is provided in the 
publication. The assignment of the signal at δ 19F = –133 ppm by Smoum et al. 
disagrees with our findings. 
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Interestingly, in the same publication by Smoum and co-workers [247], they 
postulated that there is no interaction between the fluorine in the phenyl ring and the 
catalytic triad of chymotrypsin (Figure 3.15). This postulate can be argued because it 
is well known that chymotrypsin has high specificity towards phenylalanine, whose 
aromatic ring is accommodated in a well preserved substrate recognition site of 
serine proteases, namely the hydrophobic pocket. Since PTPTB has an aromatic 
para-substituted fluorine, it is expected that two signals from this atom might be 
observed in the presence of inhibitor, one from the free state (free inhibitor) and one 
from the bound state (or enzyme-inhibitor complex).  
A two-dimensional {19F, 1H} HOESY spectrum was recorded on α-chymotrypsin in 
the presence of PTPTB (Figure 7.5). Unambiguously, the two-dimensional spectrum 
shows the spatial proximity of the N δ1-H proton from the active site to two different 
 
Figure 7.4. 19F NMR spectrum of 10 mM of PFPTB (inhibitor) in presence of 1.5 mM free 
enzyme at pH 2.3 at  B0  = 9.4 T (90° pulse length of 10 µ s, relaxation interval of 12 s, 
averaging 128 transients). WALTZ-16 was used for proton decoupling. 
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fluorine atoms. These two fluorine atoms can be assigned unequivocally as bound 
inhibitor complex signals from the fluorine atom bonded to the phenyl ring (δ 19F =   
–109.4 ppm) and from the fluorine atom bonded to the boron (δ 19F = –155.7 ppm). 
The two-dimensional {19F, 1H} HOESY spectrum (Figure 7.5) proves the points stated 
above about the disagreements with the results of Smoum et al. The signals identified 
by Smoum et al. as issuing the complex enzyme-inhibitor complex appear to have 
been incorrectly identified in one case. Our assignments for the enzyme-inhibitor 
complex only agree with the signal at −107 ppm as the aromatic fluorine resonance 
from the bound inhibitor. Possibly, Smoum et al. missed the signal at lower 
frequency at –155 ppm (see Figure 3.14) and therefore interpreted the signal at –133 
 
Figure 7.5. {19F, 1H} HOESY NMR of 10 mM of PFPTB (inhibitor) in presence of free 
enzyme at pH 2.3 at  B0  = 9.4 T. Spectra were recorded by averaging 1024 transients for 
each of the 32 t1 increments of 90 µ s (90° pulse length of 10 µ s, relaxation interval of 8.5 s). 
The 19F NMR spectrum from Figure 7.4 and the 1H NMR spectrum from Figure 7.2b have 
been used in place of the 19F and 1H projection, respectively. The mixing time , τm ,  used 
was 500 ms. WALTZ-16 was used for proton decoupling. 
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ppm as from the bound inhibitor. The signal at −133 ppm might correspond to an 
impurity in their inhibitor. 
The B-F fluorine and the phenyl ring fluorine are close to the N δ1-H proton. The 
phenyl ring of the inhibitor is probably positioned in the hydrophobic pocket. This 
pocket is part of the S1 site and close to the catalytic triad and, is therefore, close to 
the N δ1-H proton (Section 3.2.1.3). 
A fact to bear in mind is the gradual hydrolysis of PTPTB in an aqueous system. We 
observed by 19F NMR spectroscopy over time that a significant amount of fluorine 
atoms bonded to boron are hydrolysed. After four hours this effect is noticeable but 
does not affect signal intensities associated with the enzyme-inhibitor complex. 
When a borosilicate NMR tube is used in the presence of PTPTB, a very sharp peak 
appears at δ 19F = –128 ppm. This peak is assigned to hexafluorosilicic anion (SiF6−2) 
and increases over time. The first step in the etching process is the substitution of a 
surface SiOH group by a SiF group [319]. Species in which F is bonded to 
coordinated Si on the surface of the glass result from this first step. In the 19F NMR 
spectrum shown in Figure 7.4 it is possible to observe a signal at δ 19F = –143 ppm 
that must correspond to these coordinated silicon atoms, which are known to 
resonate close to this frequency [320]. There is a rapid equilibrium with free fluoride 
ions released and the fluorophile (silica in the glass) binds the free fluoride ions, 
pulling the equilibrium over towards hydrolysis. All solution-state NMR data using 
PTPTB shown in this thesis are recorded using PTFE-FEP copolymer tube inserts 
(liner) inside standard borosilicate NMR tubes to avoid unwanted signals arising 
from the interactions (etching) with the NMR tube glass.  
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7.3.2 Solid-state NMR studies of the the immobilised enzyme in presence of 
PTPTB 
Finally, after obtaining a better insight into α-chymotrypsin in the presence of PTPTB 
in the solution state by NMR, a solid-state NMR spectrum was recorded for the same 
system (Figure 7.6). It was noted that the standard MAS probe used exhibited strong 
background signals for 19F due to the construction materials. Hence, to record this 
spectrum, a pulse sequence called EASY (elimination of artefacts in NMR 
spectroscopy) [321] was utilised to eliminate these background signals. In this pulse 
sequence, two FIDs are acquired sequentially. After the acquisition of the first 
transient (it contains the wanted NMR signal and the background artefacts), the same 
experiment is repeated immediately afterwards before the T1 waiting delay. This 
second scan contains only the signal arising from the background. The artefact-free 
NMR spectrum was obtained by taking the difference of these two spectra.  
The concentration of inhibitor to immobilised enzyme was in a ratio 7:1 (similar to 
that used in the solution-state NMR experiments). 
As can be seen from the solid-state 19F NMR spectrum in Figure 7.6, free inhibitor 
signals appear at δ 19F = –115 ppm (aromatic fluorine) and –137 ppm (–BF). The 
complexed inhibitor with the enzyme appears at –109 ppm (aromatic fluorine) and at 
–149 ppm (–BF group). Fluoride anions released from the inhibitor (–120 ppm) 
appear to have triggered etching of the zirconia rotor. An almost negligible peak at   
–13 ppm (region not shown in the 19F NMR spectrum in Figure 7.6) can be attributed 
to H2ZrF6 and appears as a result of this etching reaction. Interestingly, a resonance 
at –129 ppm also appears in Figure 7.6. This can be assigned to hexafluorosilicic acid. 
The presence of silica is required for the formation of this signal to occur, as in the 
case of the borosilicate NMR tubes discussed previously. Bruker has not released 
details of the composition of their zirconia rotors but other solid-state rotor 
manufacturers have reported their composition. Doty, for instance, have reported a 
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silicon atom concentration of approximately 200 ppm in their zirconia rotors. A 
similar composition for Bruker rotors would be expected. On this basis, signals 
arising from the etching of coordinated Si species from the rotor are plausible. In a 
similar manner to the 19F NMR spectrum obtained for free enzyme in the presence of 
PTPTB (Figure 7.4), it is possible to observe a resonance at –143 ppm in the 19F NMR 
spectrum of immobilised enzyme in the presence of the same inhibitor (Figure 7.6). 
This signal is assigned to fluorine bonded to coordinated Si from zirconia rotor 
impurities. 
From the relative intensities of the signals from the free and bound aromatic 
fluorines in the spectrum shown in Figure 7.6, it is possible to say that the complex 
forms with an approximate ratio of 1:4 enzyme:PTPTB. Several factors can contribute 
 
Figure 7.6. 19F MAS NMR spectrum of 10 mM of PTPTB (inhibitor) in presence of 
immobilised enzyme recorded at  B0  = 14 T and a MAS rate of  ωR 2π  = 20 kHz, using the 
EASY pulse sequence [321] (90° pulse length of 3.1 µ s, relaxation interval of 8 s, averaging 
63488 transients). The immobilised enzyme sample is α-chymotrypsin immobilised on 
Eupergit®. 
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to the discrepancy between the ratios obtained from solution state (1:5) and solid 
state experiments. A possible reason is that an excess of inhibitor was packed in the 
MAS rotor as a result of the complications of having to work with such small 
volumes. However, the fact that the complex ratios are similar is a sign that the 
immobilised enzyme is active and the active site is accessible to the inhibitor and not 
hindered. 
7.4 Interactions with (R)-1-acetamido-2-(4-fluorophenyl)ethane-1-boronic 
acid 
7.4.1 Solution-state NMR studies of the free enzyme in presence of AFEB 
Inhibitors with high affinity to targets and thus with smaller dissociation constants, 
 Kd , are preferred over those with lower affinity and larger dissociation constants. A 
more specific inhibitor of α-chymotrypsin is 
(R)-1-acetamido-2-(4-fluorophenyl)ethane-1-boronic acid (AFEB) (Figure 7.7) with a 
dissociation constant,  Kd , of 0.6  µM [239]. Sylvia and Gerig studied this inhibitor in 
the presence of α-chymotrypsin [239, 240] (discussed in Section 3.2.2.3). They 
included the study of the effect of pH (between 8.7 and 4) on the high frequency 1H 
NMR signals from the enzyme active site. At pH = 4.0 a strong signal appears at δ 1H 
= 13 ppm together with a smaller signal at δ 1H = 18 ppm. The signals were assigned 
to Nε2-H and N δ1-H protons, respectively. A similar approach than the one proposed 
by Sylvia and Gerig [239, 240] to evaluate the interaction between chymotrypsin and 
AFEB is adopted in this Chapter to validate and confirm findings at pH 2.3.  
The characterisation by solution-state NMR of AFEB was conducted and Appendix 
G.2 summarises the NMR spectra of AFEB, confirming that the structure of the 
synthesised compound is as expected. 
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Figure 7.8b shows the 1H NMR spectrum of α-chymotrypsin in the presence of AFEB. 
Only two signals arise, at δ 1H = 13 ppm (split into two at 12.98 and 13.02 ppm) and 
13.6 ppm. The concentration of α-chymotrypsin in the measured sample, for which 
data are shown in Figure 7.8, was 1.5 mM. A two-fold excess of inhibitor was used. 
The strong peak at 13 ppm in the 1H NMR spectrum (Figure 7.8b) suggests slow 
exchange on the NMR timescale between free AFEB and that bound to the active site 
of α-chymotrypsin. The result confirms tight binding between the inhibitor and the 
enzyme. It has been previously reported that this compound forms a 1:1 
stoichiometric complex with α-chymotrypsin [240].  
The resonance at δ 1H = 13 ppm is assigned to proton Nε2-H of the free active site. A 
small signal appears next to this signal at 13.6 ppm. This resonance belongs to proton 
Nε2-H complexed with the inhibitor creating a serine adduct (Figure 3.12a). Thus 
AFEB is clearly a type 1 boronic-containing inhibitor. Interestingly, no further 
signals, those relating to proton N δ1-H, are visible to high frequency. This effect 
could be related to the low pH (2.3) in the sample and a fast exchange of this proton 
in particular. The significant difference in the signal-to-noise ratio between both 
spectra in Figure 7.8 confirms the slow rate exchange. 
As for the previous system (α-chymotrypsin in presence of PFPTB), the proton Cε1-H 
(around 9 ppm) was impossible to distinguish due to the strong 1H background 
around that region.  
 
Figure 7.7. Structure of 1-acetamido-2-(4-fluorophenyl)ethane-1-boronic acid (AFEB). 
Aromatic protons are not included for structure simplicity. 
(a)
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Figure 7.9 shows the 19F NMR spectrum of α-chymotrypsin in the presence of AFEB. 
Two signals appear, one of them at –117.6 ppm corresponding to the free inhibitor 
(Appendix G, Figure G.9) and the other at –115.4 ppm to the inhibitor bound to the 
active site of the enzyme. Approximately 25% of the inhibitor is bound to the active 
site (Figure 7.9), despite an anticipated of a ratio of 1:1 (50%) between the free and 
bound inhibitor. This discrepancy can be attributed to the presence in the sample of 
inactive enzyme with a damaged active site (around the half of the enzyme present 
in the sample). Sylvia and Gerig observed similar chemical shifts for the free and 
bound inhibitor, namely two signals with a shift separation of 2.3 ppm [239, 240]. 
Depending on the timescale of the ligand association-dissociation, information 
concerning binding kinetics and affinities can be accessed by using a variety of NMR 
techniques. In the case of slow binding kinetics, exchange spectroscopy (EXSY) can 
 
Figure 7.8. 1H NMR spectra of (a) α-chymotrypsin (1.5 mM) with CaCl2 (20 mM) and (b) 
α-chymotrypsin (1.5 mM) with CaCl2 (20 mM) and 3 mM of AFEB at pH 2.3 using 
DPFSGE sequence recorded at  B0  = 14.1 T (90° pulse length of 9 µ s, relaxation interval of 
1.4 s, averaging 4800 transients). 
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provide qualitative mapping of exchange pathways in dynamic systems., with 
separate peaks observed for each exchanging species. The most popular EXSY 
method is the NOESY-based sequence [322]. Although the mechanism of chemical 
exchange and the NOE are quite unrelated, they both share a common characteristic, 
the transfer of longitudinal magnetisation. 
Figure 7.10 shows the two-dimensional [323] EXSY NMR spectrum of 
α-chymotrypsin in the presence of the inhibitor AFEB. Diagonal peaks (–117, –117 
ppm and –115, –115 ppm) correspond to the self correlation peaks of the free and the 
bound state of the inhibitor, respectively. Off-diagonal cross-peaks (–117, –115 ppm 
and –115, –117 ppm) are produced by ligand association and dissociation during the 
mixing time,  τm .  
The spectrum in Figure 7.10 confirms that the 19F peak at –115 ppm corresponds to 
the ligand in its bound state. No additional EXSY spectra were collected as a function 
of  τm  and thus no quantitative information can be extracted relating to the 
 
Figure 7.9. 19F NMR spectrum of α-chymotrypsin (1.5 mM) with CaCl2 (20 mM) and 3 mM 
of AFEB at pH 2.3 at  B0  = 9.4 T (90° pulse length of 10 µ s, relaxation interval of 12 s, 
averaging 128 transients). WALTZ-16 was used for 1H decoupling. 
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dissociation constants or rate of exchange. Further experiments using different 
mixing times could be useful to acquire a clearer insight into the dynamics of this 
system.  
A two-dimensional {19F-1H} HOESY NMR spectrum was recorded on 
α-chymotrypsin in the presence of AFEB (Figure 7.11). No cross-peaks were observed 
in the high-frequency proton chemical shift region of the spectrum (not shown). 
Since the two-dimensional {19F-1H} HOESY NMR spectrum for α-chymotrypsin in 
the presence of PTPTB (Figure 7.5) only shows cross-peaks in the vicinity of 18 ppm 
in the 1H dimension, the situation arising in Figure 7.11 could be expected as no 
signal was found in the 18 ppm region of the 1H NMR spectrum for the 
enzyme-AFEB complex either (Figure 7.8b).  
 
Figure 7.10. Two-dimensional {19F, 19F} EXSY NMR spectrum of α-chymotrypsin (1.5 mM) 
with CaCl2 (20 mM) and 3 mM of AFEB at pH 2.3 at  B0  = 9.4 T. Spectra were recorded by 
averaging 64 transients for each of the 128 t1 increments of 33 µ s (90° pulse length of 10 µ s, 
relaxation interval of 1.5 s). The 19F NMR spectrum from Figure 7.9 has been used in place 
of the 19F projections. A mixing time,  τm , of 500 ms was used. 1H decoupling was not used. 
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Interestingly, Figure 7.11 reveals several H-F cross-peaks that lie at lower frequencies 
in the proton dimension. Cross-peaks to the bound inhibitor fluorine signal are at the 
same proton chemical shifts as the cross-peaks to the free signal, as would be 
expected for a system in which there is chemical exchange between two forms. The 
spectrum shows an intramolecular cross peak between the fluorines and the aromatic 
protons which arises at  δ(1H) = 6.8 ppm. This NOE is noticeable for the free inhibitor 
(Appendix G, Figure G.11). Cross-peaks at  δ(1H) 8.5, 4.6, 3.0 and 0.93 ppm are also 
observed in the {19F, 1H} HOESY correlation spectrum (Figure 7.11). These 
cross-peaks arise from intermolecular interactions between the enzyme and the 
inhibitor. The assignment of these protons is a difficult task since the 1H NMR 
spectrum of α-chymotrypsin has not yet been fully assigned. 
 
Figure 7.11. Two-dimensional {19F, 1H} HOESY NMR spectrum for α-chymotrypsin (1.5 
mM) with CaCl2 (20 mM) and 3 mM of AFEB at pH 2.3 at  B0  = 9.4 T. Spectra were 
recorded by averaging 1024 transients for each of the 32 t1 increments of 90 µ s (90° pulse 
length of 10 µ s, relaxation interval of 8.5 s). The 19F NMR spectrum from Figure 7.9 and the 
1H NMR spectrum from Figure 7.8b have been used in place of the 19F and 1H projection, 
respectively. The mixing time used was 500 ms. WALTZ-16 was used for 1H decoupling. 
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A simple search in the Protein Data Bank8 under the search term “chymotrypsin” 
yields more than 200 results from X-ray crystallography whereas only four from 
NMR are available. All the results for the latter are related to the protein inhibitor 
structures and none to the chymotrypsin-like enzyme structure. The structure of 
α-chymotrypsin has been completely elucidated by X-ray crystallography [168, 324, 
325] and this is possibly the main reason for the lack of interest in NMR structural 
studies on this enzyme. 
A two-dimensional {19F, 1H} HOESY NMR study of α-chymotrypsin inhibited by 
1-acetyl-4-fluorobenzyl carbazate [242] showed cross-peaks at 0.8 ppm and in the 3-5 
ppm range for protons, correlated with a single 19F peak. The publication suggests 
that these signals arise through the interaction between the fluorophenyl ring and the 
hydrophobic pocket of α-chymotrypsin. Later, in 1992, Sylvia and Gerig [239] 
detected similar interactions between AFEB and α-chymotrypsin. They observed 
cross-peaks at  δ 1H = 3.8, 4.1 and 6.9 ppm (Figure 3.13) where only the first two arise 
from intermolecular interactions.  
In Figure 7.11, an evident improvement in terms of resolution and sensitivity is 
achieved in the two-dimensional {19F, 1H} HOESY NMR spectrum of the inhibitor 
complexed to α-chymotrypsin compared with similar data obtained by Hammond 
[242] and Sylvia and Gerig [239]. In all likelihood, the majority of these cross-peaks 
observed ( δ 1H = 8.5, 4.6, 3.0 and 0.93 ppm) belong to the S1 site (Section 3.2.1.3). The 
resonance at 8.5 ppm can be assigned to backbone HN protons and the signal at 4.6 
ppm to Hα. Both could belong to Ser189, Gly216 and Gly226 from the hydrophobic 
pocket. These resonances comply with the random coil chemical shifts for these 
amino acids suggested by Wishart and Nip [326]. The cross-peak at δ 1H = 0.9 ppm 
can be assigned to methyl groups of the protein. The signal at δ 1H = 3 ppm possibly 
belongs to a Hβ  proton. Bearing in mind that this signal should belong to a proton 
                                                
8 The Protein Data Bank (PDB) is a repository for structural data of biological macromolecules.  
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close to the active site or the S1 site, one possibility is that this proton is the Hβ  
proton of His579. Further studies with a protein that has been suitably isotopically 
enriched might provide access to the confirmation of the identity of this proton. 
7.4.2 Solid-state NMR studies of the immobilised enzyme in presence of AFEB 
Figure 7.12 shows the solid-state 19F MAS NMR spectrum of α-chymotrypsin 
immobilised on Eupergit® in presence of AFEB. The concentration of inhibitor to 
immobilised enzyme was in a of ratio 2:1 (as in the solution-state NMR experiments). 
The spectrum was recorded using EASY (elimination of artefacts in NMR 
spectroscopy) [321] to eliminate unwanted signals from the background arising from 
19F in the probe structure. 
The strong signal at –117 ppm in Figure 7.12 is from the free inhibitor (AFEB). A 
high-frequency shoulder is noticeable in the expected region where the signal from 
the enzyme-inhibitor complex arises for the solution-state NMR experiment (–115 
ppm signal in Figure 7.9). This shoulder can be interpreted as the poorly resolved 
signal from the inhibitor bounded to the enzyme. One suggestion for further 
solid-state NMR experiments on this system, would be to use a probe with a smaller 
rotor size than that used to obtain the spectrum in Figure 7.12, which was 1.9 mm. If 
a smaller rotor were to be used, higher MAS rates might be attained and the 
resolution of the spectrum would be possibly be improved. For instance, a probe 
with a 1.3 mm rotor size could achieve a spinning rate of 60 kHz. However, it is 
necessary to bear in mind that there is a compromise between sensitivity and 
resolution. In general, higher spinning rates (i.e., better resolution) involve the use of 
smaller rotors and consequently a smaller volume of sample and this affects the 
                                                
9 Chemical shifts from the Biological Magnetic Resonance Data Bank [327] of Histidine Hβ protons are 
3.18 and 3.11 ppm. 
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sensitivity of the experiment (e.g., 1.3 mm rotor has a four times less sample volume 
than a 1.9 mm rotor size).  
7.5 Discussion 
It is important to raise the point that only a couple of the biophysical methods to 
evaluate binding events mentioned in Section 2.4.1.2 can be applied to immobilised 
enzyme systems (see Section 2.5.3.5). ITC has been successfully applied to studies of 
ligand interaction with immobilised enzymes [117, 118]. Another biophysical method 
used for this purpose is FAC [119, 120]. However, it is very clear that further 
development in biophysical techniques to analyse binding interactions on 
immobilised enzymes is needed.  
 
Figure 7.12. 19F MAS NMR spectrum of α-chymotrypsin immobilised on Eupergit® in 
presence of 3 mM of AFEB (Inhibitor) recorded at  B0  = 14 T and a spinning rate of  ωR 2π  
= 38 kHz, using the EASY pulse sequence [321] (90° pulse length of 2.2 µ s, relaxation 
interval of 8 s, averaging 58928 transients). 
Free
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Several NMR techniques have been developed to detect binding by monitoring the 
protein or the ligand (see Section 2.4.1.1). The majority of these techniques have only 
been applied to solution-state systems and some of them are not able to be utilised in 
solid state (e.g., diffusion experiments). Here, 19F ligand-detected and 1H 
protein-detected NMR studies were performed. Both studies exploit the simplicity of 
the use of non-isotopic labelled samples and can be applied either to non-supported 
systems (i.e., free enzyme) or to heterogeneous systems (i.e., immobilised enzyme).  
In the present research, several efforts were made to observe the active-site protons 
of immobilised enzymes by solid-state NMR. However, no signals from these 
protons were obtained. One of the possible reasons for this is the low sensitivity of 
the experiments even using the highest field magnet that is available for solid-state 
NMR in the UK (20 Tesla). One is trying to observe just a few protons in a whole 
protein; to resolve them requires very fast MAS; and yet this necessitates the use of 
very small sample volumes, as noted above. Probably, with advances in solid-state 
NMR and the use of higher fields, at some point in the future it will be possible to 
observe these high-frequency protons from the active site of serine proteases in the 
solid state. 
It is strongly advised that future studies include an analysis of enzyme kinetics for 
the systems evaluated in this thesis. These studies can be conducted by biophysical 
methods such as the measurement of initial enzymatic activity rate (see Section 4.4) 
at varying inhibitor concentrations, using non-linear regression methods to extract 
the dissociation constant ( KD ) [328]. NMR approaches can be utilised to measure this 
kinetic parameter for enzyme-ligand complexes [329]. A suitable 19F NMR approach 
for the detection of a dissociation constant in the range µM to mM is quantitative 
NOESY analysis. Scheuring et al. [330] measured the dissociation constant of a 
complex by using two-dimensional 19F NOESY experiments. Despite the fact that 
NOEs in the solid state are rare − owing to the general absence of motion on the 
correct timescale – the exploration of quantitative NOESY experiments for 
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immobilised enzymes could be an interesting approach, one which would eliminate 
the need for assembling a titration curve at different ligand concentrations. 
7.6 Conclusions 
Important information about the accesibility of inhibitors to the enzyme active site in 
the solution and the solid state was obtained. Significant insight was attained 
through the study of the enzyme in the presence of two different inhibitors using 
solution-state NMR. 
The decision taken in this thesis to study the systems using solution-state NMR 
before moving to the study of immobilised enzyme by solid-state NMR was fully 
supported by the results obtained in Section 7.3. Further clarification was achieved, 
compared with the study by Smoum et al., regarding the 19F NMR assignments for 
PFPTB in the presence of α-chymotrypsin.  
For the second inhibitor, AFEB, the assignments were in agreement with those 
obtained by Sylvia and Gerig. Better resolution and sensitivity were obtained for the 
spectra measured in this thesis compared with those of Sylvia and Gerig (1H, 19F and 
{19F -1H} HOESY NMR spectra).  
The two-dimensional HOESY experiments for both inhibitors in the presence of the 
enzyme showed how the inhibitor interacts with different regions of the active site, 
revealing a clear difference between an inhibitor with a dissociation constant,  Kd , in 
the millimolar range (PFPTB) compared with one in the nanomolar range (AFEB). 
Further experiments are necessary to better understand the cross-peak assignment 
revealed in both Sections 7.3 and 7.4. 
It was possible to interpret the solid-state 19F NMR spectrum for the 
PFPTB-immobilised enzyme complex in accordance with the solution-state results 
from the free enzyme bound with the inhibitor. 
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Unfortunately, for the second system (immobilised enzyme in presence of AFEB) it 
was not possible to obtain a resolved solid-state 19F NMR spectrum as expected. Only 
the signal for the free inhibitor (AFEB) was observed. Lack of resolution in the 
spectrum led to the observation of a shoulder for the AFEB-immobilised enzyme 
complex. 
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CHAPTER 8 
 
Summary 
The lack of guidelines governing the selection of the immobilisation method and the 
expected performance of the immobilised enzyme for a specific application seriously 
hampers the application of a rational approach to the design robust immobilised 
enzymes [331]. One of the probable reasons why this situation arises is because, as 
has been stated in earlier sections in this thesis, not many analytical tools are 
available to characterise these heterogeneous systems. To date, catalytic activity 
provides the main source of information used to evaluate immobilised enzymes.  
No single immobilisation method seems to be generally applicable if an optimised 
immobilised enzyme system is required. The immobilisation process depends on a 
broad spectrum of variables that involve the support, enzyme and medium of 
immobilisation. This intrinsic complexity is the main reason why their systematic 
study is not a straightforward task. 
NMR spectroscopy is the only structural biology method that is capable of studying 
structure and dynamics at an atomic resolution. The main goal of this thesis was to 
evaluate how informative NMR can be in the study of immobilised enzyme systems 
and the limitations of its applicability. This contribution demonstrates the fact that 
solid-state NMR provides us with a powerful tool to study these systems. Structural 
characterisation of immobilised enzymes systems (Chapter 5) and their interactions 
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with ligands (Chapter 6 and Chapter 7) by NMR were covered. However, more 
research on this topic needs to be undertaken to exploit the technique’s full potential. 
Nevertheless, incorporation of other techniques to aim for a better understanding of 
immobilised enzymes could be extremely beneficial and is strongly advised for 
future studies. Table 8.1 to Table 8.3 summarise the current methods that can be 
applied to study these heterogeneous systems.  
The characterisation of the systems10 before and after enzyme immobilisation by 
solid-state NMR was covered in Chapter 5. One of the most interesting results from 
Chapter 5 was the observation of the carbonyl groups in the immobilised enzyme by 
13C CPMAS NMR. Further characterisation of the support materials is necessary. 
These studies should attempt the quantification of pore size, carrier bound group 
and enzyme distributions for bare supports and immobilised systems, 
correspondingly.  
                                                
10 The systems are silica, alumina and Eupergit® as enzymatic supports. The characterisation also 
includes the silanisation of silica and alumina with GOPS. 
Table 8.1. Methods to measure pore size and pore size distribution of porous materials. 
Method References 
Gas Adsorption Method [126], [132] 
Mercury Intrusion Porosimetry1 [332] 
XRD2 [133] 
NMR Cryoporometry [130] 
TEM [133] 
1 Particularly good for macroporous supports 
2 Limited to regular structures such as zeolites 
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Pore size is an important factor for enzyme immobilisation. To reach high enzyme 
loading and to reduce diffusion constraints, the pore size should exceed the size of 
the enzyme [334]. Probably, for epoxide-silica systems the pore size is a controlling 
parameter for the immobilisation process, due to the high loading and activity 
obtained for these immobilised enzymes (see results in Section 5.3.1). However, if the 
pore size greatly exceeds the protein size, it may provoke another problem, namely 
diffusion constraints, when the enzyme can be too deeply embedded within the 
support particles, leading to lower retention of activity [334]. This could have 
happened in the Eupergit® systems where high loadings were obtained but 
extremely low activities were expressed (see results in Section 5.3.3). Furthermore, 
the distribution of binding sites on the carrier surface (i.e., carrier bound group 
distribution) influences the loading, activity and also the stability of the biocatalyst.  
Table 8.2. Methods for evaluating location and conformational changes on immobilised 
enzymes. 
Purpose Method References 
Location of 
immobilised 
enzyme 
Adsorption Method [79, 80] 
XRD [79] 
FTIR [333] 
Fluorescence Microscopy [81] 
TEM [82] 
Conformational 
changes on 
immobilised 
enzyme1 
CD [85, 88] 
FTIR [91-93] 
Fluorescence Spectroscopy [94-96] 
 Solid-state NMR [112]2 
1 Evaluation of the protein secondary structure 
2 References correspond to protein membrane studies 
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Some techniques that can be used for the purpose of measuring pore size and pore 
size distribution are listed in Table 8.1, with gas adsorption the most popular. 
However, an interesting approach involving the consistant use of NMR as the main 
technique would be to use NMR methods to characterise porous materials.  
NMR cryoporometry [130] and NMR relaxometry [335, 336] have been used with the 
purpose of measuring pore size distribution in porous materials such as silica gels 
[337]. NMR relaxometry is based on the fact that water molecules in pores will move 
randomly due to Brownian motion and hence the transverse relaxation time  T2  will 
be affected. Brownstein and Tarr [335] proposed a model to obtain porous 
parameters from the transverse relaxation.  
As dissolved ions (e.g., Na+) also move by Brownian motion, Rijniers et al. [339] 
showed that 23Na NMR relaxometry can be used to monitor pore size distributions in 
silica gels (i.e., Nucleosil). 23Na NMR relaxometry (e.g., CPMG experiments) can be 
explored to evaluate the supports. However, the treatment used by Rijniers et al. 
Table 8.3. Methods for evaluating interactions of immobilised enzymes with the support 
and the ligands. 
Purpose Methods References 
Enzyme-support 
interactions 
Solid-state NMR [1] 
FTIR [97-100] 
MD [99, 101-103, 106] 
ITC [338] 
Enzyme-ligand 
interactions 
ITC [117, 118] 
FAC [119, 120] 
Solid-state NMR [121-123]1 
1 References correspond for protein membrane studies 
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should be followed with caution because it is based on the assumption that the 
system does not experience a net EFG, therefore no biexponential relaxation is 
expected. These experiments could be a valuable addition to the experiments used in 
Chapter 6 where relaxation studies were conducted. The evaluation of traditional 1H 
NMR relaxometry also represents an interesting approach. 
Accessibility of the enzyme to the substrate can be deduced by information about the 
distribution and location of the enzyme within the support material. Among the 
methods used for this purpose (see Table 8.2), TEM is one of the most popular to 
literally observe enzyme location in immobilised systems. However, the solid-state 
multiple-quantum NMR experiments described in Chapter 6 were able, to some 
extent, to determine the accessibility of counter ion sites in the immobilised enzyme. 
For instance, correlation times for Na+ and labelled water decrease when the size of 
the pores increases. 
One area not explored in this thesis was the direct evaluation of conformational 
changes. Table 8.2 summarise the methods that can be used to evaluate immobilised 
enzymes in terms of conformational changes. No solid-state NMR methodology has 
been applied to immobilised enzymes so far. However, advances in the structure 
determination of labelled membrane proteins by solid-state NMR have been made in 
recent years (see Table 8.2) and these could be applied to immobilised biocatalysts if 
there is interest in using labelled enzymes in the future.  
As was mentioned earlier in Chapter 2, there are no methodologies for evaluating the 
interaction of ligands with immobilised enzymes. In Chapter 6 and Chapter 7, efforts 
to evaluate these interactions were made. Chapter 6 analyses the interaction with 
ions and water, while Chapter 7 describes the study of inhibitor interactions. The 
observation of a specific interaction with ligands can be interpreted, with a degree of 
caution, as confirmation that the protein is not unfolded and  remains in an active 
structure. 
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In Chapter 6 information about the range of motional processes related with the 
interactions of Na+ and labelled water with the immobilised enzyme was obtained by 
solid-state multiple-quantum NMR. In order to validate these results, control 
experiments with bare supports in the presence of these ligands (i.e., ions and water) 
are necessary. However, the results obtained fall inside the range of motion expected. 
In the case of Na+ (23Na), the correlation times fall within the range of allosteric 
interactions and for labelled water, the counts of water molecules fall in the range of 
water present on the surface of the protein. 
The interactions between enzyme and inhibitors were covered in Chapter 7. 
Although the main interest of this thesis was the study of immobilised enzyme 
systems, studies of free enzyme were conducted to evaluate their interactions with 
inhibitors. The reasoning behind this approach was to obtain an understanding of the 
free enzyme system first in order to better understand a more complicated system 
later: the immobilised enzyme. An improved understanding of the free enzyme in 
the presence of inhibitors was achieved − but not for immobilised systems. Our hope 
is that our efforts will provide a basis for future studies and will clarify the study of 
α-chymotrypsin in the presence of PFPTB and AFEB. Nonetheless, advances in the 
study of inhibitors interacting with immobilised enzymes were achieved: the direct 
observation of signals arising from the bound inhibitor in the solid state was 
achieved.  
The use of solid-state NMR represents one of the best options available to study 
ligand interactions in immobilised enzymes because it is a high-resolution approach, 
unlike ITC and FAC (see Table 8.3). 
The incorporation of molecular dynamics simulations for evaluating the interactions 
of ligands with enzymes or even with the surfaces of the supports could help 
tremendously in gaining a better understanding of the meaning of NMR results (e.g., 
the correlation times obtained in Chapter 6). While enzyme-surface simulations can 
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be used to aid in the design of an appropriate support material (see Table 8.3), 
applications of molecular simulation methods to studying ligand interactions in 
enzymes immobilised onto porous supports are still limited. There are problems in 
correct treatment of solid surfaces during simulations. 
Back to Figure 1.1, the diagram highlights that − currently − much of the detail of the 
state of the enzyme molecules is speculative. In this contribution our objective was to 
obtain a better insight about the state of the enzyme molecules on the support. To a 
certain extent this aim was achieved: it was possible to characterise the elements 
involved in the covalent attachment (Figure 2.10) and also, the accesibility of 
different ligands to the immobilised enzyme by NMR techniques. 
Summarising, this research has extended the current knowledge of tools for 
understanding immobilised enzymes. However, results indicate that, in the future,  
NMR will not be used in this quest as a solitary technique. The development of 
hybrid methods will certainly be the most efficient way to evaluate these 
heterogeneous systems.  
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APPENDIX A  
Technical data for supports materials 
Daiso Co, Ltd (Osaka, Japan) has kindly donated the silica supports to use in this 
project. Table A.1 summarises the main characteristics of the supports. 
Sasol Germany GmbH has provided the alumina supports. The Table A.2 
summarises the principal characteristics of the supports. 
Table A.3 summarises the principal characteristics of both types of Eupergit® 
supports. Evonik Industries has provided Eupergit® 250 L support. As a result of a 
market driven decision Eupergit® C has been discontinued several years ago and is 
no longer commercially available.  
Table A.1. Silica features.  
Commercial 
name 
Pore size / Å Particle size / 
µ m 
Specific surface 
area / (m2/g) 
Pore volume / 
(ml/g) 
Å nm 
SP-60-15P 60 6 14.0 452 0.68 
SP-100-15P 92 9.2 13.5 436 1.00 
SP-120-15P 123 12.3 15.1 335 1.03 
SP-200-15P 208 20.8 13.9 209 1.08 
SP-300-SP 291 29.1 14.2 105 0.97 
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Table A.2. Alumina features. 
Commercial 
name 
Pore size / Å Particle size / 
µ m 
Specific surface 
area / (m2/g) 
Pore volume / 
(ml/g) 
Å nm 
Pural SB-1 50 5 45 241 0.5 
Pural TH-80 80 8 45 203 not supplied 
Pural TH-100 100 10 45 157 not supplied 
Pural TH-200 200 20 45 130 not supplied 
 
Table A.3. Eupergit®  features. 
Commercial 
name 
Pore size / Å Particle size / 
µ m 
Epoxide content 
/ (µ mol/g) 
Å nm 
C 100 10 180 600 
250 L 1000 100 180 300 
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APPENDIX B  
BSA standard curve 
 
 
Figure B.1. BSA standard curve for calculation of protein concentration. Linear function: 
Absorbance=5.22 ×  Protein concentration (mg/ml)–0.0043, R2=0.998. 
!
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APPENDIX C  
Immobilisation kinetics of α-chymotrypsin 
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Figure C.1. Immobilisation kinetic of α-chymotrypsin on epoxide silica 60 Å. (a) pH 7.0 
without ammonium sulfate, (b) pH 7.0 with ammonium sulfate, (c) pH 8.0 with 
ammonium sulfate. Circles: concentration of protein in the supernatant support based on 
a function of time, triangles: amount of protein immobilised support based on a function 
of time. 
(a)
(b)
(c)
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Figure C.2. Immobilisation kinetic of α-chymotrypsin on epoxide alumina, at pH 8.0 with 
ammonium sulfate. (a) SB-1, (b) TH-80, (c) TH-100 and (d) TH-200 epoxide alumina. 
Circles: concentration of protein in the supernatant support based on a function of time, 
triangles: amount of protein immobilised support based on a function of time. 
(a)
(b)
(c)
(d)
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Figure C.3. Immobilisation kinetic of α-chymotrypsin on Eupergit®, at pH 8.0 (a) with 
ammonium sulfate (1.88 M) and (b) without. Circles: concentration of protein in the 
supernatant support based on a function of time, triangles: amount of protein 
immobilised support based on a function of time. 
(a)
(b)
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APPENDIX D  
Spin  I = 3 / 2  Frequency-Domain Lineshape 
Functions for Evolution under Relaxation 
The Fourier-Laplace Transform can be used to directly provide  and thereby to 
establish analytical frequency-domain lineshapes directly from the tensor basis 
matrix . 
The term  gives the time dependence for the interconversion of different 
forms of single-quantum coherence, including the conversion to observable 
magnetisation.  
 
 
D.1 
 
The Fourier transform of these expressions will give the frequency-domain spectrum 
for each element of the basis set. Fourier transformation of  term gives 
 F(1)(ω )
 Rtensor
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D.2 
where  is the unit matrix with the same dimension as . 
 becomes  
 
 
D.3 
Therefore, 
 
 
D.4 
With 
 
 
D.5 
The standard multiple-quantum filtration experiment allows the transverse 
relaxation function  to be measured. 
!
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a = −C(J0 + J1 + J2 ),
b = CJ2 ,
c = −C(J1 + J2 ),
 F31
(1)(ω )
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F31(1) =
6(a+ b− c)
5(a+ b− iω )(−c + iω )
= −
6C(J2 − J0 )
5(CJ1 +CJ2 + iω )(CJ1 +CJ0 + iω )
  D.6 
with a real and imaginary components, respectively 
 
 
F31(1)(ω )real =
6C(C2J02(J1 + J2 )+ J0(C2J12 −C2J22 −ω 2 )+ J2(−C2J12 −C2J1J2 +ω 2 )
5(C2J02 + 2C2J0J1 +C2J12 +ω 2 )(C2J12 + 2C2J1J2 +C2J22 +ω 2 )
  D.7 
 
 
F31(1)(ω )imaginary =
ω (2C2J02 + 4C2J0J1 + 5C2J12 + 6C2J1J2 + 3C2J22 + 5ω 2 )
5(C2J02 + 2C2J0J1 +C2J12 +ω 2 )(C2J12 + 2C2J1J2 +C2J22 +ω 2 )
 D.8 
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Mathematica routines  
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E.1. Fitting routines for triple-quantum filter experiment 
The lineshape fitting procedure routine for 23Na triple-quantum filter experiment of 
immobilised enzyme in epoxide silica with 200 Å pore size is shown below.  
 
Directory@DêUsersênicolefaureêDesktop
exp = Import@"desktopêDATA.xlsx", 8"Data", 1<D
A very large output was generated. Here is a sample of it:88-510.535, -0.132019<, 8-510.291, -0.137856<, 8-510.046, -0.143593<,
Ü4327á, 8548.697, -0.359594<, 8548.941, -0.367711<<
Show Less Show More Show Full Output Set Size Limit...
Dimensions@expD84332, 2<
ListPlot@exp, PlotRange Æ AllD
-400 -200 200 400
10
20
30
40
50
60
70
model =HaL J-J8 6 k t3 Iw0 + t2 w03M2 II1 + 4 t2 w02M Iw + t2 w w02M2 - 4 k2 t2 I4 + 12 t2 w02 + 5 t4 w04MMN íI5 I4 k2 t2 I2 + t2 w02M2 + Iw + t2 w w02M2MI4 k2 t2 I2 + 5 t2 w02M2 + w2 I1 + 5 t2 w02 + 4 t4 w04M2MMN
-J8 6 a k t3 I6.65025 ¥ 108 + 2.94113 ¥ 1026 t2M2I-4 k2 t2 I4 + 5.3071 ¥ 1018 t2 + 9.77962 ¥ 1035 t4M +I1 + 1.76903 ¥ 1018 t2M Iw + 4.42258 ¥ 1017 t2 wM2MN íI5 I4 k2 t2 I2 + 2.21129 ¥ 1018 t2M2 + I1 + 2.21129 ¥ 1018 t2 + 7.82369 ¥ 1035 t4M2 w2MI4 k2 t2 I2 + 4.42258 ¥ 1017 t2M2 + Iw + 4.42258 ¥ 1017 t2 wM2MM
w0 = 6.65025 * 108
6.65025 ¥ 108
solv = FindFit@exp, model,88a, 1712.`<, 8t, 4.663`*^-9<, 8k, 8.704`*^9<<, w, MaxIterations Æ 100D9a Æ 1686.06, t Æ 4.08676 ¥ 10-9, k Æ 8.42251 ¥ 109=
  
202 
The time-domain fitting procedure routine for 23Na triple-quantum filter experiment 
of immobilised enzyme in epoxide silica with 200 Å pore size is shown below.  
 
 
 
 
 
 
 
 
 
model2 = a *
6
5
9„R1*t - „R2*t=
: 1
5
6 a I„R1 t - „R2 tM>
sim2 = Import@"desktopêTQF200êTQF200.xlsx", 8"Data", 19, Table@i, 8i, 24, 41<D, 81, 2<<D
ListPlot@sim2, PlotRange Æ AllD980.0018, 670177.<, 80.003, 843881.<, 80.005, 873331.<,90.006, 1.00344 ¥ 106=, 90.0072, 1.02694 ¥ 106=, 80.01, 900895.<,80.0006, 348168.<, 80.015, 720924.<, 80.02, 644086.<, 80.0048, 993773.<,80.0108, 949467.<, 80.03, 487110.<, 80.04, 365774.<, 80.06, 165718.<,80.05, 277678.<, 80.08, 114910.<, 80.009, 941599.<, 80.0132, 864903.<=
0.02 0.04 0.06 0.08
200000
400000
600000
800000
1¥ 106
ManipulateB
ShowB
ListPlot@sim, PlotRange Æ AllD,
PlotBa * 6
5
9„R1*t - „R2*t=, 8t, 0, 0.1<, PlotStyle Æ Red, PlotRange Æ AllFF,8R1, -300, -50<,8R2, -100, -10<,8a, -10 * 10^7, -1 * 10^6<F
R1
R2
a
ShowBListPlot@sim, PlotRange Æ AllD,
0.020.040.060.080.10
200000400000
600000800000
1¥ 106 F
solv2 = NonlinearModelFit@sim2, model2,88a, -3.4`*^6<, 8R1, -300.`<, 8R2, -42.4`<<, t, MaxIterations Æ 100D
FittedModelB -1.27506¥106 I„-Ü18á t-„-Ü18á tM F
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The same calculations were performed using these routines for the different pore size 
systems. 
 
 
solv2@8"BestFit", "FitResiduals", "ParameterTable", "RSquared"<D:-1.27506 ¥ 106 I„-484.145 t - „-32.0238 tM,8-57.0973, -16021.8, -99779.5, 21088., 53489.6, -14704., 50988.8, -66888.3, -27846.,
25201.3, 54048.6, -753.535, 11596.4, -20948.1, 20553.6, 16529.3, 2146.65, 31535.3<,
Estimate Standard Error t-Statistic P-Value
a -2.60272¥106 90964.7 -28.6124 1.67254¥10-14
R1 -484.145 40.7222 -11.889 4.90783¥10-9
R2 -32.0238 2.0639 -15.5162 1.20293¥10-10
, 0.997222>
Show@
ListPlot@sim2, Axes Æ 8True, False<,
AxesLabel Æ 8te, None<, PlotRange Æ All, PlotStyle Æ BlackD,
Plot@Evaluate@model2 ê. solv2D, 8t, 0, 0.1<, Axes Æ 8True, False<,
PlotStyle Æ 8Black, Dashed<, PlotRange Æ AllDD
0.00 0.02 0.04 0.06 0.08 0.10
te
R1=slow
R2=fast
R2 = R2f +
Pb
Pb
R2b
R1 = R1f +
Pb
Pb
R1b
a = Evaluate@HR1 ê R2L ê. solvD
15.1183
teopt = EvaluateB LogA R2R1E
R1 - R2
ê. solvF
0.00600703
tc =
H1 ê 8L 5 * a - 9 + 25 * a2 - 58 * a + 49
6.65025 * 10^8
êê N
6.21114 ¥ 10-9
2   Fitting time domain 200 A thesis.nb
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E.2. Fitting routine for four-quantum and five-quantum evolution 
experiment 
The fitting procedure routine for 17O four-quantum evolution experiment of 
 
model1 = a * ⅇR*t
{a ⅇR t}
sim1 = Import["dropbox/NMR experiments/Relaxation/17O/TQF10017O.xls",{"Data", 3, Table[i, {i, 3, 12}], {2, 3}}]
ListPlot[sim1, PlotRange → All]
2. × 10-6, 794 400., {0.00003, 689500.}, {0.00006, 589700.}, {0.000102, 385100.},{0.00013, 420300.}, {0.00016, 293 200.}, {0.000202, 175 300.},{0.00023, 230100.}, {0.000302, 130 500.}, {0.000402, 90 970.}
0.0001 0.0002 0.0003 0.0004
200000
400000
600000
800000
solv1 = FindFit[sim1, model1, {{a, -1.18`*^6}, {R, -500}}, t, MaxIterations → 100]{a → 815729., R → -6140.64}
solv2 = NonlinearModelFit[sim1, model1,{{a, -1.18`*^6}, {R, -500}}, t, MaxIterations → 100]
FittedModel 815729. ⅇ-6140.64 t 
solv2[{"BestFit", "FitResiduals", "ParameterTable", "RSquared"}]
815729. ⅇ-6140.64 t, {-11371.8, 11014.8, 25 367.6, -50941.1,
53139.7, -12186.9, -60662.4, 31412.2, 2809.62, 21870.7},
Estimate Standard Error t- Statistic P- Value
a 815729. 29664.5 27.4985 3.29835×10-9
R -6140.64 418.393 -14.6767 4.56196×10-7 , 0.994117
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immobilised enzyme in epoxide silica with 100 Å pore size is shown below.  
The fitting procedure routine for 17O five-quantum evolution experiment of 
immobilised enzyme in epoxide silica with 100 Å pore size is shown below.  
 
model1 = a * ⅇR*t
{a ⅇR t}
sim1 = Import["dropbox/NMR experiments/Relaxation/17O/TQF10017O.xls",{"Data", 4, Table[i, {i, 3, 10}], {2, 3}}]
ListPlot[sim1, PlotRange → All]
0.00001, 4.925 × 106, 0.00101, 3.07 × 106,
0.00201, 2.193 × 106, 0.00301, 1.418 × 106, 0.00401, 1.053 × 106,{0.00501, 826300.}, {0.00601, 547 200.}, {0.00701, 400 000.}
0.001 0.002 0.003 0.004 0.005 0.006 0.007
1×106
2×106
3×106
4×106
5×106
solv1 = FindFit[sim1, model1, {{a, -1.18`*^6}, {R, -500}}, t, MaxIterations → 100]
a → 4.82515 × 106, R → -388.739
solv2 = NonlinearModelFit[sim1, model1,{{a, -1.18`*^6}, {R, -500}}, t, MaxIterations → 100]
FittedModel 4.82515×106 ⅇ-388.739 t 
solv2[{"BestFit", "FitResiduals", "ParameterTable", "RSquared"}]
4.82515 × 106 ⅇ-388.739 t,{118576., -188 330., -15 858.6, -79 410.3, 37 888.6, 138 144., 80 691.6, 83 748.6},
Estimate Standard Error t- Statistic P- Value
a 4.82515×106 110641. 43.6109 9.73073×10-9
R -388.739 15.6068 -24.9083 2.75595×10-7 , 0.997892
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Finally, α  and  τ c  were evaluated for this system. 
The same calculations were performed using this routine for the different pore size 
systems. 
 
 
Show[
ListPlot[sim1, Axes → {True, True},
AxesLabel → {τm, Relative intensity}, PlotRange → All, PlotStyle → Blue],
Plot[Evaluate[model1 /. solv1], {t, 0, 0.008}, Axes → {True, False},
PlotStyle → {Purple, Dashed}, PlotRange → All]]
0.002 0.004 0.006 0.008
τm
1×106
2×106
3×106
4×106
5×106intensity Relative
0.000 0.002 0.004 0.006 0.008
τm
α = EvaluateR 	 -6140.64035589877`
 /. solv1
0.0633059
tc = 15*(1-α)+ (5 (1-α) (45-13 α))16 α7.24125 * 10^8 // N
7.3169 × 10-9
2     ftd 5Q 100 17O.nb
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APPENDIX F  
List of chemicals 
The information about the chemicals used in each section of the experimental 
Chapter (Chapter 4) is detailed in this Appendix. If a chemical is used in more than 
one section, it has been described only once (by appearance order). 
F.1. Quantification of Epoxides Groups  
Table F.1 shows the chemicals used in Section 4.1. 
Table F.1. List of chemicals used in quantification of epoxides groups. 
Substance Chemical formula Purity (%) Supplier 
Crystal violet C25H30N3Cl 90 Sigma-Aldrich 
Perchloric acid HClO4 72 Sigma-Aldrich 
Acetic acid CH3CO2H 99.85 (glacial) Sigma-Aldrich 
Acetic anhydride (CH3CO)2O 98 Sigma-Aldrich 
Tetraethylammonium 
bromide 
(C2H5)4N(Br) 98 Sigma-Aldrich 
Potassium hydrogen 
phtalate 
C8H5KO4 99 Alfa Aesar 
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F.2. Protein Analysis, immobilised protein determination and evaluation 
of immobilised enzyme 
Table F.2 shows the chemicals used in Sections 4.2, 4.3 and 4.5. 
 
 
Table F.2. List of chemicals used in Protein analysis, immobilised protein determination 
and evaluation of immobilised enzyme. 
Substance Chemical formula Purity (%) Supplier 
Bovine serum 
albumin 
- 96 Sigma-Aldrich 
Coomassie 
brilliant blue G-
250 
C47H48N3NaO7S2 99 Thermo Scientific 
Ethanol CH3CH2OH 95 Acros Organics 
Orthophosphoric 
acid 
H3PO4 85 Acros Organics 
Potassium 
phosphate 
monobasic 
KH2PO4 98 Sigma-Aldrich 
Potassium 
phosphate 
dibasic  
K2HPO4 98 Sigma-Aldrich 
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F.3. Enzyme activity determination and evaluation of immobilised 
enzyme 
Table F.3 shows the chemicals used in Sections 4.4 and 4.5. 
Table F.3. List of chemicals used in enzyme activity determination and evaluation of 
immobilised enzyme. 
Substance Chemical formula Purity (%) Supplier 
N-Acetyl-L-tyrosine ethyl 
estermonohydrate (ATEE) 
C13H17NO4 ×  H2O 99 Sigma-Aldrich 
Tris(hydroxymethyl)amino 
methane (Tris base) 
C47H48N3NaO7S2 99.9 Sigma-Aldrich 
Hydrochloric acid CH3CH2OH 95 Acros Organics 
Calcium chloride CaCl2 96 Sigma-Aldrich 
α-Chymotrypsin from 
bovine pancreas (type II) 
- 85 Sigma-Aldrich 
Sodium hydroxide  NaOH 98 Sigma-Aldrich 
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F.4. Immobilisation procedure 
F.4.1 Activation of Support 
Table F.4 shows the chemicals used in Section 4.5.1. 
 
 
 
 
Table F.4. List of chemicals used in activation of support. 
Substance Chemical formula Purity (%) Supplier 
Silicon dioxide SiO2 - Daiso 
Aluminium oxide Al2O3 - Sasol 
Toluene C6H5CH3 99.5 Acros Organics 
3-
Glycidoxypropyl-
trimetoxhysilane 
(GOPS) 
C9H20O5Si 98 Sigma-Aldrich 
Tetrahydrofuran 
(THF) 
C4H8O 99 Fluka 
Methanol  CH3OH 99.8 Sigma-Aldrich 
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F.4.2 Covalent binding of the Enzyme 
Table F.5 shows the chemicals used in Section 4.5.2. 
 
Table F.5. List of chemicals used in covalent binding of the enzyme. 
Substance Chemical formula Purity (%) Supplier 
Ammonium sulfate C13H17NO4 ×  H2O 99 Sigma-Aldrich 
Sodium acetate CaCl2 96 Sigma-Aldrich 
Sodium chloride - 85 Sigma-Aldrich 
Silica gel with moisture 
indicator (blue) 
SiO2 (CoCl2) 97 (≤  1) Sigma-Aldrich 
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F.5. Nuclear magnetic resonance 
F.5.1 Solution-state NMR 
Table F.6 shows the chemicals used in Section 4.7.1 and Chapter 7. 
 
Table F.6. List of chemicals used in solution-state NMR. 
Substance Chemical formula Purity (%) Supplier 
Deuterium oxide D2O 99.8 Sigma-Aldrich 
Dimethyl sulfoxide-d6 (CD3)2SO 99.9 Sigma-Aldrich 
Potassium 4-
fluorophenyltrifluoroborate 
FC6H4BF3K 95 Sigma-Aldrich 
R-1-acetamido-2-(4-
fluorophenyl)ethane-1-
boronic acid 
C10H13BFNO3 - 
Prof Gibson, 
University of 
Strathclyde 
Tetramethylsilane Si(CH3)4 99.5 Sigma-Aldrich 
Trichlorofluoromethane CFCl3 99.5 Sigma-Aldrich 
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F.5.2 Solid-state NMR 
Table F.7 shows the chemicals used in Section 4.7.2, Chapter 5, Chapter 6 and 
Chapter 7. 
Table F.7. List of chemicals used in solid-state NMR. 
Substance Chemical formula Purity (%) Supplier 
17O enriched water H217O 99 Cambridge isotope 
laboratories 
Adamantane C10H16 96 Sigma-Aldrich 
Polytetrafluoroethylene 
(PTFE) 
(CF2CF2)n 85 Sigma-Aldrich 
Kaolinite SiO2/Al2O3 100 Sigma-Aldrich 
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APPENDIX G  
Characterisation of inhibitors by solution-
state NMR 
G.1. Potassium 4-fluorophenyl trifluoroborate 
The characterisation and confirmation of the structure of a commercial PFPTB 
(Figure 3.11d) was conducted by solution-state NMR. The sample was dissolved in 
90% DMSO/10% DMSO-d6. The concentration of inhibitor in the NMR tube was 5 M. 
Figure G.1 shows the notation used for the proton and carbon assignment. Figure G.2 
shows the 1H NMR spectrum of PFPTB where two triplets are present. The signal at 
6.8 ppm is assigned to the pair of protons closer to the single fluorine atom (H2) and 
the signal at 7.3 ppm to the pair of protons closer to boron (H1). These assignments 
were confirmed with the two-dimensional {19F, 1H} HOESY spectrum (Figure G.3). 
The mixing time,  τm , for the free inhibitor was optimised by observing a maximum 
in signal intensity, with a  τm  value of around 8 seconds being found. The 
two-dimensional {19F, 1H} HOESY spectrum of PFPTB (Figure G.3) provides a very 
clear interpretation of the intramolecular NOE between the fluorine atoms and 
protons of the inhibitor. 
The 19F NMR spectrum of PFPTB is presented in Figure G.4. It can be seen from this 
spectrum that the NMR results confirm the two different fluorine atoms present in 
the inhibitor. The high frequency resonance (–118.3 ppm) is assigned to the fluorine 
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atom bonded to the phenyl group and the low frequency signal (–138.7 ppm) to the 
fluorines that are bonded to the boron atom. 
The 13C NMR spectrum of the inhibitor is shown in 2.5. The high concentration (5 M) 
of sample allows a well resolved spectrum to be obtained. The doublet at high 
frequency with an isotropic chemical shift of 161 ppm is assigned to the carbon 
bonded to the single fluorine (C4) and the broad resonance at 146 ppm to the carbon 
bonded to the boron atom (C1). Carbon atoms from the phenyl ring arise at 133 and 
113 ppm, with these signals corresponding to the pair of carbons closer to the single 
fluorine (C3) and to the boron atom (C2), respectively. 
Figure G.6 provides the 11B NMR spectrum of PFPTB that agrees with the chemical 
shift expected for a boron atom bonded to a fluorine atom at 3 ppm. 
G.2. (R)-1-acetamido-2-(4-fluorophenyl)ethane-1-boronic acid 
 (R)-1-acetamido-2-(4-fluorophenyl)ethane-1-boronic acid (AFEB) (Figure 3.11b) is 
presently not commercially available. Professor Colin Gibson and one of his 
students, James Campbell, from University of Strathclyde collaborated in the 
synthesis of AFEB. Basically, the synthetic path followed was the one reported by 
Martichonok and Jones [340]. The characterisation by solution-state NMR confirms 
the structure and a purity of around 50 mol % from the 11B NMR spectrum (Figure 
G.7). The low purity of the inhibitor synthesised did not affect our experiments.  
 
Figure G.1. Structure of 4-fluorophenyl trifluoroborate (PFPTB). 
H1
H1H2
H2
C1
C2
C2C3
C3
C4
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Figure G.2. 1H NMR spectrum of potassium 4-trifluorophenyltrifluoroborate (5 M in 90% 
DMSO/10% DMSO-d6) at  B0  = 11.75 T (90° pulse length of 11 µ s, relaxation interval of 0.5 
s, averaging 16 transients). 
 
Figure G.3. {19F, 1H} HOESY NMR spectrum of potassium 4-trifluorophenyltrifluoroborate 
(5 M in 90% DMSO/10% DMSO-d6) at  B0  = 9.4 T. Spectra were recorded by averaging 
1024 transients for each of the 16 t1 increments of 310 µ s (90° pulse length of 10 µ s, 
relaxation interval of 8.5 s). WALTZ-16 was used for proton decoupling. The 19F NMR 
spectrum along the F2 dimension corresponds to the spectrum shown in Figure G.4 and the 
1H NMR spectrum along F1 dimension to the spectrum shown in Figure G.2. 
H1 H2
δ2 (19F ppm)
δ 1
 (1
9 F
 pp
m
)H2
H1
BF
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Because of the restrictive amount of AFEB synthesised (only 25 mg), the 
characterisation by solution-state NMR was performed using a realtively low 
concentration (3 mM). 
Figure G.8 shows the notation used here for the proton and carbon assignment. The 
1H NMR spectrum is provided in Figure G.10. The signal at 2.0 ppm is assigned to 
the H1 protons, 2.4 ppm to H3, 2.7 ppm to H4, 7.0 ppm to H6, 7.2 ppm to H5 and 9.0 
ppm to H2. 
The 19F NMR spectrum (Figure G.9) shows a single peak at –117 ppm as expected 
from the fluorine atom in the phenyl ring. 
Figure G.7 presents the 11B spectrum of AFEB where it is possible to observe two 
signals. It was expected that only one resonance would be observed for this nucleus. 
In the last step of the synthesis BCl3 is used to hydrolyse and remove a protecting 
group. It seems not all BCl3 was removed. The presence of this compound does not 
affect the system of study, therefore no further purification was conducted. The 
resonance at 11 ppm is assigned to BCl3 and the high frequency signal (19 ppm) to 
AFEB. 
 
Figure G.4. 19F NMR spectrum of potassium 4-trifluorophenyltrifluoroborate (5 M in 90% 
DMSO/10% DMSO-d6) at  B0  = 11.75 T (90° pulse length of 10 µ s, relaxation interval of 12 
s, averaging 16 transients). WALTZ-16 was used for proton decoupling. 
BF
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The two-dimensional {19F, 1H} HOESY spectrum of AFEB shows only one cross-peak 
signal, corresponding to the intramolecular NOE between the H6 protons and the 
fluorine atom (Figure G.11).  
The concentration used was not enough to record a one-dimensional 13C experiment 
with a decent signal-to-noise ratio therefore an indirect through-bond technique was 
applied. Figure G.12 shows the two-dimensional {1H, 13C} HSQC spectrum where F2 
represents 1H dimension and F1 13C. The presence of a variety of cross-peaks is 
noticeable. The cross-peaks from left to right are assigned to H1-C1, H3-C3, H4-C4, 
H6-C7 and H5-C6. 
  
 
2.5. 13C NMR spectrum of potassium 4-trifluorophenyltrifluoroborate (5 M in 90% 
DMSO/10% DMSO-d6) at  B0  = 11.75 T (90° pulse length of 7.5 µ s, relaxation interval of 15 
s, averaging 1024 transients). WALTZ-16 was used for proton decoupling. 
C4
C1
C3
C2
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Figure G.8. Structure of (R)-1-acetamido-2-(4-fluorophenyl)ethane-1-boronic acid. 
 
Figure G.7. 11B NMR spectrum of R-1-acetamido-2-(4-fluorophenyl)ethane-1-boronic acid 
(3 mM in 90% H2O/ 10% D2O) at  B0  = 9.4 T (90° pulse length of 12.2 µ s, relaxation interval 
of 0.5 s, averaging 4096 transients). 
 
Figure G.6. 11B NMR spectrum of potassium 4-trifluorophenyltrifluoroborate (5 M in 90% 
DMSO/10% DMSO-d6) at  B0  = 9.4 T (90° pulse length of 10 µ s, relaxation interval of 2 s, 
averaging 4 transients). 
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Figure G.9. 19F NMR spectrum of R-1-acetamido-2-(4-fluorophenyl)ethane-1-boronic acid 
(3 mM in 90% H2O/ 10% D2O) at  B0  = 9.4 T (90° pulse length of 10 µ s, relaxation interval 
of 12 s, averaging 16 transients). 
 
Figure G.10. 1H NMR spectrum of R-1-acetamido-2-(4-fluorophenyl)ethane-1-boronic acid 
(3 mM in 90% H2O/ 10% D2O) at  B0  = 9.4 T (90° pulse length of 12 µ s, relaxation interval 
of 2 s, averaging 16 transients). 
H1
H3H4H5 H6
H2
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Figure G.12. {1H, 13C} HSQC NMR spectrum of AFEB (3 mM in 90% H2O/ 10% D2O) at  B0  = 
9.4 T. Spectra were recorded by averaging 128 transients for each of the 128 t1 increments 
of 30 µ s (90° pulse length of 12 µ s, relaxation interval of 2 s). 
 
Figure G.11. {19F, 1H} HOESY NMR spectrum of 
R-1-acetamido-2-(4-fluorophenyl)ethane-1-boronic acid (3 mM in 90% H2O/ 10% D2O) at 
 B0  = 9.4 T. Spectra were recorded by averaging 128 transients for each of the 8 t1 
increments of 57 µ s (90° pulse length of 10 µ s, relaxation interval of 8.5 s). WALTZ-16 was 
used for proton decoupling. 
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